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ABSTRACT 
In the nematode genus Anisakis, nine species are currently genetically recognized among which 
Anisakis simplex (s. s.) and Anisakis pegreffii have been recognised to be relevant for humans as a 
result of their zoonotic role in causing the disease, Anisakiasis. In addition to infection with this 
parasite, Anisakis can also cause allergic sensitisation. To date, A. simplex allergens have been 
described to represent the largest number for any parasite nematode accepted by the WHO/IUIS 
nomenclature committee. However, few data exist on the existence of such proteins in the sibling 
species, A. pegreffii. A. pegreffii has been reported as the causative agent of invasive anisakiasis in 
Europe, Japan and South Korea. It is reported as the most widespread anisakid species known to 
affect commercial fish from Mediterranean waters. Studies on A. pegreffii and identification of 
molecules released at the interface of host-parasite relationship are of crucial importance and may 
provide a basis for designing better novel diagnostic and therapeutic strategies. 
A detailed review on the current knowledge regarding Anisakis spp, particularly A. simplex, and its 
immunogenic proteins is presented in Chapter 1. This chapter presents an understanding of the current 
status on the increasing number of Anisakis simplex molecules identified to attack key pathways in 
the mammalian immune system. Through phylogenetic analysis, relationships of these proteins with 
homologs in other nematodes and invertebrates are presented and major A. simplex allergenic protein 
structures were modelled. This provides the foundation for further investigation of these proteins and 
their presence in A. pegreffii, and further guides their biological and genomic explorations.  
Chapter 2 describes the materials and methods generally used in this study while Chapter 3 follows 
up on the information provided in Chapter 1 on A. simplex immunogenic proteins. These proteins 
were investigated in A. pegreffii using high throughput mass spectrometry (LC/MS-MS). This 
method analysed and identified proteins present in the crude extract (CE) as well as 
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excretory/secretory (ES) products of A. pegreffii. The results obtained showed that over 90 % of 
allergenic and immunogenic proteins identified in A. pegreffii proteome have also been described in 
A. simplex. Furthermore, most of the proteins identified in A. pegreffii ES (~80%) were found to be 
homologs of proteins in the ES of other helminths. The results of this chapter therefore emphasizes 
the cryptic speciation of the two sibling species, A. simplex and A. pegreffii, as well as affirming the 
notion that parasites employ a conserved set of proteins for parasite–host interaction mechanisms and 
host immune response evasion. Furthermore, the result from this chapter also suggests the probable 
absence of allergy-reducing molecules in A. pegreffii, which may be a contributing factor as to why 
Anisakis nematodes are able to elicit overt hypersensitivity reactions (allergy); in addition to 
inducing a Th-2 biased immune response.  
One of the main discoveries in the proteomic analysis of A. pegreffii CE and ES in chapter 3 was the 
observation that a number of proteins identified as part of A. pegreffii ES molecules in this study 
were not predicted to be secreted molecules. This raised the thought that such proteins must have 
reached the exterior or released by novel or alternative mechanisms, Hence, Chapter 4 was initiated 
to investigate and identify by LC-MS/MS, the exosomes of A. pegreffii and their cargo content. 
Abundant round-shaped materials with the expected size of exosomes were obtained after 
ultracentrifugation and they were visualized by transmission electron microscopy (TEM). Among the 
proteins identified were key exosome markers which include Heat Shock protein (HSP)-70, enolase 
and elongation factor 1-alpha. The result from this chapter constitutes the first report of the existence 
and composition of exosome-like vesicles in the L3 larvae of the parasite, A. pegreffii. The identified 
structures appear to play critical role in transportation of immunomodulatory and allergenic proteins 
such as leucine aminopeptidase (LAP) and tropomyosin (TM), respectively. In addition, high 
portions of proteins enriched in A. pegreffii exosomes were implicated in carbohydrate metabolism, 
indicative that the parasite's main energy source is probably derived from carbohydrate metabolism. 
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Exosomes might be involved in transporting proteins needed for this function within the parasites 
and to the host for parasite survival. These proteins are stabilized against degradation by 
encapsulation within vesicles. It is demonstrated in this study for the first time, that parasite 
exosomes contain high concentrations of allergens, including the pan-allergen tropomyosin, 
providing evidence for the route of allergic sensitisation to live parasites. The result of this chapter, 
suggests that the secretion of certain proteins in this parasite, follow non-conventional pathways. 
Chapter 5 investigates, through immunoproteomic analysis, proteins from the CE and ES of A. 
pegreffii that are cross-reactive with serum IgE antibody of confirmed shellfish allergic patients. In 
the ES, we identified 2 different reactive proteins that satisfied the criteria for putative cross-reactive 
allergens as defined for this study and these were fructose bisphosphate aldolase 1 and enolase. In 
the CE, these proteins were also identified- tropomyosin as fructose bisphosphate aldolase 1 and 
enolase. Tropomyosin, one of the three proteins identified, had been previously described as a cross-
reactive allergen in both shellfish and Anisakis parasite. The two other novel putative cross- reactive 
allergens described in this chapter are proteins with close homologues in fish. 
Finally, in Chapter 6, a protease, leucine aminopeptidase (LAP) reported to be implicated in 
immunomodulation in other helminths, was characterized. LAP of Anisakis was cloned, expressed 
and purified by IMAC in a bacterial host. The activity of the enzyme was investigated and its 
location in A. pegreffii determined using histochemical methods. This protease was found 
predominantly in the gut lumen of A. pegreffii and in addition was shown to interact with cathepsin 
proteases by cleaving in particular, the inactivated cathepsin L5 of Fasciola hepatica and releasing 
the activated form. The result of this study depicts Anisakis LAP as a protein of interest in 
immunomodulatory activities and further investigation of this enzyme as a potential therapeutic 
candidate could be explored. 
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In summary, the results of this study highlights the proteins that are enriched in the proteome of A. 
pegreffii and the mechanisms employed  by this parasite to release secreted molecules to sites of 
activity. It also demonstrates that A. pegreffii secretes specific sets of proteins that are preserved 
against degradation by being enclosed within vesicles. In addition, putative cross-reactive allergens 
were defined for A. pegreffii and an immunogenic protein (LAP) was characterized. Opportunities 
for further exploitation of the proteins identified in A. pegreffii, in a therapeutic context, are provided 
by the results of this study. 
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1.1 Introduction 
This review aims to provide an overview of the current status of knowledge regarding Anisakis 
species, and their immunogenic proteins. Anisakis species are marine parasitic nematodes, of which the 
larvae are considered to be the most important biological hazards present in “seafood” products. 
Accidental consumption of raw, undercooked, or improperly processed (e.g. marinated) seafood 
infested by the third stage larvae (L3) of Anisakis spp. causes a parasitic zoonosis, known as 
anisakidosis.  
In this review, firstly, the history, classification, current distribution, life cycle, larval burden and 
economic impact on fish, as well as risk factors of infection in humans, are discussed. This is followed 
by the description of disease (Anisakiasis) and the complications caused by this parasitic nematode, 
the probable reason for prevalence of allergic conditions associated with this disease, diagnosis, 
management, and control of the disease. Thirdly, the review describes the immunogenic proteins of 
Anisakis and excretory/secretory products. Secretory products are molecules secreted from cells or 
glands with particular biological functions. On the contrary, excretory products are metabolic products 
released from the body. Both may sometimes be difficult to distinguish from one another and they vary 
from one parasite to another (Ditgen et al., 2014) . Hence, the term ES describes molecules actively 
secreted by helminths and by-products that are released during physiological processes (White and 
Artavanis-Tsakonas, 2012, Hewitson et al., 2009). These molecules are known to play important roles 
in inducing a Th2-skewed immune response, and are known to consist of regulatory and anti-
inflammatory components as well.  
In addition, this review emphasizes the importance of proteomic and bioinformatics analysis in the 
study of the excretory/secretory products (ES) of parasites. Finally, the review summarises the current 
status of allergenic and immunogenic proteins described so far in A. simplex, as well as addressing 
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proteins with immunogenic relevance, which are not necessarily allergens in Anisakis spp. In this 
review, gaps in the current understanding of immunogenic proteins identified in the food-borne 
parasite, A. pegreffii are identified, which has resulted in the rationale for this study. 
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1.2 History of Anisakis spp 
Anisakis spp. is a parasite with worldwide distribution. It is a nematode which belongs to the Phylum 
Nemathelmintes, Class Nematoda, Ascarida order, suborder Ascaridina, subfamily Anisakinae, 
superfamily Ascaridoidea and Anisakidae family. This family includes the genera Pseudoterranova, 
Contracaecum, Hysterothylacium and Anisakis (Smith and Wootten, 1978). The Anisakis genus was 
created from the genus Ascaris Linnaeus as a subgenus, in 1845, by Felix Dujardin (Dujardin, 1845). 
The name Anisakis was coined from two Greek words ‘anis’ (which means ‘different’) and ‘akis’ 
(which means ‘spine’ or ‘spicule’). Dujardin named this new subgenus ‘Anisakis” as he stated that the 
new subgenus consisted of species which have males with unequal spicules. Phylogenetic studies have 
shown that the human parasite most closely related to Anisakis is Ascaris (Blaxter et al., 1998). 
Anisakis spp, are parasitic nematodes, known to have complex life-cycles involving a number of 
different hosts, including squid and fish as paratenic or intermediate hosts, while having marine 
mammals such as seals as final definitive hosts (Ubeira et al., 2000, Akbar and Ghosh, 2005).  
1.3 Anisakid nematode classification 
Anisakis is found worldwide, but are differentially distributed geographically and employ different 
host species (Jabbar et al., 2013). The larvae of Anisakid nematodes were classified into two types, 
Anisakis type 1 and II by Berland (Berland, 1961). The classification was based on some of their 
morphological features, which include presence, or absence of mucron at the tail tip and the length of 
the ventriculus. However, due to lack of precise detailed characteristics for species identification using 
morphological features, molecular tools such as the sequencing of the internal transcribed spacer (ITS) 
region of ribosomal DNA, allozyme analysis and polymerase chain reaction coupled with restriction 
fragment length polymorphism have been employed to allow species-specific identification (Shamsi et 
al., 2009, Umehara et al., 2006, Iglesias et al., 2008). Several studies have shown that the first and 
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second internal transcribed spacers (ITS-1 and ITS-2) of nuclear ribosomal DNA (rRNA) provide 
appropriate genetic markers for anisakid species identification irrespective of their stage of 
development (Jabbar et al., 2013, Jabbar et al., 2012, Shamsi et al., 2011). In addition, PCR-coupled 
mutation scanning of the ITS-1 and/or ITS-2, integrated with targeted sequencing (Gasser et al., 2006)  
and phylogenetic analysis furnishes a powerful approach for investigating  the genetic composition of 
populations of anisakid (Jabbar et al., 2013, Jabbar et al., 2012).  
Using molecular approaches therefore, identifying Anisakid nematodes to the species level and 
revealing cryptic species has been made possible (Mattiucci and Nascetti, 2006, Mattiucci et al., 2008). 
With these molecular approaches, the genus Anisakis has been described to comprise two major 
clades; the first clade includes the A. simplex-complex (A. simplex sensu stricto [s.s.], A. pegreffii, A. 
simplex C) as well as A. typica and two sister-species A. nascettii and A. ziphidarum (Mattiucci et al., 
2014). The second clade consists exclusively of the A. physeteris- complex (A. brevispiculata, A 
paggiae, A. physeteris) (Kuhn et al., 2011, Mattiucci et al., 2014). Both A. simplex-complex and A. 
physeteris-complex are considered cryptic species, distinguishable only by means of molecular 
analyses as well as slight morphological differences (e.g. tail length/total body length ratio; spicule 
length) (Mattiucci et al., 2014, Chen et al., 2008). A. simplex and A. pegreffii have been reported as the 
most important zoonotic species of the genera Anisakis . The other genera in the subfamily Anisakinae, 
collectively known as the anisakids, are Pseudoterranova, Contracaecum and Hysterothylacium 
(Nieuwenhuizen and Lopata, 2013).  
1.4 Current distribution of Anisakis spp. 
Anisakis simplex s.s. has exclusively been recorded by means of molecular methods from hosts in the 
northern hemisphere, mainly in the Atlantic and Pacific Ocean, whilst Anisakis pegreffii is predominant in 
the southern hemisphere and the Mediterranean Sea  (Kuhn et al., 2016, Ceballos-Mendiola et al., 2010, 
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Martin-Sanchez et al., 2005, Mattiucci and Nascetti, 2008, Mattiucci et al., 2008). According to Kuhn 
et al (Kuhn et al., 2016), an accumulation of occurrences along Japanese coastal waters has also been 
observed for A. pegreffii, and this was explained to likely be as a result of increased economic research 
interests in potential harmful organisms in commercially highly significant and often consumed raw 
fish species. In addition, Anisakis pegreffii has also been identified to have a distribution along the 
North American West Coast, between South America and the Antarctic Peninsula, as well as South 
Africa and New Zealand.  
1.5 Anisakis natural life cycle 
Anisakis eggs hatch in sea water and the larvae developing from the eggs are eaten by crustaceans 
(copepods, decapods, isopods, amphipods, and euphausiids) with molluscs. It is known that the most 
important first intermediate hosts in the Anisakis life cycle are the Euphasiids (Krill) (Smith and 
Wootten, 1978). Infected krill eaten by fish or squid becomes a source of Anisakis for the fish or squid. 
The Anisakis larvae encyst on the intestines and other visceral organs of these intermediate hosts; the 
parasite does not develop further and remains at the third stage of the larvae development (L3 stage). 
The life-cycle comes to a completion when such infected fish/squid are eaten by marine mammals 
such as whales, seals and dolphins. In these definitive hosts, the larvae grow to the L4 stage and 
subsequently to the adult stage. The nematode feeds, grows, mates and then release eggs in the host 
faeces into the sea water (Pozio, 2013). 
As it is common among parasites with complex life cycle, the morphology of Anisakis varies with the 
different stages in which it is found and the host it infects. In fish, it is found in a coiled shape, which 
when uncoiled, is about 2cm long. As shown in figure 1.1, humans become accidental hosts when 
undercooked or raw fish and cephalopods, contaminated with the parasite, Anisakis, are consumed.  
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Figure 1.1: The life cycle of Anisakis spp. 
(Source: http://www.dpd.cdc.gov/dpdx) 
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1.6 Larval burden and economic impact of Anisakis in fish  
The repeated transfer of larvae among fish may result in the extensive accumulation of larvae, 
particularly in large and older fish (Chou et al., 2011). These fish hence, can harbour hundreds or 
thousands of encapsulated larvae and thus increase the probability of infecting other fish and 
subsequently humans. It is thought that most species of cephalopods and fish can potentially harbour 
these marine parasitic nematodes as 200 fish and 25 cephalopods species have been identified to act as 
hosts for Anisakis spp (Abollo et al., 2001). However, prevalence has also been associated with the 
biology and the feeding behaviour of these intermediate hosts.  
Recently, the prevalence of infection among cephalopods and fish is reported to be on the increase and 
among factors that may contribute to this is the increased attention focused on this parasite and its 
public health importance. From a public health point of view, migration to the muscles of the fish by 
these parasites (depending on the condition of the fish after they are caught and the time between death 
and evisceration) may result in higher number of larvae in the muscles, which is the part of the fish 
that is consumed by humans (Pozio, 2013). A high prevalence of Anisakis larvae have been found in 
species of fish, crustaceans and cephalopods that are commercially important (Vidaček et al., 2009), 
decreasing the commercial value of fish and impacting human health. This has resulted in economic 
and public health concerns with regards to Anisakis and its infection (Smith and Wootten, 1978, 
Audicana et al., 2002). 
1.7 Risk factors of infection in human  
The most commonly implicated species of Anisakis in human infections are A. simplex, A. pegreffii 
and Pseudoterranova spp (Chai et al., 2005). There is frequent diagnosis of this parasite infection in 
countries where it is common for humans to ingest raw or lightly cooked fish infected with L3 larvae 
(Pozio, 2013). Consumption of undercooked or marinated fish, such as Japanese sushi and sashimi, 
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Scandinavian gravlax (dry, cured salmon), Dutch salted or smoked herring, Hawaiian lomilomi salmon 
(raw salmon), Spanish boquerones en vinagre (pickled anchovies), Filipino kinilaw (chopped, 
marinated fish), Latin American ceviche (raw fish seasoned with lemon juice), Italian  raw anchiove, 
(traditionally served with vinegar sauce without prior freezing), and Spain ungutted sardines (charcoal-
grilled) are risk factors of infection with this zoonotic parasite (Alonso-Gomez et al., 2004, Chai et al., 
2005).  
1.8 Anisakis human infection (Anisakiasis) 
Anisakiasis is the infection caused by the consumption of raw or partially cooked fish contaminated 
with the third stage larvae (L3) of Anisakis (Bucci et al., 2013). Anisakiasis was first described in the 
Netherlands (van Thiel et al., 1960). The symptom in the patient was acute localized enteritis of 
terminal ileum. Surgical operation showed a small nematode penetrating the mucus membrane. The 
larva was identified as Anisakis simplex 3rd-stage larva. Since then, several cases of this zoonotic 
infection have been described in other countries (Bucci et al., 2013).  
Two main mechanisms are reported to be responsible for Anisakiasis: allergic reactions and direct 
tissue damage (Choi et al., 2009). The allergic reactions range from urticaria and angioedema to life-
threatening anaphylactic shock, usually associated with gastrointestinal symptoms (Choi et al., 2009). 
Allergic reactions may occur subsequent to the primary infection of Anisakis and exposure to allergens 
in the food. Invasion of the gut wall by the parasite sometimes results in development of eosinophilic 
granuloma or perforation, which causes direct tissue damage (Choi et al., 2009). The part of the 
digestive tract in which Anisakis larvae is lodged, after consumption of raw or lightly cooked fish 
infected with L3 larvae and the type of Anisakis spp ingested, determines largely the clinical 
manifestation of Anisakiasis observed. Penetration of the gastric mucous results in inflammation, 
which gives rise to some of the symptoms (Valls et al., 2003). Anisakis can cause gastrointestinal 
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infection, which may be classified as acute, chronic, ectopic or allergic reactions (Bucci et al., 2013). 
Gastric infections have been reported mostly in Japan while in Europe, intestinal diseases are more 
commonly reported (Hochberg and Hamer, 2010). 
Over 20,000 cases of Anisakiasis had been reported worldwide prior to 2010 and over 90% of these 
were from Japan and the remaining cases from Italy, Netherlands, Spain, Germany, Asia and South 
America (EFSA BIOHAZ, 2010). 
1.8.1 Gastric Anisakiasis 
Gastric anisakiasis usually develops from 1 to 8 hours after ingestion of raw fish (Park et al., 2008). It 
presents with a sudden onset of pain in the epigastric region of the gut and it is accompanied by nausea 
and vomiting. Expulsion of live larva through the nose or mouth may occur (Ramanan et al., 2013). 
This acute anisakiasis usually involves the stomach and sometimes mimics angina-like chest pain 
(Machi et al., 1997).  It is known to completely resolve upon removal of the ingested larvae within 12 
h of consumption by upper endoscopy (Bucci et al., 2013).  
1.8.2 Intestinal Anisakiasis 
Enteric anisakiasis may sometimes take up to a few days to develop in contrast to gastric anisakiasis 
(Park et al., 2008). Intestinal anisakiasis (including duodenal anisakiasis) causes direct damage to the 
gut wall. In many cases of intestinal anisakiasis, the terminal ileum is involved (Shirahama et al., 1992, 
Repiso Ortega et al., 2003). Symptoms are presented as constant or intermittent abdominal pain, 
vomiting or diarrhoea and sometimes fever. These symptoms are usually seen 5-7 days after seafood 
ingestion (Hochberg and Hamer, 2010). Misdiagnosis is common with intestinal anisakidosis because 
of the non-specific nature of the symptoms. It has been misdiagnosed as Crohn’s disease, appendicitis 
and colon cancer (Ramanan et al., 2013). Localization of A. simplex in the intestinal wall presents the 
chronic form of Anisakiasis. In this form, symptoms would usually persist for months with weight 
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loss, abdominal cramp, diarrhoea and may present with difficulty in diagnosis. In the chronic stage, 
larvae may cause formation of granuloma (Pozio, 2013).  
1.8.3 Ectopic or Extraintestinal Anisakiasis 
Ectopic anisakiasis is less common than the other forms of anisakiasis  (Nawa et al., 2005). In some 
cases, the larvae are able to migrate to other organs or in the peritoneal cavity presenting symptoms 
related to the organs in which they are localized. Penetration into the peritoneal cavity or other visceral 
organs (extraintestinal anisakiasis) by larvae may cause eosinophilic granuloma, which may be 
confused with neoplasm (Nawa et al., 2005).  It may also result in haemorrhagic ascites (Akbar and 
Ghosh, 2005).  Tonsillar and laryngeal ansiakiasis, where the larvae migrate up into the tonsils from 
the back of the oesophagus, has been reported (Bhargava et al., 1996, Kwak and Yoon, 2012). 
Pulmonary anisakiasis resulting from anisakid entry into the pleural cavity through penetration of the 
diaphragm causing eosinophilic pleural effusion has also been described (Saito et al., 2005, Matsuoka 
et al., 1994). 
1.8.4 Gastroallergic Anisakiasis 
The allergic form presents within hours of consumption of infected undercooked fish and may result in 
cases of hypersensitivity reactions, urticaria, angioedema, anaphylactic shock and chronic debilitating 
conditions (Fernandez de Corres et al., 1996, Bucci et al., 2013). 
Sometimes, concurrent gastrointestinal symptoms may also be present (Choi et al., 2009). High levels 
of IgE specific to A. simplex characterises allergic anisakiasis (Caballero and Moneo, 2002). Though 
rare, it has however been shown that allergic reactions could present as autoimmune pancreatitis, 
nephrotic syndrome, allergic gingivostomatitis, intractable chronic pruritus or rheumatic disease 
(Eguia et al., 2003, Gallo et al., 2012, Pezzilli et al., 2007, Meseguer et al., 2007, Cuende et al., 1998).   
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Bronchial hyperactivity and dermatitis have been associated with Anisakid sensitization in fish-
processing workers (Nieuwenhuizen et al., 2006). Many Anisakis allergens are resistant to degradation 
by the digestive enzyme pepsin, implying immunological reactions might occur after exposure to 
Anisakis antigens alone (Audicana et al., 2002). There are also some cases where consumption of 
cooked or canned fish appears to have led to Anisakis-specific allergic reactions (del Pozo et al., 1996). 
Hence, Anisakiasis disease shows an interesting interaction between allergic response and parasitic 
infections even though both do not usually intermingle inspite of having many facets of immune 
responses that are similar (Nieuwenhuizen and Lopata, 2013). 
1.8.5 Anisakiasis complications 
Anisakiasis sometimes presents as a disease with few specific manifestations but then mimics other 
disease conditions (Yeum et al., 2002). In the stomach, chronic gastric anisakidosis usually occurs as a 
result of an inflammatory response to dying larvae and may mimic peptic ulcers, gastric cancer or 
chronic gastritis (Hwang et al., 2012, Hochberg and Hamer, 2010). Sometimes patients presents with 
pneumoperitoneum and gastric perforation (Ito et al., 2007). A few reports exists of the discovery by 
endoscopy, of Anisakis worm at the base of a gastric ulcer (Takeuchi et al., 2000).  
Intestinal anisakiasis may present as eosinophilic gastroenteritis (Gomez et al., 1998). However, it has 
been reported that eosinophilic granuloma formation around the larvae sometimes presents as a tumor 
or intestinal obstruction (Montalto et al., 2005, Ishii et al., 2009). Colonic anisakiasis has been reported 
to sometimes simulate a tumor of the colon, since this infection is associated with edema, acute 
phlegmonous reaction, and/or granuloma formations around the larvae, which results in a mass effect 
thereby resulting in misdiagnosis as a colon cancer (Matsumoto et al., 1992).  
Other complications of Anisakiasis include a case of duodenal anisakiasis associated with duodenal 
ulcer (Hwang et al., 2012), diagnosis of spontaneous spleen rupture and appendicitis secondary to 
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Anisakis simplex infection (Valle et al., 2012). In another report by (Rushovich et al., 1983), a patient 
presented with symptoms resembling those of acute appendicitis, and was found to have an 
inflammatory omental mass as a cause of his illness. Subsequent examination showed that the omental 
mass contained Anisakis larvae (Rushovich et al., 1983). The florid inflammatory response released by 
the host as a result of the penetration of  the larva(e) through the intestinal wall was thought to have 
resulted in the death of the parasite (Rushovich et al., 1983). 
1.9 Probable reason for the high prevalence of clinically overt allergic conditions 
in Anisakiasis 
While all patients with the different forms of gastric or intestinal anisakiasis produce specific IgE, the 
high prevalence of clinically overt allergic conditions in Anisakis spp parasitism has been suggested to 
be due to the fact that humans are not a natural host for this parasite, and parasitism by Anisakis is only 
acute or ‘intermittent’ (repeated acute parasitism by Anisakis). Hence, differences may be expected 
between the pathogenesis of Anisakis compared to those of other helminths in humans.  
In addition, more than 90% of Anisakiasis cases described have been reported to be caused by a single 
larva (Audicana and Kennedy, 2008), as compared to helminths in which numerous larvae are required 
for established infections. The chronicity and the burden of helminth infection are considered essential 
factors with regards to protection against allergy. In a study performed in Venezuela, it was shown that 
individuals with heavy infection by helminths were less likely to have a positive skin test to house dust 
mite (HDM) (Lynch et al., 1987). Symptoms of allergy improved after anti-parasitic treatment in 
lightly infected individuals but became worse in those who were heavily infected (Lynch et al., 1993). 
This study showed that a heavy parasitic infection protects against allergy whilst a light exposure to 
helminths lead to increase in airway symptoms due to potentiation of Th2 responses (Ndiaye and 
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Bousquet, 2004). Due to this factor, it is suggested that Anisakis may lack immunoregulatory features 
typical of other chronic helminthiasis. 
1.10 Anisakis short-term infection  
It has been reported that anisakiasis is usually a self-limiting disease, which is cured by conservative 
management for 1 to 2 weeks after the onset of symptoms (Hwang et al., 2012). A. simplex L3 is not 
known to survive in vivo beyond 3 weeks post infection. This cannot be explained solely by the fact 
that humans are accidental hosts for this parasite. Rather, differences in the immunological-inducing 
properties of this nematode from other helminth parasites must be taken into account.  
Toxocara canis, an ascaridoid parasite has been reported to be able to avoid the damaging effects of 
cellular component type of inflammatory responses associated with tissue-invading helminths, by a 
rapid sloughing off of the areas of its cuticle in contact with the immune response, hence, it is 
continuously releasing surface antigens (Deardorff et al., 1991). This may explain the ability of T. 
canis infective juveniles to evade the host’s immune attack and complete its complex tissue migration 
through all organs in the hosts’ body. In contrast, it has been established that A. simplex L3 do not 
slough their cuticle and macrophages are able to degrade the Anisakis cuticle. The inability of Anisakis 
to slough the cuticle and also escape the deleterious effect of adherence of macrophages in vivo, may 
be a contributing factor to the short-time infection period of Anisakis spp in human hosts (Deardorff et 
al., 1991). 
1.11 Anisakiasis diagnosis 
The diagnosis of anisakiasis can be made in several ways: (1) by endoscopic examination, which may 
reveal an ulcerated bleeding lesion within the stomach or duodenum, at the centre of which may be a 
worm measuring approximately 2 to 2.5 cm by 1 to 2 mm. Recently, a capsule endoscopy 
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demonstrated small intestine anisakiasis out of  reach of fibre endoscopy (Nakaji, 2009).  (2) By 
barium studies, which may show narrowing of the intestinal lumen in areas with mucosal 
inflammation, a thread-like filling defect suggestive of a worm on imaging studies in some cases 
(Matsui et al., 1985); and (3) serial measurement of specific and total IgE when it is not known if the 
presence of specific IgE is due to a past infection or is associated with the present case (Daschner et 
al., 1999). 
Imaging may be useful in guiding the diagnosis although standard X-ray is non-specific. However, 
localized stenosis as a result of focal edema may be shown by small-bowel X-ray (Matsui et al., 1985). 
When history and clinical suspicion are integrated with sonography, an easy and inexpensive 
alternative, that is noninvasive and with high sensitivity, is provided (Matsui et al., 1985).  
1.12 Anisakiasis management/treatment 
Since treatment for acute anisakiasis is dependent on endoscopic removal of the nematode parasite 
from the gastrointestinal wall if performed within 12 h from time of ingestion, it has been suggested 
that this parasitosis should be considered in the accident and emergency department (Bucci et al., 
2013). Where the larvae are not removed, the disease can become chronic as the larval remains 
become surrounded by inflammatory cells, which permits Anisakiasis disease to mimic other diseases 
(Audicana et al., 2002). Treatment with anthelminthics has also been reported as there are some reports 
of albendazole or thiabendazole treatment in isolated cases of human anisakiasis (Pacios et al., 2005). 
1.13 Control measures to minimise Anisakiasis 
Storage, after-harvest handling and fish preparation are the focus of preventive measures. Migration of 
larvae into the muscle might be prevented by immediate evisceration of fish after being caught, thus 
reducing the zoonotic potential of the parasite. However, since this immediate cleaning may most 
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likely be done at sea, with the high possibility of removed contaminated viscera being thrown back 
into the sea and eaten by other fish, the prevalence of infection may actually be heightened 
(McClelland et al., 1990). 
Fish intended for raw or semi-raw consumption have been recommended to be frozen at -35˚C or 
below for 15 hours or at -20˚C or below for at least 7 days by the United States Food and Drug 
Administration (F.D.A., 2011). However, it has been noted that fish freezing does not prevent the 
occurrence of allergic reactions. Anisakid larvae are known to be resistant to marinating, cold-smoking 
and salting. They have also been shown to survive being microwaved. Hence, for consumption at 
home, it is recommended that fish is cooked until the core temperature reaches 60˚C or higher for a 
minimum of 10 minutes (Sakanari and McKerrow, 1989). 
1.14 Immunogenic proteins of Anisakis and the Excretory/Secretory System 
Several proteins associated with allergens and antigenicity have been discovered in Anisakis spp. 
Anisakiasis, in many cases, leads to IgE-mediated allergic reactions such as urticaria, angioedema, 
asthma and sometimes even anaphylaxis in highly sensitized persons (Daschner and Pascual, 2005). 
Ventura and colleagues (Ventura et al., 2008) highlighted three possible antigen sources of A. simplex 
that are responsible for an immune response in the parasitized host  (1) somatic antigens with a 
molecular mass of between 13 and 150 kDa (2) Secretory/excretory proteins (ES antigens) that allow 
the penetration of A. simplex into the gastric mucosa (Sakanari and McKerrow, 1990) and (3) 
superficial antigens present in the parasite cuticle, which are likely involved in chronic inflammation 
(Baeza et al., 2001).   
Parasites are known to be masterful modulators of the immune systems of their hosts. They are known 
to divert host responses to their own advantage (Tritten et al., 2017). The excretory/secretory 
molecules released by parasites have been identified as major contributors in the host-parasite 
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interaction (Tritten et al., 2017) and are known as significant players in immunomodulation. Several 
parasite-derived proteins have been demonstrated to induce a Th2-biased immune response, in 
combination with regulatory and anti-inflammatory components (Harnett, 2014, Ditgen et al., 2014). 
ES products have several functions during infection, and these include host tissue penetration and host 
immune response evasion as they elicit immune responses (including antibody production) both in fish 
and mammals (Mehrdana and Buchmann, 2017). 
Anisakis infection of human hosts is not an exception. It involves complex interactions mediated by 
excretory/secretory (ES) products (Bahlool et al., 2013). ES proteins from anisakid nematodes, in 
particular Anisakis simplex, are currently used for diagnostic purposes and recent evidence suggests 
that they may also have a therapeutic potential in immune-related diseases (Mehrdana and Buchmann, 
2017). 
1.15 Integration of bioinformatics and proteomic tools in identifying 
immunogenic proteins 
Scientific research has changed in recent years, mainly due to the completion of numerous genomes in 
addition to the development and application of high-throughput technologies including gene 
expression microarrays and mass spectrometry. This has also brought about new and increasing 
opportunities to enhance our knowledge of biological systems (Uloa and Rodriguez, 2008). 
Proteomics is the large scale identification and characterization of all expressed proteins in a given cell 
(in a given state). This includes all protein modifications and isoforms, protein interaction networks, 
and high order complexes of proteins (Uloa and Rodriguez, 2008). An important advancement in 
proteomics has been achieved by the integration of bioinformatics tools to analyze the results of those 
experiments (Uloa and Rodriguez, 2008). In the last few decades, the isolation and identification of a 
potential allergenic/immunogenic molecule of an organism or tissue includes protein component 
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extraction, extracted protein separation and detection. (Mari et al., 2010). Advances in mass 
spectrometry-based proteomics now enable the measurement of multiple properties for thousands of 
proteins, including their isoform expression, turnover rate, abundance, subcellular localization, 
interactions and post-translational modifications (Larance and Lamond, 2015). Together, these 
advances in the multidimensional analysis of the proteome are transforming our understanding of 
various cellular and physiological processes (Larance and Lamond, 2015). The helminth secretomes 
have become a rich source of novel drug targets, diagnostic markers and immunomodulatory proteins  
(Ditgen et al., 2014). The proteomic analysis of many helminths has been performed on a large scale 
using both bioinformatics and proteomics, including the secretome of Ascaris suum (Jex et al., 2011) 
and Brugia malayi (Bennuru et al., 2009). Little data exists on large scale analysis of the secretome of 
Anisakis spp, particularly A. pegreffii, which is further explored in this study. 
1.16 Described allergens of A. simplex  
In an investigation carried out by Faeste and colleagues (Faeste et al., 2014) in which potential 
allergens were characterized using sera from A. simplex-sensitized patients and proteome data obtained 
by mass spectrometry, a considerable number of the detected A. simplex proteins could be classified 
into 33 allergen families. According to the authors, the classification was only made with respect to 
specific peptide sequence motifs and domains and is without prejudice to the actual allergenicity of the 
respective proteins. Another study by Arcos et al. (Arcos et al., 2014) using proteomic assay, identified 
twenty-eight different allergenic proteins in Anisakis spp. Recently, a transcriptome study of both A. 
simplex and A. pegreffii was performed by Baird et al. (Baird et al., 2016) using comparative analyses 
with sequence data available in public databases. Thirty-six (A. simplex) and 29 (A. pegreffii) putative 
allergens were identified.  
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Of all these allergens described for A. simplex (Baird et al., 2016, Faeste et al., 2014, Arcos et al., 
2014), fourteen of them have been accepted in the International Union of Immunological Societies 
(IUIS) database. The method and accession numbers of all protein sequences described, in this chapter 
to infer evolutionary relationship between Anisakis spp. proteins and homologues from other 
organisms, are detailed in the method section. 
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Table 1.1: List of Allergens of A. simplex in IUIS Database. 
 
Name Protein Name Molecular 
Weight 
(kDa) 
Organism References 
Ani s 1  Ani s 1 21 A. simplex (Moneo et al., 2000) 
Ani s 2 Paramyosin 100  A. simplex (Perez-Perez et al., 2000) 
Ani s 3 Tropomyosin 33 A. simplex (Asturias et al., 2000a) 
Ani s 4 Cystatin 9 A. simplex (Rodriguez-Mahillo et al., 2007, Moneo 
et al., 2005) 
Ani s 5 SXP/RAL-2 15 A. simplex (Kobayashi et al., 2007) 
Ani s 6 Serine protease inhibitor 7 A. simplex (Kobayashi et al., 2007) 
Ani s 7 Ua3 recognized allergen 139 A. simplex (Rodriguez et al., 2008) 
Ani s 8 SXP/RAL-2 16 A. simplex (Kobayashi et al., 2007) 
Ani s 9 SXP/RAL-2 15 A.simplex (Rodriguez-Perez et al., 2008) 
Ani s 10 Not given 23 A.simplex (Caballero et al., 2011) 
Ani s 11 Not given 30 A. simplex (Kobayashi et al., 2011) 
Ani s 12 Not given 33 A. simplex (Kobayashi et al., 2011) 
Ani s 13 Haemoglobin 37 A. simplex (Gonzalez-Fernandez et al., 2015) 
Ani s 14 New major allergen 23.5 A. simplex (Kobayashi et al., 2015) 
Note: Allergens accepted in the International Union of Immunological Societies (IUIS) Database. 
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1.16.1 Ani s 1 Protein (Serine Protease Inhibitor) 
Ani s 1 (a serine protease inhibitor), is described as a major allergen from A. simplex. It is an 
excretory/secretory gland protein (Quiazon et al., 2013b) and the first Kunitz-type protease inhibitor to 
be purified from a nematode. It was demonstrated to be a major allergen because it is recognized by 
sera from more than 80% of Anisakis-allergic patients (Kobayashi et al., 2008). The amino acid 
sequence of Ani s 1 lacks similarity to other known allergenic proteins (Moneo et al., 2000) This may 
explain the absence of cross-reactivity (Moneo et al., 2000). In addition, Ani s 1 has no similarity to 
other A. simplex serine protease inhibitors but was found to be homologous to troponin C of 
Onchocerca volvulus (Arrieta et al., 2000). The native function of Ani s 1 of A. simplex is still 
unknown. The modeled structure of Ani s 1 is shown in Figure 1.2A. This protein was found to have a 
functional EF-hand Ca2+ binding motif (Arrieta et al., 2000). The phylogeny of Ani s 1 with 
homologous proteins from other nematodes and invertebrates shows Ani s 1 of both A. simplex and A. 
pegreffii clustered closest to major allergen of Ani s 1 homologue of Toxocara canis (Figure 1.2B).  
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Figure 1.2.  Ani s 1-modelled structure and phylogenetic tree. 
 
(A). A. simplex Ani s 1-modelled structure. (Model Template PDB ID:  1bik.1A, Sequence 
identity- 28 %; SWISS-MODEL platform) (B) A. simplex Ani s 1 – Molecular evolutionary 
relationship with homologous proteins. 
1.16.2 Ani s 2 (Paramyosin) 
Ani s 2, also named paramyosin (100kDa), is known to be a somatic antigen. It is a highly conserved 
protein found in the muscle of invertebrates. Kagawa et al. (Kagawa et al., 1989) suggested it has an 
alpha helical-coiled structure as described for C. elegans. It has been reported to behave as a strong 
immunogen in a number of infections caused by Dirofilaria, Taenia, Schistosoma and Onchocerca 
(Grandea et al., 1989b, Steel et al., 1990, Laclette et al., 1991). Native paramyosin (n-paramyosin) 
from the fish parasite A. simplex has been reported to exhibit 80% specific IgE-binding as compared 
with only 20% reactivity with its recombinant form (rParamyosin) (Perez-Perez et al., 2000). 
According to Perez-Perez et al. (Perez-Perez et al., 2000), possibilities that may exist to explain this 
difference include the presence of conformational epitopes in the n-paramyosin, which is absent in the 
r-paramyosin as a result of improper protein folding (Perez-Perez et al., 2000). The modeled structure 
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of Ani s 2 is shown in Figure 1.3A. The phylogenic tree (Figure 1.3B) shows close evolutionary 
relationship between paramyosin proteins of A. simplex, A. pegreffii, A. suum and T. canis.  A closer 
relationship between the paramyosin (Der f 11) of house dust mite (HDM) [Dermatophagoides 
pteronnysinus] and the paramoysin of some helminths was observed in the phylogenetic tree. It has 
been established that HDM antigens are major causative agents of allergic diseases such as asthma, 
rhinitis, conjunctivitis, and atopic dermatitis (Acevedo and Caraballo, 2011, Valmonte et al., 2012); 
and some antigens have been shown to be commonly shared between intestinal parasites and the 
environment. This may play a role in the modulation of allergic immune responses resulting in a 
growing interest in the investigation of cross-reactivity between common helminths and dust mites 
allergy diseases affecting humans (Valmonte et al., 2012). 
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Figure 1.3.  Ani s 2-modelled structure and phylogenetic tree. 
 
(A). A. simplex Ani s 2 modelled structure. (Model Template PDB ID 5tby.1.A, Sequence 
identity- 18 %; SWISS-MODEL platform) (B) A. simplex Ani s 2 - Molecular 
evolutionary relationship with homologous proteins.  
 
1.16.3 Ani s 3 (Tropomyosin) 
Ani s 3 is a heat stable somatic allergen and has an alpha helical protein coiled-coil secondary 
structure. Anisakis tropomyosin belongs to a family of phylogenetically conserved structural proteins. 
The amino acid sequence has regions of high percentage identity among and between different 
invertebrate and vertebrate tropomyosins (Asturias et al., 2000a, DeWitt et al., 2004, Jenkins et al., 
1998). Tropomyosin is associated with muscle contraction in invertebrates and is found to be present 
in low concentrations in mite bodies and extracts. The invertebrate tropomyosins cause allergy in 
humans with high IgE cross-reactivity and, therefore, are referred to as pan-allergens (Aki et al., 1995). 
A B
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It is also known as an important source of cross-reactivity between Anisakis and other invertebrates, 
suggesting clinical relevance of the immunological cross-reactivity of Ani s 3 (Sereda et al., 2008). 
Allergic cross-reactivity between Anisakis and the domestic mites A. siro and L. destructor has been 
reported, in which tropomyosin was implicated (Johansson et al., 2001). Hence it is not surprising to 
see their relatedness in the phylogenetic tree shown in Figure 1.4B.  Tropomyosin has also been 
implicated in the cross-reactivity between mites and human parasites (Acevedo et al., 2009). Hence, 
sensitization to mite tropomyosin could be a marker of previous exposure to parasites, and other 
allergens and vice versa. The modeled structure of Ani s 3 is shown in Figure 1.4A. Phylogenetic 
analysis (Figure 1.4B) shows Ani s 3 clustering closest to the tropomyosin of A. lumbricoides and Loa 
loa. It is also interesting to note from the phylogeny that tropomyosin of mites (A. siro, D. farina, B. 
tropicalis, L. destructor) cluster closer to tropomyosin of crustaceans (crab-P. sanguinoletus and 
lobster-J. lalandii). Studies have demonstrated that allergens from snails, crustaceans, cockroaches, 
and others cross-react with house dust mite allergens (Johansson et al., 2001). 
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Figure 1.4.  Ani s 3-modelled structure and phylogenetic tree. 
 
(A). A. simplex Ani s 3 modelled structure. (Model Template PDB ID 1c1g; Sequence identity- 
59 %; SWISS-MODEL platform) (B) A. simplex Ani s 3 - Molecular evolutionary relationship 
with homologous proteins. 
 
 
 
  
A
B
Ani s 3
Chapter 1 
27 
 
1.16.4 Ani s 4 (Cysteine protease inhibitor) 
Ani s 4 was identified from A. simplex and defined as an allergen of somatic origin. It has however, 
also been identified as a significant component of the ES products of A. simplex. It is a low molecular 
weight protein, which is characterized by high stability to pepsin-digestion, heat and freezing. It is 
recognised by only 27–30% of patients’ sera, but seems to be particularly important in provoking 
anaphylaxis in allergic consumers (Moneo et al., 2005). Although Ani s 4 is classified as a minor 
allergen (< 50% IgE sero-positivity), it is considered an important allergic protein due to its clinical 
relevance in being implicated in allergic reactions after eating well-cooked or canned fish (Rodriguez-
Perez et al., 2008). Figure 1.5A shows the modelled structure of Ani s 4. The phylogeny of Ani s 4, 
shown in Figure 1.5B, indicates Ani s 4 clusters closest to the cysteine protease inhibitor (CPI) of 
Halioitis discus hannai (abalone) and Loa loa (filarial nematode of humans). 
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Figure 1.5.  Ani s 4-modelled structure and phylogenetic tree. 
 
(A). A. simplex Ani s 4 modelled structure. (Model Template PDB ID 4it7.1.A; Sequence identity- 
53 %; SWISS-MODEL platform) (B) A. simplex Ani s 4 - Molecular evolutionary relationship with 
homologous proteins. 
 
 
A B
Ani s 4
Chapter 1 
29 
 
1.16.5 SXP/RAL-2 family Protein Allergens in Anisakis (Ani s 5, Ani s 8, Ani s 9) 
The SXP/RAL-2 family of proteins have been detected exclusively in nematodes infecting both plants 
and animals (Jones et al., 2000, Chandrashekar et al., 1994, Tytgat et al., 2005a). Apparently, 
homologs of these proteins have not been identified outside the Nematoda.This family of proteins are 
hence termed ‘nematode-specific proteins.’ The SXP/RAL-2 family contains the DUF 148 domain, 
which consists of two conserved motifs, SXP-1 and SXP-2; however the functions of these domains 
are unknown. A number of members of this protein family have been described as immunologically 
active proteins (Tytgat et al., 2005a). They are known to have a signal peptide indicative of a secreted 
protein and they have also been reported to be secreted on the surface of the nematode’s cuticle where 
they appear to carry out a structural or protective function (Tytgat et al., 2005b). Some of these 
proteins have been identified as targets for nematode vaccines due to the protection they conferred 
upon immunization (Fujiwara et al., 2007). Members of this protein family in nematodes include the 
immunodominant hypodermal antigen OV17 from Onchocerca volvulus (Fujiwara et al., 2007, Gallin 
et al., 1989), Ac-16 from Ancylostoma caninum, Bm-SXP-1 of Brugia malayi, AS16, AS14 protein 
from Ascaris suum and the antigens WB14 and SXP from Wuchereria bancrofti (Fujiwara et al., 2007, 
Rao et al., 2000). This protein has also been predicted from the C. elegans genome (Garcia-Mayoral et 
al., 2014).  
Three SXP/RAL-2 proteins have been detected in A. simplex and described as allergens namely: Ani s 
5 (15kDa), Ani s 8 (15kDa) and Ani s 9 (14kDa). The 3D structure of Ani s 5 was the first structure of 
an Anisakis allergen to be solved (Figure 1.6A) and also the first structure of an SXP/RAL-2 protein 
(Garcia-Mayoral et al., 2014). It is assumed that Ani s 5 and other members of the SXP/RAL-2 family 
of proteins of Anisakis spp (Ani s 8 and 9) are secreted into the human gastrointestinal tract from 
ingested third-stage larvae of A. simplex (Kobayashi et al., 2007) . The SXP/RAL-2 proteins of A. 
simplex s.s. have been described as clinically relevant even though they are minor allergens. This is 
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because they are heat stable allergens implicated in allergic episodes with canned or well-cooked fish 
(Moneo et al., 2005). 
The phylogeny of the SXP/RAL-2 proteins of A. simplex (Figure 1.6B) showed Ani s 8 and Ani s 9 to 
be distantly related while Ani s 9 is observed to be closely related to As14 of A. suum and Ani s 8 is 
shown to be evolutionary closer to Onchocerca volvulus protein. Furthermore, Ani s 5 clustered closer 
to OV-17 antigen of T. canis than with intra-species protein homologs of Anisakis SXP/RAL-2 
proteins. The similarity of the SXP/RAL-2 family of proteins suggests these homologous proteins 
might share some biological properties. No cross reactivity has been reported yet between A. simplex 
SXP/RAL-2 proteins and other homologous protein in other nematodes. 
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Figure 1.6.  Ani s 5, Ani s 8 and Ani s 9-modelled structure and phylogenetic tree. 
 
(A). A. simplex Ani s 5 solved structure and also the modelled structure for Ani s 8 with Ani s 9. 
(PDB ID: 2mar.1.A; SWISS-MODEL platform) (B) A. simplex Ani s 5, Ani s 8 and Ani s 9 - 
Molecular evolutionary relationship with homologous proteins. 
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1.16.6 Ani s 6 (Serine protease inhibitor) 
Ani s 6 (a cysteine-rich serine protease inhibitor, 7kDa), is a minor allergen of Anisakis simplex as it is 
recognized by <50% of infected allergic patients. It was the first protease inhibitor experimentally 
identified as an allergen in nematodes, sharing high sequence identity with serine protease inhibitors 
from other animals such as the protease inhibitor Api m 6 of honeybee (Apis mellifera- 29% sequence 
identity); PrInh6 of tsetse fly (Glossina morsitans morsitans-30% sequence identity); malaria mosquito 
(30% sequence identity) and chymotrypsin-elastase inhibitor ixodidin of cattle tick (Boophilus 
microplus-36% sequence identity) (Kobayashi et al., 2007). The modelled structure and the 
phylogenetic analysis of Ani s 6 are shown in Figure 1.7A and B, respectively. Ani s 6 is observed to 
clusters closer to protease inhibitors of Anopheles sinensis, a mosquito, and of T. canis.  
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Figure 1.7.  Ani s 6-modelled structure and phylogenetic tree. 
 
 (A). A. simplex Ani s 6-modelled structure. (Model Template PDB ID 2p3f.1.C; Sequence 
identity- 42 %; SWISS-MODEL platform) (B) A. simplex Ani s 6 - Molecular evolutionary 
relationship with homologous proteins. 
 
 
1.16.7 Anisakis simplex Allergenic Proteins with Repetitive Sequences. 
A number of parasites have been described to have antigenic proteins with short repetitive sequences, 
which usually would elicit a strong humoral immune response in the infected host. Such parasites 
include the malaria parasite (Tetteh et al., 2005). In Anisakis simplex, 5 different proteins (Ani s 7, Ani 
s 10, Ani s 11, Ani s 11-like and Ani s 12) have been identified with repetitive sequences (Kobayashi 
et al., 2011). Repetitive unique motifs including four Cys residues at regular intervals, which have not 
been recognized in any proteins from any other organisms, have been found in A. simplex. However, 
no significant sequence similarities have been observed among the repeats (Kobayashi et al., 2011). 
A B
Ani s 6
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1.16.7.1 Ani s 7 
Ani s 7, a protein of 139kDa molecular weight,  has been found to be the most important 
excretory/secretory product Anisakis simplex allergen, since it is recognized by 100% of allergic 
patients and it is the only allergen of A. simplex discovered so far with this property (Anadon et al., 
2009). The allergenicity of this molecule has been attributed mainly to the presence of a novel (CX17– 
25CX9–22CX8CX6) tandem repeat motif not seen in any previously reported protein. The result of a 
study by Anadon et al. (Anadon et al., 2009) demonstrated that native Ani s 7 is a secreted protein and 
is recognized by the rats immune system from only live larvae (i.e. during the acute phase of 
infection). Another investigation by Cuellar et al. (Cuellar et al., 2012)  concluded that Ani s 7 could 
be used to detect active infections while Ani s 1 would detect old infections from the complex mixture 
of proteins in A. simplex. Ani s 7’s modelled structure is shown in Figure 1.8A, while its phylogenetic 
relationship with homologous proteins is shown in Figure 1.8D. 
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Figure 1.8.  Ani s 7, Ani s 12 and Ani s 14-modelled structure and phylogenetic tree. 
 
(A). A. simplex Ani s 7-modelled structure. (Model Template PDB ID 3gqc.1.A; Sequence identity- 
14 %; SWISS-MODEL platform) (B) A. simplex Ani s 12 modelled structure. (Model Template 
PDB ID 1bbi.1.A; Sequence identity- 27 %; SWISS-MODEL platform)  (C). A. simplex Ani s 14 
modelled structure. (Model Template PDB ID 5ydg.1.A; Sequence identity- 17 %; SWISS-
MODEL platform); (D). A. simplex Ani s 7, Ani s 12 and Ani s 14 - Molecular evolutionary 
relationship with homologous proteins.  
 
1.16.7.2 Ani s 12  
Ani s 12 of A. simplex is a newly discovered allergen found to have novel tandem motif with four Cys residues 
(Kobayashi et al., 2011). Little knowledge is so far available on whether their allergenic epitope is 
conformational or not.  It is described as having a tandem repeat structure with its repetitive sequence CX13–
25CX9CX7,8CX6 made up of 40–52 amino acid residues and which has been found to be much longer than those 
of the Ani s 11 and Ani s 11-like proteins. Ani s 7 has also been described as a novel protein with nineteen 
repeats (CX17– 25CX9–22CX8CX6) of a closely similar motif to Ani s 12 (Rodriguez et al., 2008). Ani s 7 and Ani 
s 12 have been found to have no significant similarity with each other even though similar tandem motifs are 
A B C
D
Ani s 7 Ani s 12 Ani s 14
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contained in both. According to Kobayashi et al. (Kobayashi et al., 2011), this suggests that Ani s 12 has 
specific IgE epitopes differing from the major IgE epitope proposed for Ani s 7. The modeled structure and 
phylogeny of Ani s 12 are shown in Figures 1.8 B and D, respectively.  
1.16.7.3 Ani s 14 
Ani s 14, a 24kDa protein, is the most recently described major allergen of A. simplex as it is 
recognized by more than 50% of Anisakis allergic patients. It is the sixth major allergen of A. simplex 
described to date. Two homologous sequences at positions 5-44 and 54-97 have been described to date 
characterize this protein. These two regions in this allergen share 36% sequence identity and their 
common structure has been defined as CX8CX6CX22, 26. It is interesting to know that while Ani s 7 and 
Ani s 12 possess tandem repeats of similar structure with four residues of Cys at regular intervals, 
there are however no sequence similarity among the repeats of Ani s 7, Ani s 12 and Ani s 14. Another 
unique feature found in Ani s 14 is the presence of three kinds of redundant sequences- Gly-Gly-Met 
(positions 127-129 and 200-202), Ser-Ser-Met-Leu-Ser (positions 14-19 and 21-26) and Cys-Ile-Ala 
(positions 5-7 and 97-99) (Kobayashi et al., 2015). Kobayashi et al. (Kobayashi et al., 2015) suggested 
that these redundant sequences might represent IgE binding epitopes as repetitive sequences tend to be 
recognized by the human immune system. In addition, it is reported that Ani s 14 has no known 
domain or motifs and does not belong to any protein family, even though it has similarity in its amino 
acid sequence with Ani s 7, Ani s 12 and a hypothetical protein from dog roundworm (Toxocara 
canis). The biological functions of these proteins are not known and neither is the function of Ani s 14. 
The modelled structure and phylogeny of Ani s 14 with homologous proteins (Ani s 7 and Ani s 12) is 
shown in Figures 1.8C and D. 
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1.16.7.4 Ani s 10 
Ani s 10, a protein of 22kDa molecular weight, has been reported to possess a sequence composed of 
seven almost identical repetitions of 29 amino acids each; with each of these repeats having theoretical 
cleavage sites for trypsin and pepsin (Caballero et al., 2011). Ani s 10 is presumed to be either a 
somatic or cuticular antigen as the protein band corresponding to Ani s 10 was not observed in the 
excretion/secretion products from the parasite (Caballero et al., 2011). Though classified as a minor 
allergen as a result of 39% positive reactivity by Anisakis allergic patients, it has been found to be 
clinically important.  This is because the IgE binding capacity of this allergen is not affected by heat 
treatment, implying its stability to heat (Caballero et al., 2011). This signifies that the standard 
precaution of cooking seafood before consumption may not be sufficient to prevent allergic reaction to 
this allergen. Hence, in a dead larvae found in fish derived food, this allergen could elicit an allergic 
response.  Among the 39% of patients with sero-positivity against the Ani s 10 allergen, patients with 
urticarial symptoms were the most frequent (53%), followed by patients with anaphylaxis, 
epigastralgia and vomiting symptoms (23%) (Caballero et al., 2011). Ani s 10 has been shown to be 
homologous to Ani s 11 and two Ani s 11-like proteins from A. simplex share 49 and 43% sequence 
identity, respectively. The phylogeny of Ani s 10 with other homologous proteins is shown in Figure 
1.9B. No template was found for Ani s 10 to model its structure.  
1.16.7.5 Ani s 11 and Ani s 11-like allergens 
Ani s 11 and Ani s 11-like protein are described as structurally unique allergens as they have five or 
six types of short repetitive 6-15 amino acids sequences (Kobayashi et al., 2011). This structural 
feature has been found in Ani s 10 allergen, which has 43% sequence identity to Ani s 11-like protein. 
It is suggested that both Ani s 11 and Ani s 11-like protein might be surface antigens because parasite 
antigenic proteins with tandem repeats have been found to be localized on the body surface and are 
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often readily recognized by hosts, probably for protection against host immune responses (Leid et al., 
1987). Both proteins have different chain lengths, (Ani s 11-307 amino acids, Ani s 11-like- 160 amino 
acids), yet they share 78% sequence identity. Ani s 11 and Ani s 11-like allergens from A. simplex 
were identified by a chemiluminescent immunoscreening method developed by Kobayashi et al. 
(Kobayashi et al., 2011).  Functions for these proteins are still unknown. A recent study by Carballeda-
Sangiao et al. (Carballeda-Sangiao et al., 2016) has shown the Ani s 11-like allergen to be a pepsin and 
heat resistant major allergen of A. simplex. Figure 1.9A and B shows the modelled structure and the 
molecular relationship of Ani s 11 of A. simplex to homologous proteins. 
 
Figure 1.9.  Ani s 11-modelled structure and phylogenetic tree for Ani s 11 and Ani s 
10. 
 
(A). A. simplex Ani s 11-modelled structure. (Model Template PDB 5van.1.A; Sequence identity- 
24 %; SWISS-MODEL platform); (B). A. simplex Ani s 10 and Ani s 11 - Molecular evolutionary 
relationship with homologous proteins.  
 
A
B
Ani s 11
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1.16.8 Ani s 13 (Haemoglobin) 
The haemoglobin protein was first described in the stage 3 larvae of A. pegreffii by Nieuwenhuizen et 
al. (Nieuwenhuizen et al., 2013). It was found associated with the excretory-secretory ducts and was a 
highly expressed protein. Their result showed that A. pegreffii haemoglobin has high similarity to 
haemoglobin of a related marine nematode, Psuedoterranova decipiens. Gonzalez-Fernandez et al. 
(Gonzalez-Fernandez et al., 2015) extended their investigation to describe that this haemoglobin 
protein is also present in A. simplex and has no cross-reactivity to Ascaris haemoglobin. Over 50% of 
studied patient sera (64.3%) with features of Anisakis parasitism recognized A. simplex haemoglobin 
and it has therefore been classified as a new major allergen of A. simplex (Ani s 13). Five epitopes 
have been defined on this protein with the most important epitopes being Epitope 2 and 5 for IgE 
binding and specificity (Gonzalez-Fernandez et al., 2015). Epitope 5 in A. simplex haemoglobin has 
been found to be absent in Ascaris haemoglobin and has been suggested to be probably responsible for 
the specificity of IgE reactivity from Anisakis-positive patients. Modelled structure of A. simplex 
haemoglobin is shown in Figure 1.10A. In comparison with other nematodes, the phylogeny (Figure 
1.10B) shows closer clustering to the haemoglobin protein of T. canis than to other nematode 
haemoglobin.  
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Figure 1.10.  Ani s 13-modelled structure and phylogenetic tree 
 
(A). A. simplex Ani s 13-modelled structure. (Model Template PDB ID 1o1m.1.A; Sequence 
identity- 19 %; SWISS-MODEL platform) (B) A. simplex Ani s 13 - Molecular evolutionary 
relationship with homologous proteins. 
 
1.17 Other Allergens in A. simplex  
Other allergens of A. simplex still under investigation include the fructose-1, 6-bisphosphatase family (Ani s 
FBPP), and is already reported to be a wheat flour allergen (Baur and Posch, 1998, Kim et al., 2006). Others 
include Cytochrome c oxidase subunit 3 (Ani s CCOS3), cytochrome b (Ani s Cytochrome B), NADH 
dehydrogenase subunit 4L (Ani s NADHDS4L), and Troponin-like protein (Ani s Troponin) (Kim et al., 2006, 
Mohandas et al., 2014). These above-named proteins have been given allergome codes; however, little literature 
exists to establish their allergenicity. In addition, an antigenic protein of 42kDa molecular weight was described 
in the somatic extract of Anisakis larvae by Sugane et al. (Sugane et al., 1992). This protein was reported to 
A
B
Ani s 13
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react only with A. simplex infected human sera. However, investigation into this protein as an allergen is still 
inconclusive. 
Enolase, another allergenic protein found in A. simplex (Rodriguez et al., 2006) has also been investigated for 
immunogenic activity. Enolases from several microorganisms have been implicated in tissue invasion as well as 
in allergic disorders in humans (Ito et al., 1995, Simon-Nobbe et al., 2000, Baldo and Baker, 1988, Pancholi, 
2001).  Recent Anisakis transcriptome identified this protein as a putative allergen of Anisakis based on >70% 
sequence similarity with already described allergens in allergen database from other organsims (Baird et al., 
2016).  
1.18 Implication for invertebrate cross-sensitivity/cross-reactivity 
When a specific IgE to a particular antigen binds with another allergen, which shares significant 
structural and sequential similarity to the specific allergen, then a cross-reactivity syndrome is present 
(Singh et al., 2008). The implication of this is that a patient can be caught in a web of continuous 
reactivity to allergens (i.e. when patients try to avoid a specific allergen source, an allergen that a 
patient is already sensitized to could be hiding in another food source). Several studies have shown by 
a variety of methods, possible cross-reactivity with Anisakis simplex by carbohydrates, 
phosphorylcholine, other anisakid or ascarid nematodes, and in addition, other arthropods such as dust 
mites, chironomids or crustaceans (Perteguer et al., 2003a, Daschner et al., 2000, Valero et al., 2003, 
Pascual et al., 1997, Johansson et al., 2001, Lozano et al., 2004, Perteguer et al., 2003b, Fernandez-
Caldas et al., 1998, Iglesias et al., 1996, Lorenzo et al., 2000). This is not surprising as homologs of 
some of these proteins in other nematodes were found to perform similar functions when in human 
hosts. 
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1.19 Implications for allergy diagnosis 
Clinical history may be less clear if patients are exposed to multiple agents in their environment at the 
same time. Furthermore, use of specific IgE alone to diagnose Anisakis allergy is confronted by the 
fact that even asymptomatic individuals can have Anisakis-specific IgE as a result of immunologic 
cross-reactivity with other helminths (e.g. Ascaris, hookworm) or invertebrates such as cockroaches, 
dust mites and shrimp (Asturias et al., 2000b, Moneo et al., 1997). Cross-reactivity to other allergens 
complicates the diagnosis of Anisakis allergy and is responsible for the cause of false diagnosis (Valls 
et al., 2003). 
1.20 Non-allergenic proteins in A. simplex but with immunogenic activity 
1.20.1 AniSerp 
AniSerpin (44.6kDa), a novel serpin with anticoagulant capacity was identified in A. simplex and 
unlike other serine protease inhibitors of A. simplex which inhibit Kunitz and elastase proteases, this 
protease inhibitor inhibited human thrombin. It was also found to reversibly inhibit a cathepsin G and 
L. This ability to inhibit human thrombin makes this serine inhibitor suitable for use as an 
anticoagulant (Valdivieso et al., 2015). No parasitic nematode serpin has yet been described to have 
this anticoagulant property. Experimental evidence has shown the serpin (SPN-2) of B. malayi to be 
involved in evasion of host immune response by its ability to inhibit two serine neutrophil-derived 
proteases (Zang et al., 1999).  
1.20.2 Macrophage Migration Inhibitory Factor 
One of the earliest cytokines derived from activated T cells is the macrophage migration inhibitory 
factor (MIF), which is believed to prevent the random migration of macrophages (Bloom and Bennett, 
1966). A number of MIF homologs have been isolated from parasitic nematodes; two types have thus 
far been identified: the type 1 MIF homologs and the type 2 MIF homologs (Gregory et al., 1997, 
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Pastrana et al., 1998). The type 1 MIF homologs were reported to bear a greater amino acid similarity 
with mammalian MIFs than the type 2 MIF homologs. Parasite MIF homologs were also found to have 
similar ability with those of mammalian MIF (Pastrana et al., 1998). However, it was reported recently 
by Cho et al. (Cho et al., 2007) that the MIF of hookworms, which is type 2 MIF structurally, 
functions differently from those of the mammalian MIF. MIF-like protein of A. simplex (As)-MIF) 
from larvae of Anisakis simplex third-stage larvae was cloned by Park et al. (Park et al., 2009) and was 
shown to induce a complete inhibition of eosinophilia and goblet cell hyperplasia in mice and reduce 
profoundly the quantity of Th2-related cytokines (IL-4, IL-5, and IL-13) in the bronchial alveolar 
lavage fluid among other immunological responses elicited by this protein. The result of this study 
suggests that As-MIF may be one of the molecules that affects host immune regulation and therefore 
may be functioning as a host immune modulator.  
1.21 Paucity of Data on the Protein Repertoire of A. pegreffii  
This review has summed up the present understanding and the current status of Anisakis simplex and 
its increasing number of molecules used to attack key pathways in the mammalian immune system. 
Five allergenic proteins Ani s 1, Ani s 2, Ani s 9, Ani s 12 and Ani s 13 have been compared between 
Anisakis simplex and A. pegreffii. Quiazon et al. (Quiazon et al., 2013a) reported that A. simplex s.s 
and A. pegreffii share the same amino acid sequences for Ani s 9. Tropomyosin as an allergen has also 
been described for A. pegreffii (Asnoussi et al., 2017). However, the presence of other IUIS allergens 
described for A. simplex are yet to be identified in A. pegreffii proteome. In addition, in all the large-
scale proteomic experiments described for Anisakis spp (Faeste et al., 2014, Arcos et al., 2014), the 
whole worm extract of the L3 stage of Anisakis had been used. There is paucity of data on how much 
of all these proteins identified are from the excretory/secretory channel.  
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This study seeks to identify what proportion of proteins already described for A. simplex are present in 
A. pegreffii proteome using 1D-Gel LC-MS/MS. Furthermore, this study aimed to explore the protein 
repertoire of A. pegreffii excretory/secretory product in comparison with the whole parasite extract as 
well as with other helminths. In addition, similarities of Anisakis allergenic proteins, in structure and 
immunochemistry, to allergenic proteins from other invertebrates, particularly TPM, are a major 
reason for difficulty in diagnosis of Anisakis allergy. It is anticipated that knowledge on cross-
reactivity would minimise the number of allergens for diagnosis as well as allergic disorder therapies 
(Singh et al., 2008). This study extends investigation of cross-reactive allergens of Anisakis to A. 
pegreffii as well as identification of immunomodulatory molecules of A. pegreffii. 
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The aims of this study therefore are: 
• Chapter 3: To identify and compare the immunogenic proteins from the secretome and 
whole parasite extract of Anisakis pegreffii. 
• Chapter 4: To elucidate the role of microvessicles (exosomes) in the cargo and 
dissemination of Anisakis pegreffii immunogenic molecules. 
• Chapter 5: To analyze in Anisakis pegreffii, novel cross-reactive allergens to shellfish. 
• Chapter 6: To characterize medically important protease molecules of Anisakis pegreffii. 
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 GENERAL METHODS CHAPTER 2:
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2.1 Parasite Materials 
Anisakis larvae were collected from Neoplatycephalus richardsoni (Tiger flathead), purchased from a 
local seafood market in Melbourne without cleaning and transported immediately on ice to the RMIT 
Biotechnology laboratory. Each fish was dissected according to established protocols, and the body 
cavity and internal organs (liver, gut, stomach and gonads) were examined for the presence of L3s of 
Anisakis spp. (Jabbar et al., 2013). When detected, live Anisakis larvae were removed, encapsulated 
larvae were freed from the capsule and thoroughly washed three times in physiological saline (pH 7.4) 
(Werner et al., 2011). Approximately 50 Anisakis L3s were stored in 70% ethanol at -20 °C for 
molecular identification and the preparation of crude protein extract (CE). A part of the nematodes 
were cleared in lactophenol and another part dehydrated in ascending grades of ethanol (20%, 30%, 
50%, 70% and 100%) for morphological identification.  The remaining live larvae (~50) were 
subjected to further experimental procedures for collection of excretory/secretory (ES) products. 
2.1.1 Preparation of parasite crude extracts (CE) 
Proteins were extracted from A. pegreffii L3s (n = 50) by snap freezing in liquid nitrogen, followed by 
homogenization in 2.5 ml of extraction buffer (0.1M Tris (hydroxymethy1) aminomethane and 0.5M 
glycine buffer; pH 8.7). Sonication (3 cycles; 30s on 15 s off; amplitude of 37%) was performed and 
protein extracts centrifuged at 4 °C for 10 minutes at 14,000 x g using in-house developed laboratory 
protocols for protein extraction. The supernatant was filtered (0.45 μm filter; Millipore, Billerica, MA, 
USA) and concentrated using Millipore protein concentration columns (3kDa, 5 kDa and 10kDa cut-
off; Amicon Ultra). Protease inhibitor cocktail (Sigma Aldrich; P8340) was added to sample aliquots 
which would not be used for protease activity study following the manufacturer’s instruction. This was 
to avoid proteolytic degradation. Protein concentrations were measured with the Bradford reagent and 
samples stored at – 80 °C prior to further use. 
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2.1.2 Preparation of excretory/secretory products (ES) 
Live A. pegreffii L3s were thoroughly washed in physiological saline (pH 7.4) to remove contaminant 
fish tissues, and subsequently maintained in RPMI 1640 culture medium with 10 mM L-glutamine 
(GIBCO, Invitrogen) containing 0.2 mg/ml gentamycin (10 mg/ml GIBCO, Invitrogen), 1 mg/ml 
streptomycin (Sigma) and 1,000 U/ml penicillin (Kelapharma). Individual L3s were incubated in 500 
µl of medium per well for 3 days (Zhu et al., 1998). Parasite viability (motility) was checked daily 
under a stereomicroscope, and the culture fluid collected every 24 h and replaced with fresh medium. 
The filtered supernatant (0.22 μm filter; Millipore, Billerica, MA, USA) was stored at −80 °C prior to 
further use. Following molecular identification of each L3, the filtrates were pooled. Pooled ES 
products were concentrated using Millipore protein concentration columns (5 kDa cut-off; Amicon 
Ultra), and the total protein content was determined using the Bradford assay (Okutucu et al., 2007). 
The filtered and concentrated protein extracts were stored at −80 °C until further use. 
2.2 Molecular Characterization  
2.2.1 Isolation of Genomic DNA 
Genomic DNA was extracted from the mid-section of individual larvae as described by Jabbar et al. 
(Jabbar et al., 2012). Briefly, the tissue was suspended in 200 µL of 20mM Tris-HCl (pH 8.0), 100mM 
EDTA, and 1% sodium dodecyl-sulphate containing 10 mg/mL proteinase K (Amresco, USA). 
Incubation was at 370C for 18 h. Total genomic DNA was isolated from the homogenised suspension 
using a mini-column (Wizards DNA Clean-Up System, Promega, WI, USA) according to the 
manufacturer’s protocol. 
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2.2.2 ITS-1 and ITS-2 Region Amplification and Sequencing 
Two nuclear ribosomal loci were PCR-amplified using the primers SS1/NC13R (ITS-1) and SS2/NC2 
(ITS-2) as described by Jabbar et al. (Jabbar et al., 2012). Briefly, PCR was conducted in a 50 µL 
volume containing 10mM of Tris-HCl (pH 8.4), 50mM of KCl (Promega), 3.5mM  MgCl2, 200 µM of 
each of deoxynucleotide triphosphate (dNTP), 5 pmol of each primer and 1 U of GoTaq polymerase 
(Promega) under the following cycling conditions: 940C/5 min (initial denaturation), followed by 35 
cycles of 940C/30 s (denaturation), 550C/40 s (annealing), 720C/40 s (extension), followed by a final 
extension at 720C/5 min. For each set of PCRs, negative (no-DNA) and known positive controls were 
included, 5 µL of each amplicon was examined on a 1.5% w/v agarose gel stained with ethidium 
bromide and photographed. Amplicons representing the ITS-2 profile was subjected to bi-directional, 
automated sequencing using (separately) the same primers employed in PCR (308bp). 
2.2.3 PCR-RFLP analysis 
The genetic marker described by Zhu et al. (Zhu et al., 1998), D’Amelio et al. (D'Amelio et al., 2000) 
and Abe and Yagi (Abe and Yagi, 2005) were used to distinguish the L3 larvae of the Anisakis spp. 
PCR amplification of the 5.8S rRNA region of the parasite with NC5 (forward 5”-
CGTAGGTGAACCTGCG-3’) and NC2 (reverse’-TTAGTTTCTTTTCCTCCGCT-3’) primers was 
performed. The restriction endonucleases, HhaI and HinfI, were used in RFLP analyses of the 
amplified product of the ITS rRNA region. Digested products were analysed by electrophoresis on a 
3% agarose gel and visualized using the Gel doc system (Biorad)  (Lee et al., 2009). 
2.3 Mass Spectrometry 
2.3.1 Gel electrophoresis  
The extracted proteins were subjected to SDS-PAGE gel-electrophoresis as previously described 
(Abdel Rahman et al., 2010, Kamath et al., 2014b). In brief, the protein extracts (CE and ES, 
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separately) were briefly heated in Laemmli buffer and 15 µg (per lane) separated on a 12% bis-
acrylamide gel (BioRad, Hercules, CA, USA). The separated proteins were detected by staining with 
Coomassie brilliant blue R250 (BioRad, Hercules, CA, USA). 
2.3.2 In-Gel Tryptic Digestion 
Tryptic in-gel digestion was performed by cutting the entire gel lane for excretory/secretory (ES) 
products and crude extract (CE) separately, after staining with Coomassie brilliant blue R250 (BioRad, 
Hercules, CA, USA). Each gel lane was cut into 24 piece slices (horizontally) with each gel piece kept 
in sterile eppendorf tubes (1.5ml) for liquid chromatography-tandem mass spectrometric (LC-MS/MS) 
analysis. The destained gel piece was reduced with 10 mM DTT in 50mM triethylammonium 
bicarbonate (TEAB) (55 °C/45 min) and alkylated with 55 mM iodoacetamide made up in 50mM 
TEAB (incubated at room temperature (in the dark/30 min). Samples were then incubated with 200 
ng/µl sequencing grade trypsin (Sigma Aldrich) (incubated at 37 °C/ overnight). The digestion was 
stopped by the addition of formic acid (FA) to a final concentration of 1% and dried in a vacuum 
centrifuge.  
2.3.3 In-Solution Tryptic Digestion and LC-MS/MS Analysis 
The in-solution digestion was performed by using 1mg/ml each of the ES and CE as well as pellets 
obtained from exosome proteins precipitated by acetone. This was mixed with 500µl of 0.5 M 
triethylammonium bicarbonate buffer (TEAB), reduced with 100 µl of 10 mM dithiothreitol and 
incubated at 600C for 1 h. Subsequently, 200 µl of 200 mM methyl methanethio-sulfonate in 
isopropanol was added and incubated for 10 min at room temperature. The solution was digested with 
trypsin (resuspended in TEAB) at a ratio of 1/50 (amount trypsin/protein) overnight at 370C. Dried 
peptides were dissolved in 40µl 0.1% formic acid and subsequently analysed. 
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2.3.4 LC-MS/MS Analysis  
The digested sample was analysed by LC-MS/MS using a Q-Exactive mass spectrometer (Thermo 
Scientific). Peptides were resuspended in 0.1% formic acid and analyzed by LC-MS/MS using a Q 
Exactive Plus mass spectrometer coupled to an Ultimate Ultra High Performance Liquid 
Chromatography [3000 UHPLC] (Thermo Fisher Scientific, San Jose, CA).  Sample was injected onto 
a PepMap C18 trap column (75 μM x 2 cm, 3 μM, 100 Å, Thermo Fisher Scientific, San Jose, CA) at 5 
μL/min for 5 min using 0.05% trifluoroacetic acid (TFA), /3% acetonitrile and then separated through 
a PepMap C18 analytical column (75 μM x 50 cm, 2 μM, 100 Å, Thermo Fisher Scientific, San Jose, 
CA) at a flow rate of 300 nL/min. The temperature of both columns was maintained at 50 °C. During 
separation, the percentage of solvent B (solvent B is 0.1% FA in acetonitrile) in mobile phase was 
increased from 3% to 25% in 23 min, from 25% to 40% in 2 min and from 40% to 85% in 2 min. Then 
the columns were cleaned at 85% solvent B for 2 min before decreasing the % B to 3% in 0.1min and 
re-equilibrating for 10.9 min. LC-MS/MS procedures were performed at the Mass Spectrometry and 
Proteomics Facility Bio21, The University of Melbourne, Australia. 
2.3.5 Protein identification 
2.3.5.1 Identification of Peak list obtained from MS/MS spectra 
Peak lists obtained from MS/MS spectra were identified using, Mascot (Matrix Science, London, UK; 
v. 2.4.1), X! Tandem version X! Tandem Vengeance (2015.12.15.2) [PMID 14976030] (Craig and 
Beavis, 2004);  MS-GF+ (version Beta; v10282)  (Kim and Pevzner, 2014), and MyriMatch version 
2.2.140 [PMID 17269722]. The search was conducted using SearchGUI version [3.2.20] [PMID 
21337703] (Vaudel et al., 2011). 
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2.3.5.2 Protein identification and Database Used 
Protein identification was conducted against two concatenated target/decoy databases. The first 
database was A. pegreffii transcriptome database (Baird et al., 2016) holding 33747 target sequences 
(version of December 24th 2016). The second database was of concatenated target/decoy [PMID 
20013364] version of the Anisakis simplex (20990, 99.3%), Anisakis pegreffii (96, 0.5%), Anisakis 
berlandi (16, <0.1%), Contracaecum osculatum (12, <0.1%), Contracaecum rudolphii (12, <0.1%), 
Anisakis simplex x Anisakis pegreffii (2, <0.1%), Ascaris suum (1, <0.1%), Haemonchus contortus (1, 
<0.1%), Scomber japonicus (1, <0.1%), Trichuris trichiura (1, <0.1%) complement of the UniProtKB 
[PMID 14681372] (version of [29012018] , 21132 (target) sequences).The decoy sequences were 
created by reversing the target sequences in SearchGUI. 
2.3.5.3 Identification setting 
The identification settings were as follows: Trypsin, Specific, with a maximum of 2 missed cleavages 
20 ppm as MS1 and 0.5 Da as MS2 tolerances; fixed modifications: Carbamidomethylation of C 
(+57.021464 Da),  variable modifications: Oxidation of M (+15.994915 Da), fixed modifications 
during refinement procedure: Carbamidomethylation of C (+57.021464 Da), variable modifications 
during refinement procedure: Acetylation of protein N-term (+42.010565 Da), Pyrolidone from E (--
18.010565 Da), Pyrolidone from Q (--17.026549 Da), Pyrolidone from carbamidomethylated C (--
17.026549 Da). 
2.3.5.4  Peptide and Protein Inference 
2.3.5.4.1 Peptide Shaker for peptide and protein inference 
Peptides and proteins were inferred from the spectrum identification results using PeptideShaker 
version 1.16.15 [PMID 25574629]. Peptide Spectrum Matches (PSMs), peptides and proteins were 
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validated at a 1.0% False Discovery Rate (FDR) estimated using the decoy-hit distribution. All 
validation thresholds are listed in the Certificate of Analysis available in the supplementary 
information. Post-translational modification localizations were scored using the D-score [PMID 
23307401] and the phosphoRS score [PMID 22073976] with a threshold of 95.0 as implemented in the 
compomics-utilities package [PMID 21385435]. A phosphoRS score above was considered as a 
confident localization. Spectrum counting abundance indexes were estimated using the Normalized 
Spectrum Abundance Factor [PMID 15282323] adapted for better handling of protein inference issues 
and peptide detectability. 
2.3.5.4.2 Scaffold for peptide and protein inference 
 For a second opinion of protein inference, identification and validation, Scaffold software (version 
Scaffold_4.5.1, Proteome Software Inc., Portland, OR) was used to validate MS/MS based peptide and 
protein identifications. Peptide identifications were accepted if they could be established at greater 
than 95.0% probability. Peptide probabilities from the search engines were assigned by the Peptide 
Prophet algorithm (Keller et al., 2002) with Scaffold delta-mass correction. Protein identifications 
were accepted if they could be established at greater than 99.0% probability and contained at least 2 
identified peptides.  Protein probabilities were assigned by the Protein Prophet algorithm (Nesvizhskii 
et al., 2003). Proteins that contained similar peptides and could not be differentiated based on MS/MS 
analysis alone were grouped to satisfy the principles of parsimony. Proteins sharing significant peptide 
evidence were grouped into clusters. An estimate of the relative abundance of the predicted proteins in 
the trypsin digestion (within the samples) was assessed using the normalized spectral abundance factor 
generated in the Scaffold (NSAF) software system. 
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2.3.5.4.3 Data deposited in Proteome Exchange 
The mass spectrometry data along with the identification results have been deposited to the ProteomeXchange 
Consortium [PMID 24727771] via the PRIDE partner repository [PMID 16041671] with the dataset identifiers 
[Project Name: Proteomic Analysis and Molecular Characterization of Anisakis pegreffii Allergenic and 
Immunogenic proteins; Project accession: PXD008816; Project DOI: 10.6019/PXD008816]. 
2.4 Anisakis allergens- molecular evolutionary relationship with homologous 
proteins 
Described sequences of Anisakis allergens were retrieved from the Uniprot (http://www.uniprot.org/) 
and NCBI (http://www.ncbi.nlm.nih.gov/protein/) databases. For a comprehensive search of Anisakis 
allergens homologous proteins, the BlastP program was performed in the non-redundant protein 
sequences (nr) databases. The result was compared with the TBlastN search. Algorithm parameters 
were set to the default. Sequences with E-values below 1 X 10-4 and bits score of >50 were selected as 
homologous proteins (Pearson, 2013). Phylogenetic and molecular evolutionary analyses were 
conducted using MEGA version 6 (Tamura et al., 2013).ClustalW was used for multiple sequence 
alignments with the default parameters and a neighbour-joining (NJ) tree was constructed with the 
aligned homologous protein sequences in MEGA. The following parameters were used for the 
phylogenetic tree construction: Poisson model, bootstrap (1000 replicates; random seed) and complete 
deletion of gaps or missing data. 
Accession Numbers for Ani s 1 and homologous proteins (A)- Ani s 1 Anisakis simplex (AGC60035), 
Ani s 1 Anisakis  pegreffii (AGC60032), major allergen Ani s 1 Toxocara canis (KHN76275.1), 
Hypothetical protein (HP) of Loa  loa (EFO13778), Ancylostoma ceylanicum (EYC23835) and 
Wuchereria bancrofti (EJW78328); thyroglobulin type-1 (TT-1) and proteinase inhibitor I2 (PII2) 
domain containing protein of Haemonchus contortus (CDJ92662) and Strongyloides  ratti 
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(CEF62937);  uncharacterized protein (UP) of Caenorhabditis elegans (NP_504413), Hypothetical 
protein of Pristionchus pacificus (KKA75732), Kunitz/Bovine pancreatic trypsin inhibitor (KBPTI) 
domain protein of Necator americanus (XP_013309260), Oesophagostomum dentatum (KHJ91434), 
Dictyocaulus viviparous (KJH50140) and Ancylostoma duodenale (KIH61880); Kunitz inhibitor of C. 
elegans (NP_508632) and major allergen Ani s 1 of Ascaris suum (ERG81619). 
Accession Numbers for Ani s 2 and homologous proteins (B)-Ani s 2 of A. simplex (AGC60024) and 
A. pegreffii (AGC60020); Paramyosin protein of A. suum (ERG78965), Onchocerca volvulus 
(QO2171), D. viviparous (ABO07440), T.canis (KHN76665), A. caninum (ABC86903), Dirofilaria 
immitis (P13392), C. elegans (NP_492085), Stronglyloides stercoralis (CEF65593), Trichuris 
trichuira (CDW56486), Trichinella spiralis (XP_003371652), Brugia malayi (XP_001892373), Blo t 
11 allergen of Blomia tropicalis (Q8MUF6), Der F 11 allergen of Dermatophagoides 
farinae(AIO08864) and HDM allergen of Dermatophagoides pteronyssinus (AA073464); paramyosin-
like protein of W. bancrofti (AAG31484), Hypothetical protein of L. loa (XP_003141094),  Myosin 
tail protein of H. contortus (CDJ96841), Ancylostoma ceylanicum (EPB69247) and Necator 
amerticanus (XP_013295008). 
Accession Numbers for Ani s 3 and homologous proteins (C)-Ani s 3 A. simplex (Q9NAS5), 
Tropomysoin protein of A. lumbricoides (ACN32322). L. loa (EJD75137), Heligmosomoides 
polygyrus (ABV44405), Teladorsagia circumcincta (ADB27966.1), Trichinella spiralis 
(XP_003372651), C. elegans (BAA07540), Jasus lalandii (AFY98827) and P. sanguinolentus 
(ABL89183);Allergen Der f 10 of D. farinae (ABU97468), Blo t 10 Blomia tropicalis (ABU97466), 
Allergen Aca s 10 of Acarus siro (ABL09305) and allergen Lep d 10 of Lepidoglyplus destructor 
(Q9NF24). 
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Accession Numbers for Ani s 4 and homologous proteins (D)-Ani s 4 A. simplex (CAK50389),  CPI of 
A. lumbricoides (ADR51550), Cysteine protease inhibitor (CPI) of Haliotis discus hannai (AEI59124) 
and H polygyrus (AGA95986); Proteinase Inhibitor I25 of H. contortus (CDJ92568) and S. rattii 
(CEF69048); Onchocystatin protein of A. suum (ERG82219) and T. canis (KHN76703); Nippocystatin  
protein of Nippostrongylus brasiliensis (BAB59011), cystatin domain protein of N. americanus 
(XP_013296854), O.dentatum (KHJ94005),  C. elegans (NP_504565) and D. viviparous (KJH50325); 
cystatin proteinase inhibitor (CPI) protein of L. loa (XP_003136654), Cystatin 3 protein of A. 
duodenale (AGB07555). 
Accession Numbers for the SXP/RAL-2 proteins (Ani s 5, Ani s 8 and Ani s 9 )and their homologous 
proteins (E)-SXP/RAL-2 protein A. simplex (BAF43534), solution structure of Ani s 5  A. simplex ,Ani 
s 8 -1 A. simplex (A7M6Q6), Ani s 9 A. simplex (B2XCP1), protein of unknown function DUF of H. 
contortus (CDJ91573), SXP protein of Strongylus vulgaris (AGF90534) and W. bancrofti 
(AAC70783);  immunodominant hypodermal antigen (Ac16) of A. caninum (ABD98404) and 
Onchocertca ochengi (ACB70199), uncharacterised protein (UP) of C. elegans (NP_496220), 
hypothetical protein (HP) of N. americanus (XP_013290850), Ag1 of Baylisascaris schroederi 
(ACJ03761) and A. lumbricoides (ACJ03764); Ag2 of Baylisascaris schroederi (ACJ03762) and A. 
lumbricoides (ADB45852); As14 and As 16 of A. suum (BAB67769), (BAC66614); SPX-1 of L. loa 
(XP_003142836) and B. malayi (AAA27864), antigen WbL1 of W. bancrofti (ABO40019), antigen 
WB14 of W. bancrofti (AAC17637), B. malayi antigen (AAA67319) and OV-17 protein of t. canis 
(KHN84076).  
Accession Numbers for Ani s 6 (Proteinase inhibitor) and homologous proteins (F)- Ani s 6 of A. 
simplex (BAF43535), chymotrypsin inhibitor-like Diaschasma alloeum (XP_015111868), 
chymotrypsin inhibitor-like proteins of Megachile rotundata (XP_003700660), Nasonia vitripennis 
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(XP_001607538), Acromyrmex echinatior (XP_011050597), Polistes canadensis (XP_014599121) and 
Apis mellifera (KFD56018); hypothetical protein of A. ceylanicum (EYC24268) and T. suis 
(KFD56018); uncharacterised protein (UP) of C. elegans (NP_001076745), trypsin inhibitor like 
cysteine rich domain protein O. dentatum (KHJ89305), protease inhibitor 18 domain containing 
protein H. contortus (CDJ97122), bifunctional nitrile hydratase NIT4B of T. canis (KHN75744), 
chymotrypsin/elastase isoinhibitor 2 to 5 protein of T. canis (KHN80612) and PC-like protein 
Anopheles sinensis (KFB35567). 
Accession Numbers for Ani s 7, Ani s 12, Ani s 14 and homologous proteins (H)-UA3-recognized 
allergen of A. simplex (ABL77410), hypothetical protein (HP) of T. canis (KHN86688), Ani s 12 
allergen of A. pegreffii (AGC60028), Ani s 12 of A. simplex (AGC60030) and Ani s 14 of A. simplex 
(BAT62430) 
Accession Numbers for Ani s 10, Ani s 11, Ani s 11-like and homologous proteins (H)- Ani s 10 
allergen precursor A. simplex (ACZ95445), Ani s 11 allergen precursor A. simplex (BAJ78220), Ani s 
11-like protein 2 precursor A. simplex (BAJ78222), Ani s 11-like protein precursor A. simplex 
(BAJ78221), hypothetical protein of Branchiostoma floridae (XP_002592239) and proline-rich 
extensin-like protein EPR1 Clupea harengus (XP_012681730) 
Accession Numbers for Ani s 13 (Hemoglobin) and homologous proteins (I)- Hemoglobin of A. 
pegrefii (AFY98826), P. decipiens (CAA77743) and T. canis (AAL58703); globin-like protein of C. 
elegans (NP_498974) and Ascaris suum (ERG78975); unnamed protein product of N. brasiliensis 
(AAA72047), hypothetical protein (HP) of P. pacificus (KKA75577), globin domain of H. contortus 
(CDJ94105), A. ceylanicum (EPB66765), S. rattii (CEF61039), N. americanus (XP_013305040), A. 
duodenale (KIH66592), B. malayi (XP_001901554), O. dentatum (KHJ93008), W. bancrofti 
(EJW76352), D. viviparus (KJH47358), L. loa (XP_003136972) and glb-1 P. pacificus (KKA75692). 
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2.5 Template Search for A. simplex Allergenic Protein Structure Modelling 
Template search with Blast and HHBlits has been performed against the SWISS-MODEL template 
library (SMTL, last update: 2018-02-07, last included PDB release: 2018-02-02). The target sequence 
was searched with BLAST (Altschul et al., 1997) against the primary amino acid sequence contained 
in the SMTL. An initial HHblits profile has been built using the procedure outlined in (Remmert et al., 
2011), followed by 1 iteration of HHblits against NR20. The obtained profile has then be searched 
against all profiles of the SMTL. A total of 16 templates were found. 
2.5.1 Template Selection 
For each identified template, the template's quality has been predicted from features of the target-
template alignment. The templates with the highest quality have then been selected for model building. 
2.5.2 Model Building 
Molecular models are built based on the target-template alignment using ProMod3. Coordinates, which 
are conserved between the target and the template, are copied from the template to the model. 
Insertions and deletions are remodelled using a fragment library. Side chains are then rebuilt. Finally, 
using a force field regularizes the geometry of the resulting model. In case loop modelling with 
ProMod3 fails; an alternative model is built with PROMOD-II (Guex and Peitsch, 1997). 
2.5.3 Model Quality Estimation 
The global and per-residue model quality has been assessed using the QMEAN scoring function 
(Benkert et al., 2011). For improved performance, weights of the individual QMEAN terms have been 
trained specifically for SWISS-MODEL. 
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2.5.4 Ligand Modelling 
Ligands present in the template structure are transferred by homology to the model when the following 
criteria are met (Gallo-Casserino, to be published): (a) The ligands are annotated as biologically 
relevant in the template library, (b) the ligand is in contact with the model, (c) the ligand is not 
clashing with the protein, (d) the residues in contact with the ligand are conserved between the target 
and the template. If any of these four criteria is not satisfied, a certain ligand will not be included in the 
model. The model summary includes information on why and which ligand has not been included. 
2.5.5 Oligomeric State Conservation 
Homo-oligomeric structure of the target protein is predicted based on the analysis of pairwise 
interfaces of the identified template structures. For each relevant interface between polypeptide chains 
(interfaces with more than 10 residue-residue interactions), the Qscore Oligomer (Mariani et al., 2011) 
is predicted from features such as similarity to target and frequency of observing this interface in the 
identified templates (Kiefer, Bertoni, Biasini, to be published). The prediction is performed with a 
random forest regressor using these features as input parameters to predict the probability of 
conservation for each interface. The QscoreOligomer of the whole complex is then calculated as the 
weight-averaged QscoreOligomer of the interfaces. The oligomeric state of the target is predicted to be 
the same as in the template when QscoreOligomer is predicted to be higher or equal to 0.5. 
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3.1 Introduction 
Anisakis pegreffii is known to be relevant for humans as a result of the zoonotic role it plays in causing 
the disease, anisakiasis (Mattiucci et al., 2017). To date, A. pegreffii has been reported as the causative 
agent of invasive anisakiasis in Europe (Italy, Croatia) (D'Amelio et al., 1999, Fumarola et al., 2009, 
Mattiucci et al., 2011, Mladineo et al., 2016, Mattiucci et al., 2013) and also in Japan (Umehara et al., 
2007, Arai et al., 2014) and South Korea (Lim et al., 2015). The geographical distribution of A. pegreffii 
includes the Atlantic and Pacific Austral waters as well as the Iberian Atlantic coast waters. It is the most 
widespread anisakid species known to affect commercial fish from Mediterranean waters (Mattiucci et al., 
2017). Although humans are accidental hosts of this parasite in which the parasite can survive for a short 
period of time but cannot reproduce, studies on this nematode, its infection and molecules released at the 
interface of host-parasite relationship are of crucial importance (Bao et al., 2017, Pravettoni et al., 2012, 
Audicana and Kennedy, 2008), To understand the biology of Anisakis pegreffii, knowledge of the history 
of helminth and their immunomodulatory mechanisms is of utmost importance. 
3.1.1 Helminth and the Th-2 Immune response 
It is known that helminths vary greatly in their biology. They exist within their host, particularly humans, 
in different developmental stages such as eggs, larvae or adult form. In addition, different species have 
preferences for different locations in their host, which include the lungs, colon, intestines, liver and 
others. Inspite of their wide range of characteristics, helminth parasites seem to elicit similar immune 
responses in their human hosts. Most helminths are known to induce modified T-helper (Th) 2 immune 
responses, accompanied by a wide range of immunoregulatory mechanisms, which helps to control 
excessive Th1 immunity that prevents parasite colonization (Ito, 2015, Hernandez et al., 2013, Trinchieri 
and Gerosa, 1996). 
Chapter 3 
 
62 
 
3.1.2 The Hygiene Hypothesis 
The emergence of autoimmune diseases in the developed world has been linked to hygiene, some 
believing that the disappearance of endoparasites has been an important immune modifier (Bach, 2002, 
Weinstock et al., 2002). The hygiene hypothesis was proposed by Strachan (Strachan, 1989) over 25 
years ago, when he suggested that early-life exposure of children to infection stimulates correct 
development of their immune system and protects them from diseases such as airway allergy, which 
comes in the form of seasonal rhinitis (Strachan, 1989). He indicated that the absence of these early-life 
infections predisposes children to hyperactivity and inappropriate immune responses as seen in allergy 
(Strachan, 1989). It was then observed that over the periods in which early-life infections were eradicated 
by good hygiene in the developed world (Western world), there was a corresponding positive association 
with development of epidemic immunopathological diseases such as allergic asthma. Helminth infection 
which had been eradicated mainly by hygiene practices during this period began to receive attention 
(McSorley et al., 2013). Epidemiological studies of atopy (Feary et al., 2011) or asthma (Leonardi-Bee et 
al., 2006), thereafter, suggested that parasitic infection did have a protective effect against these 
immunopathological diseases.  
3.1.3 Helminth Infection and Immunomodulation 
Several experiments, since the hygiene hypothesis was proposed, have shown that helminth infection can 
alleviate immune-mediated diseases such as multiple sclerosis (MS) (Correale, 2014, Fleming, 2013, 
Correale and Farez, 2013), inflammatory bowel disease (IBD) (Lu et al., 2014, Ferreira et al., 2013, 
Ruyssers et al., 2009, Smith et al., 2007) and diabetes (Zaccone and Cooke, 2013, Mishra et al., 2013, 
Lund et al., 2014). This is because it has been discovered that helminths possess immunomodulatory 
mechanisms that not only ensure their own survival in host body, but also respond to non-helminth 
antigens such as host self-antigens and allergens (McSorley and Maizels, 2012). Production of 
immunoregulatory cytokines such as IL-10, TGF-ß, and the increased activity of regulatory T and B cells 
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with alternatively activated macrophages (AAM), have been associated with establishment of helminths 
parasites in the host for long periods. Furthermore, helminths have been found to promote B cells to 
produce IgG4 antibodies, which counteract the IgE responses (Allen and Maizels, 2011, Grencis, 2015, 
Taylor et al., 2012, Hussaarts et al., 2011). In the last few years, as a result of these attributes of 
helminths, there have been developments in the field of helminth-therapies that have led to novel 
strategies in immune-mediated diseases treatment. Trichuris suis ova (TSO) has been used for the 
treatment of MS (Fleming et al., 2011, Rosche et al., 2013) and IBD (Sandborn et al., 2013), a treatment 
based on the concept of the hygiene hypothesis (Bach, 2017). T. suis is also now a commercially available 
treatment called Ovamed (http://www.ovamed.de/tso/publications). 
3.1.4 Use of Helminth for Treatment of Immune-Mediated Disease 
The treatment of human immune-mediated diseases with live helminths appeared to have had several 
drawbacks such as accidental infection, reduced immune response to viral, bacterial, protozoal infection 
and increased susceptibility to them, atopic reaction, poor acceptance with consuming eggs or live worms, 
problems with licensing worldwide, reduced efficacy of vaccine and the need to re-treat or re-ingest the 
parasite to maintain the benefit as well as because species like T. suis have a limited survival time in 
humans (McSorley and Maizels, 2012). However, a proposed solution to this problem was the use of 
somatic extracts and excretory/secretory (ES) products of helminths. Although, the mechanism of 
helminth therapy in inflammatory diseases is not clear, the immunomodulatory characteristics of 
helminths have been linked to the molecules secreted by these parasites. Diverse studies have shown that 
helminth- secreted products are able to manipulate host immune response and suppress the innate and 
adaptive immune response to helminths and unrelated antigens (Yatsuda et al., 2003) .  
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3.1.5 Somatic Extract and Excretory/Secretory Products of Helminth  
In several models, it has been shown that helminth infections lead to the generation of Th2 responses as 
well as anti-inflammatory/regulatory responses (van Riet et al., 2007). It is generally known that 
instructions for the development of specific immune responses are largely mediated by dendritic cells 
(DC), found in peripheral tissues as sentinel cells, which upon activation, migrate to draining lymph 
nodes to activate naıve T cells. The DCs not only present antigens but also provides signals that 
determine polarization of T cell development towards a Th1, Th2 or regulatory T cell phenotype 
(Kapsenberg, 2003). 
Helminth excretory/secretory products have been discovered to modify DCs in different ways ranging 
from influencing the DC maturation status to affecting the downstream signaling within the DCs (van 
Riet et al., 2007). Well characterized helminth derived molecules such as the filarial secreted glycoprotein 
ES-62 (Whelan et al., 2000), lyso-phosphatidylserine from S. mansoni (lysoPS) (Jenkins and Mountford, 
2005, van der Kleij et al., 2002), Ascaris derived PAS-1 protein (reference), and others have been found 
to be associated with Th2 immune skewing as well as induction of tolerogenic immune response 
stimulating naıve T cells to become regulatory T cells. Interaction with hosts’ adaptive immune response 
to down-regulate T- and B-cell responses via the induction of regulatory T cells or the anti-inflammatory 
cytokines IL-10 and TGF-b in the chronic phase of helminth infection has also been documented for the 
secretory molecules of helminths (Maizels and Yazdanbakhsh, 2003). 
Other parts of the hosts’ body defence have also not been spared the deleterious effects of helminth 
secreted molecules. For instance, complement function compromise has been demonstrated by a 
schistosomula excretory/secretory molecule (Ouaissi et al., 1981) as well as host immunoglobulin 
degradation (Auriault et al., 1981). These helminth molecules have also been shown to neutralize host 
derived immune molecules as shown in Schistosoma mansoni eggs which secrete a chemokine binding 
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protein (smCKP) that blocked IL-8 induced neutrophil migration in a contact hypersensitivity model 
(Smith et al., 2005), indicating that this molecule may protect the parasite from an inflammatory attack.  
Other additional wide range of parasite functions are attributed to these excretory–secretory (ES) products 
and these include penetration, establishment and survival in host tissues (Rosenzvit et al., 2006). 
Therefore, the characterization of ES products would aid in increasing the understanding of the 
mechanisms underpinning the strategies used by parasites for increasing the efficiency and persistence of 
infection in the host (Virginio et al., 2012). Proteomic analysis including mass spectrometry have helped 
the identification of ES products from in vitro cultures of parasitic helminths and has led to the 
identification of candidate host protective antigens and immunomodulators alike (Hewitson et al., 2008, 
Hewitson et al., 2011, Hewitson et al., 2013, Victor et al., 2012, Virginio et al., 2012) 
Anisakis pegreffii possesses a complex life cycle involving many species of organisms as hosts 
(intermediate and definitive hosts) (Bao et al., 2017). A major intermediate host of this nematode are sea-
foods, particularly fish, which are increasingly being consumed as healthy diets. As much as it has been 
established that live parasites of Anisakis are required to cause infection, it is known that molecules 
produced by this parasite are very potent being thermostable, pepsin-resistant and being able to survive in 
low pH (Caballero and Moneo, 2004). The significance of these thermostable and pepsin-resistant 
molecules is that in food previously contaminated by this parasite, but in which the parasite has been 
killed due to heat treatment, molecules released by the parasite could still cause gastroallergic reactions in 
hosts due to their heat and pepsin stability (Caballero and Moneo, 2004). This implies that with the 
importance of fish and fish products as major source of essential nutrient supply to humans, realistic 
alteration of food preparation, storage practices as well as the possibility of supplying and certifying fish 
foods free from Anisakis parasites or its secreted molecules to avoid allergic sensitization and recall might 
lack effectiveness. It is therefore imperative to understand the biology of this organism, the effector 
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molecules released at the point of host-parasite relationship, the functions of these molecules and how 
they may affect humans’ health. These would aid in the development of better diagnostic platforms and 
also identify molecules that may be beneficial for human health, particularly for treatment of autoimmune 
diseases.  
A number of studies have been carried out on the protein content of the sibling species of Anisakis 
pegreffii, known as Anisakis simplex (Arcos et al., 2014, Faeste et al., 2014, Bahlool et al., 2013). The 
proteomic analysis of the crude parasite extract of A. simplex was investigated by Faeste et al. (2014). In 
addition, a 2D gel proteomic analysis of the crude extract of A. simplex, A. pegreffii and their hybrid was 
also investigated by Arcos et al. (2014), even though only a few spots from the 2D gel were analysed.  
Furthermore, a few other studies have looked at individual proteins in the ES of A. simplex (Raybourne et 
al., 1986, Perteguer et al., 1996, Park et al., 2012) and of recent a protein from the ES of Contracaecum 
spp was also investigated (Mehrdana and Buchmann, 2017). To our knowledge there is no report as yet 
on extensive proteome analysis of A. pegreffii and its excretory/secretory molecules.  
Recently, the transcriptomes of A. pegreffii and A. simplex were investigated (Baird et al., 2016), the 
result of which has provided a first insight into the molecular biology of these parasites. This in addition 
to the whole genome sequence of A. simplex made available by Wellcome Trust Sanger Centre (2015), gives 
an excellent platform to investigate exclusively, by high thoroughput mass spectrometry (LC/MS/MS), 
the proteome of A. pegreffii, particularly proteins released by its excretory/secretory (ES) system. The 
knowledge of how the ES protein content of A. pegreffii differs from other helminths with regards to 
allergens and immunomodulation is crucial. This chapter is a follows up on the information provided in 
Chapter 1 on A. simplex immunogenic proteins. 
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The aims of this study therefore are: 
1) Investigate in A. pegreffii the presence of the immunogenic proteins described for A. simplex 
using high throughput mass spectrometry (LC/MS-MS). 
2) Profile the proteins associated with the excretory/secretory system of A. pegreffii and 
compare them to those obtained in the crude extract of the same species and the sibling 
species, A. simplex. 
3) Identify the mechanisms employed to release secreted molecules to sites of activity. 
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3.2 Specific Methods 
3.2.1 Experimental Design and Statistical Rationale 
Excretory/secretory (ES) product collection, crude extract preparation and SDS-PAGE analysis of protein 
were performed with at least two biological replicates and three technical replicates. The general methods 
of parasite materials collection; molecular identification of A. pegreffii, preparation of excretory/secretory 
products (ES) and parasite crude extracts (CE); 1D- LC-MS/MS analysis and protein identification are as 
described in the general methods in Chapter 2. 
3.2.2 Morphological Characterization by Scanning Electron Microscopy 
Scanning Electron Microscopy (SEM) was performed on L3 larvae of Anisakis spp. The L3 larvae were 
fixed in 2% paraformaldehyde and 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.0) 
(Electron Microscopy Sciences) for 1 hour at room temperature.  After fixation, samples were washed 
with same buffer 3 times and then dehydrated in a series of ethanol solutions (50%, 70%, 90%, 95% and 
2X 100%) and embedded in Agar 100 resin (Agar Scientific, Stansted, UK) to anchor the sample for 
surface coating. Larvae samples were processed in a critical point drier “Bomer-900” with Freon 13, and 
then sputter coated with a thin layer of gold in an Edwards S150 sputter coater. Samples were mounted on 
SEM stubs for scanning. SEM imaging was performed using a FEI Quanta 200 ESEM (ESEMTM) or the 
XL 30 scanning Electron Microscope (Philips) operating under high vacuum. All measurements were in 
micrometers.  
3.2.3 Secretome Prediction 
 Protein sequences were analysed for the presence of signal peptides and transmembrane regions using 
SignalP 4.0 (Petersen et al., 2011), TMHMM 2.0 (http://www.cbs.dtu.dk/services/TMHMM/),  and 
information from the Uniprot database. Sequences with no signal peptides were analysed for non-classical 
secretion pathway, using SecretomeP2.0. The SecretomeP neural network (NN)-score threshold value for 
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non-classically secreted proteins was >0.6 (Bendtsen et al., 2004). Gene Ontology (GO) annotation of 
molecular function, subcellular localization and biological processes were performed using Blast2GO 
(Conesa et al., 2005)  and confirmed using Uniprot (Uniprot, 2015).  
3.2.4 Bioinformatic analysis 
 The sequences of identified proteins that were uncharacterized were used in a Blast search of the non- 
redundant National Centre for Biotechnology Information (NCBI) protein sequence database to identify 
homologous proteins. In addition, sequences of selected immunomodulatory proteins from other 
helminths were also used in a Blast search against A. pegreffii transcriptome database as well as the A. 
simplex genome database to identify homologous proteins in Anisakis spp. Homology was inferred and 
recognized by using statistical E-values below 1 X 10-4, bits scores of >50, and in addition a stricter 
threshold of sequence coverage length percentage (>50%) and sequence similarity of >40%. Domains 
present in the matched proteins and query proteins were searched using Prosite (http://prosite.expasy.org) 
to confirm homology. 
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3.3 Results 
3.3.1 Morphological Identification of Anisakis  
Tiger flathead fish (Figure 3.1), purchased from seafood retail shops were dissected. Eencysted larvae of 
Anisakis were macroscopically observed lining the gut of infected fish (Figure 3.2). 
 
Figure 3.1.  Tiger Flathead (Platycephalus richardsoni) 
 
 
Figure 3.2.  Encysted larvae (L3) in the intestinal tissue of Dissected Tiger Flathead 
Encysted larvae
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Morphological characterization was by optical microscopy and the scanning electron microscopy (SEM) 
visualization of certain features of the L3 larvae, which identified the larvae as Anisakis Type 1 larvae. 
Analysis of the anterior end of the larvae showed the mouth of the larvae rounded with dorsal and 
ventrolateral lips. The tooth was located ventral to the mouth. At the posterior end, the excretory pore 
opening was situated between the ventrolateral lips. The rectum opened at the anus and the anal tail is 
rounded, with a terminal mucron (Figures 3.3 and 3.4). The presence of a tail mucron was the principal 
character that differentiated Anisakis type I from Anisakis Type II.  
 
Figure 3.3.  Morphological Characterization by Optical Microscopic Examination 
 
A-Posterior end showing mucron (Leica Optical Microscope Mag X40) 
B-Posterior end showing mucron (S2-11 Stereo Microscope) 
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Figure 3.4:  Morphological Characterization by Electron Microscopic Examination. 
 
(A). Posterior end of Anisakis spp, showing mucron. (B) Mucron and anal pore of Anisakis spp. (C) 
Anterior part of Anisakis spp showing the mouth, excretory pore, lips and boring tooth. 
Mucron
A 
B  C 
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3.3.2 Molecular Characterization  
3.3.2.1 ITS-1 and ITS-2 amplification 
First and second internal transcribed spacers of nuclear ribosomal DNA (ITS-1 and ITS-2) from A. 
pegreffii were amplified using PCR from the genomic DNA of the identified type 1 Anisakis L3 
larval morphotypes to give a 441- and 308-bp product for ITS-1 and ITS-2 regions, respectively 
(Figure 3.5).  
 
 
Figure 3.5.  ITS-1 and ITS-2 of A. pegreffii Amplification by PCR 
 
Lanes 1=Molecular marker (100bp ladder from NEB); Lane 2=negative control; Lanes 3-
15=Amplified products of DNA samples of Anisakid larvae fom Tiger Flathead fish. 
 
3.3.2.2 PCR-RFLP analysis  
Anisakis pegreffii was identified to species level by PCR-RFLP and DNA sequencing of amplified 
product. Larvae identification of the ITS 5.8 rRNA region of A. pegreffii produced a fragment of 
approximately 1000bp (Figure 3.6). Three clear bands of 330, 280 and 240bp were observed in RFLP 
1       2       3       4      5     6    7      8      9     10     11    12   13    14     15
441bp-ITS-1
308bp ITS-2
500bp
500bp
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patterns digested with HinfI for A. pegreffii (Figure 3.7), whilst digestion with HhaI produced two 
fragments of 550 and 430bp (Figure 3.7). Anisakis typica was used as negative control with 2 bands 
observed for digestion with HinfI (350 and 620bp) and 4 bands for digestion with HhaI (320, 240, 
180 and 160bp) (Figure 3.7). The A. typica larva was recovered along with A. pegreffii larvae in 
infected fishes dissected in this study. For A. simplex sensu stricto, three bands would be observed for 
digestion with HinfI (620, 250 and 80bp) and the same 2 fragments as for A. pegreffii HhaI digestion 
if present. No A. simplex larva was identified during the period of this study. 
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Figure 3.6. Amplification of the rRNA ITS-1 region of Anisakis L3 larvae 
 
M=Molecular marker (100bp Ladder from NEB); Lane 1= negative control; Lanes 2-6=A. 
pegreffii L3 larvae amplified product of DNA samples; Lane 7=A negative control of a different 
Anisakid species larvae.  
 
 
Figure 3.7.  Molecular characterization of AP by PCR-RFLP of rRNA ITS region 
M=Molecular marker (100bp Ladder from NEB); Lane 1- 6 =A. pegreffii L3 larvae ITS-1 region 
amplified product, digested with Hinf1; Lane 7=A negative control of a different Anisakid species 
larva digested with Hinf1.  
 
Lanes 1-5 = A. pegreffii L3 larvae ITS-1 region amplified product, digested with Hha1; Lane 6 = 
A negative control of a different Anisakid species larva digested with Hha1. 
 
Three clear bands of 330, 280 and 240bp were observed in RFLP patterns digested with HinfI for 
A. pegreffii whilst digestion with HhaI produced two fragments of 550 and 430bp. Anisakis typica 
was used as negative control with 2 bands observed for digestion with HinfI (350 and 620bp) and 
4 bands for digestion with HhaI (320, 240, 180 and 160bp) 
M   1     2     3      4     5     6    7
1000bp
500bp
550bp
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500bp
330bp
280bp
240bp
M  1   2   3  4    5  6   7   M   1   2   3   4   5   6
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3.3.3 Sodium Dodecyl Sulphate–Polyacrylamide Gel Electrophoresis (SDS–PAGE) analysis 
Crude extracts (CE) and excretory/secretory (ES) products of proteins from A. pegreffii were 
separated by SDS-PAGE. The protein profiles of the CE and ES products of L3 larvae of A. pegreffii 
are shown in Figure 3.8. The analysis revealed a complex and distinct banding pattern for both CE 
and ES. Most of the proteins were distributed between 10 –250 kDa. The ES showed a profile with 
major bands between >37 and 150 kDa. The ES of A. pegreffii, however, appeared to have more 
proteins at the lower molecular weight sizes, particularly below 15kDa as shown by SDS-PAGE and 
in the subsequent proteomic analysis obtained thereafter. The crude extract however, showed more 
proteins profiled than for ES. 
 
Figure 3.8.  12% SDS-PAGE protein profiles of somatic and excretory/secretory 
proteins of Anisakis pegreffii. 
 
Lane M=Molecular Marker (unstained, Biorad); Lane 1=A. pegreffii somatic extract; Lane 2=A. 
pegreffii excretory/secretory product. 
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3.3.4 Database searching and protein identification 
The crude extract and ES product SDS-PAGE gel lanes were each cut into 24 gel pieces for tryptic 
peptide analysis by LC/MS/MS. OMSSA and X! Tandem search engines results, based on spectra 
assigned to tryptic peptide sequences at the 95% confidence level and a probability of greater than 
99.0% with at least 2 identified unique peptides were then linked to protein identification. The 
resulting peptide masses, patterns and sequences were compared to the protein database entries for 
the transcriptome of Anisakis pegreffii using both Scaffold software and Peptide shaker with 
SearchGui.  
The numbers of unique matching peptides detected varied from 2 to 76. Proteins identified with only 
1 unique peptide were excluded from this analysis. A total of 726 proteins (from both crude and ES 
products) were identified for A. pegreffii from A. pegreffii transcriptome database. Different isoforms 
of some specific proteins were found distributed in both the CE and ES.  Two hundred and thirty-five 
proteins identified by molecular masses were unique to A. pegreffii crude extract (Figure 3.9) while 
148 proteins were unique to the excretory/secretory product. A large number of proteins (a total of 
343 proteins) were shared between the ES and CE (Figure 3.9). Eighty one (11%) of total proteins 
identified was hypothetical proteins. None of the selected allergy-reducing protein molecules from 
other helminths used in a Blast search against A. pegreffii proteome, transcriptome database as well 
as the A. simplex genome resulted in any homolog in Anisakis. 
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Figure 3.9.  Venn diagram showing the distribution of  Anisakis pegreffii Proteome 
proteins. 
 (N=726 proteins).  
 
3.3.5 Secretory pathway prediction of A. pegreffii proteins.  
The secretory pathway prediction for all proteins (726 proteins) identified in this study, predicted 5% 
with signal peptides and 25% as being secreted through the non-classical secretory pathway; resulting 
in a total of 30% proteins predicted as secretory proteins. However, experimentally, 46% of the total 
proteins identified were identified as secretory products.  
3.3.6 Crude extract of A. pegreffii 
Two hundred and thirty-five proteins were identified exclusively in the CE of A. pegreffii. Eighteen 
of these were hypothetical proteins with molecular weights below 45kDa, except for four of these 
proteins with sizes between 64-102kDa. In the crude extract, the major molecular function categories 
were binding (GO: 0005198), oxidoreductase (GO: 0016491) and structural molecule (0005198) 
Anisakis pegreffii proteome analysis
Total ES 
proteins=491
Proteins unique to 
excretory/secretory  
(ES) product
N=148
Proteins 
shared
N=343
Proteins unique to 
crude extract (CE)
N=235
Total CE 
proteins
N=578
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activities (Figure 3.10). Highly abundant proteins identified in A. pegreffii CE included proteins 
involved in metabolic processes, proteins associated with oxidoreductase activities, transcription or 
translation processes (RNA binding/ribonucleoproteins), structural molecule activity proteins, motor 
proteins and cellular processes proteins. Most of the proteins found in crude extract were derived 
from cell parts, macromolecular complex, organelles, organelle parts, membrane and membrane parts 
(Figure 3.11). Table 3.1 shows the top 30 abundant proteins unique to the crude product of A. 
pegreffii. 
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Figure 3.10.  Molecular Function Terms (Level 2) for Proteins in A. pegreffii Crude 
Extract. 
 
 
Figure 3.11.  GO annotation of the cellular component of A. pegreffii proteins in 
Crude Extract. 
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Table 3.1: Top Thirty Abundant Proteins Identified In A. Pegreffii L3 larvae Crude 
Extract. 
 
# Presence 
of signal 
peptide 
SecretomeP 
Prediction 
Uniprot 
Accession 
Protein Name 
(BlastP) 
Organism GO 
Annotation 
1 N Y F1L2J6 calponin-like 
protein ov9m 
A. suum GO:0003779 
2 N N A0A0B2VVW7 Myosin-4  (Unc-
54) 
T. canis GO:0003779 
GO:0003774 
GO:0005524 
 
3 N N F1L3R9 paramyosin A. suum GO:0003774 
4 N N F1KRV7 pyruvate 
carboxylase 1 
A. suum GO:0004736 
GO:0006090 
5 N N F1KT77 nuclease domain-
containing protein 
1 
A. suum GO:0031047 
6 N Y A0A0B2VZN8 Succinate 
dehydrogenase 
[ubiquinone] 
flavoprotein 
subunit, 
mitochondrial 
T. canis GO:0016491 
GO:0055114 
7 N N F1KU54 dimethylglycine A. suum GO:0016491 
GO:0055114 
8 N N F1L8F3 putative glutamine 
synthetase 
A. suum GO:0004356 
GO:0006542 
9 N N F1LBZ4 60s ribosomal 
protein L6 
A. suum GO:0003735 
GO:0006412 
10 N N F1KTS9 Glycine cleavage 
system P-protein 
domain containing 
protein 
A. suum GO:0016491 
GO:0055114 
11 N N A0A0M3KB56 227 kDa spindle-
and centromere-
associated protein 
[Ascaris suum] 
uncharacterized 
protein in Anisakis 
simplex 
Anisakis 
simplex 
- 
12 N N F1KUZ9 vinculin A. suum GO:0005198 
GO:0051015 
GO:0007155 
13 N Y U1MSW0 bm-dap-1 protein 
(death associated 
protein) 
A. suum - 
14 N Y F1L9N2 putative enoyl A. suum GO:0003824 
GO:0008152 
15 N N U1M5C9 heat shock 70kDa 
protein 4 
A. suum GO:0000166 
GO:0005524 
16 N N U1MRY4 putative trans-2- A. suum GO:0016491 
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enoyl- reductase GO:0055114 
17 N N A0A0M3K9A3 small heat shock 
(protein lethal 2 
essential for life) 
A. suum  
18 N N F1LHE1 40S ribosomal 
protein S14 
A. suum GO:0003735 
GO:0006412 
19 N N A0A0B2W7B0 hypothetical protein 
(Spectrin beta 
chain) 
T.  canis GO:0003779 
GO:0005200 
GO:0007010 
GO:0051693 
20 N N Q9XYS5 dihydrolipoyl 
dehydrogenase-
binding protein 
A. suum GO:0016746 
GO:0008152 
21 N N A0A0B2V0E7 Malonate-CoA 
ligase 
T.  canis GO:0016874 
GO:0008152 
22 N N F1LHC0 60S ribosomal 
protein L30 
A. suum GO:0003735 
GO:0006412 
23 N N F1KYL5 putative glycogen 
synthase 
A. suum GO:0016740 
GO:0005978 
24 N N F1LAJ2 40s ribosomal 
protein SA 
A. suum GO:0003735 
GO:0006412 
25 N N U1MIY7 succinate-
semialdehyde 
A. suum GO:0016491 
GO:0055114 
26 N N F1KS22 Trifunctional 
enzyme subunit 
alpha 
A. suum GO:0016491 
GO:0055114 
GO:0008152 
27 N N F1KPK1 bmkettin (Titin-
Immunoglobin-like 
domain) 
A. suum - 
28 N N F1KSG5 ubiquitin-activating 
enzyme E1, variant 
A. suum GO:0005524 
GO:0016874 
GO:0006464 
29 N N A0A0M3IZK3 beta-tubulin isotype 
1 
A.  simplex GO:0005200 
GO:0005525 
GO:0007010 
GO:0007010 
30 N N A0A0B2VZB3 40S ribosomal 
protein S17 
T. canis GO:0003735 
GO:0006412 
 
Note: Selection based on quantitative value of normalized total spectra identified in the crude 
extract of A. pegreffii L3 larvae.
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3.3.7 Excretory/Secretory Proteins of Anisakis pegreffii 
Of the 148 proteins exclusively found in the ES, twenty-five (17%) were hypothetical proteins for 
which there were no homologous proteins found. The molecular weights of these ES hypothetical 
proteins ranged from 9kDa to 44kDa. The three major molecular function categories in the ES were 
binding (GO: 0005198), peptidase (GO: 0008233) and transferase (GO: 0016740) activities (Figure 
3.12). Motor activity was not found in the ES, but was common in the CE. Most of the molecules 
identified in the ES of A. pegreffii were predominantly localized in the intracellular parts, 
macromolecular complex, membrane, organelles and extracellular region parts (Figure 3.13). 
Difference in the biological processes of proteins found in both ES and CE is highlighted in Figure 
3.14. Table 3.2 shows the top 30 abundant proteins unique to the excretory/secretory product of A. 
pegreffii. 
 
Figure 3.12.  Distribution of Gene Ontology Molecular Function Terms (Level 2) for 
Proteins Uniquely Identified in A. pegreffii Excretory/Secretory Products. 
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Figure 3.13.  GO annotation of the cellular component of A. pegreffii proteins 
unique to Excretory/Secretory Product. 
 
 
Figure 3.14.  Biological processes of proteins in the crude and excretory/secretory 
proteins of A. pegreffii. 
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Table 3.2: Top Thirty Abundant Proteins Identified in A. pegreffii 
Excretory/Secretory Products.  
# Signal 
peptide 
SecretomeP 
Prediction 
Uniprot Protein Name 
(BlastP) 
Organism GO 
annotation 
1 N Y F1LBC9 putative cuticular 
collagen 12 protein 
A. suum GO:0042302 
2 N N A0A0B2UVC6 Cuticle collagen dpy-
5 
T. canis GO:0042302 
3 N N F1L7L2 Annexin A. suum GO:0005509 
4 N N F1L8K5 S-methyl-5’-
thioadenosine 
phosphorylase 
A. suum GO:0016740 
Go:0009116 
5 N N A0A0B2VMG6 Maltate-
glucoamylase 
intestinal 
T. canis GO:0003824 
GO:0005975 
6 Y N A0A183V4J4 Uncharacterized 
protein 
T. canis - 
7 N N F1KQL5 Aminopeptidase N A. suum GO:0004177 
GO:0006508 
8 Y N U1MUG1 Cbn-ccg-1 protein A. suum - 
9 Y N A0A0M3J0R4 Uncharacterized 
protein 
A .simplex GO:0016021 
10 N N A0A0M3KJU5 Uncharacterized 
protein 
A .simplex - 
11 N N A0A0B2VMZ9 Collagen alpha-5(VI) 
chain 
T. canis GO:0042302 
12 Y N U1NL31 Uncharacterized 
protein 
A. suum GO:000847 
GO:0043085 
13 N N F1L375 3-hydroxyacyl-CoA 
dehydrogenase 
A. suum GO:0016491 
GO:0006831 
14 N N U1MDI1 Purine nucleoside 
phosphorylase 
A. suum GO:0004731 
GO:0009116 
15 N N U1NJ88 Proteasome subunit 
alpha type 
A suum GO:0004175 
GO:0006508 
16 N N F1L093 Carbonic anhydrase A suum GO:0006730 
17 N N U1NGD9 3-oxoacyl-reductase A suum GO:0016491 
18 Y N U1NCC6 Neprilysin-1 A. suum GO:0004222 
19 N Y U1LX65 Galectin A. suum GO:0030246 
20 N N A0A0M3KJW8 Uncharacterized 
protein 
A .simplex GO:0004867 
GO:0010951 
21 Y N F4MST7 ANISERP protein A .simplex GO:0005615 
22 N Y A0A183UR79 Uncharacterized 
protein 
T. canis GO:0036374 
GO:006508 
GO:006751 
23 N N A0A0B2VPT0 Snaclec 
bothrojaracin subunit 
alpha 
T. canis - 
24 N N A0A0B2V7Q3 Putative serine T. canis GO:0008233 
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protease GO:0006508 
25 Y N A0A0B2VW18 Hemicentin-1 
thrombospondin 
type-1 [TSP1] repeat 
T. canis - 
26 N N A0A0B2UX03 Uncharacterized 
protein 
T. canis - 
27 N N A0A0B2URF5 Glucosamine-6-
phosphate isomerase 
T. canis GO:0016853 
GO:0005975 
28 N N F1KYX7 UTP-glucose-1-
phosphate 
urisdylyltransferase 
A. suum GO:0016740 
GO:0008152 
29 N Y F1LGJ2 Endochitinase A. suum GO:0005975 
30   F1L6Z5 Sepiapterin A. suum - 
Note: Selection based on quantitative value of normalized total spectra identified in the crude 
extract of A. pegreffii L3 larvae.
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3.3.8 Proteins common to both crude and excretory/secretory products 
A total of 335 proteins were shared between the CE and ES. The two major molecular function categories 
in the proteins shared by CE and ES were binding (GO: 0005198) and transferase (GO: 0016740) 
activities (Figure 3.15) while major biological processes identified among these groups of proteins are 
embryo development and metabolic processes (Figure 3.16). The cellular components of these commonly 
shared proteins between CE and ES are shown in Figure 3.17. The Gene ontology (GO) term assigned to 
this protein is GO: 0006869 as it is associated with lipid transport. 
 
Figure 3.15.  Molecular functions of proteins common to Crude extract and 
Excretory/Secretory products of A. pegreffii. 
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Figure 3.16.  Biological Processes of proteins common to crude extract and 
excretory/secretory products. 
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Figure 3.17.  GO annotation of the cellular component of A. pegreffii proteins common 
to both crude and excretory/secretory products. 
 
3.3.9 Allergens identified 
Of the previously described fourteen IUIS allergens of A. simplex, 9 were identified in this study by 
proteomic analysis in A. pegreffii (Table 3.3). Among the 6 non-IUIS allergens accepted for Anisakis, 3 
were identified in this study from the proteome of A. pegreffii (Table 3.3). Of the putative allergens, 
described in the transcriptome of A. pegreffii, Hsp70, cyclophilin, enolase and glutathione–s-transferase 
were identified in the A. pegreffii proteome (Table 3.4).  
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Table 3.3: Allergens of A. simplex Identified in A. pegreffii L3 larvae Proteome. 
 
IUIS Names Protein name Molecular 
Weight 
(kDa) 
Identified in  A. 
pegreffii 
proteome (This 
study) 
CE         ES 
References 
 
Ani s 1 Ani s 1 21 Yes  Yes  (Moneo et al., 2000) 
Ani s 2 Paramyosin 100 Yes  No  (Perez-Perez et al., 
2000) 
Ani s 3 Tropomyosin 33 Yes  No  (Asturias et al., 2000a) 
Ani s 4 Cystatin 9 Yes  Yes  (Rodriguez-Mahillo et 
al., 2007, Moneo et al., 
2005) 
Ani s 5 SXP/RAL-2 15 Yes  Yes  (Kobayashi et al., 2007) 
Ani s 6 Serine protease 
inhibitor 
7 No  No  (Kobayashi et al., 2007) 
Ani s 7 (major 
allergen) 
Ua3 recognized 
allergen 
139 No  Yes  (Rodriguez et al., 2008) 
Ani s 8 SXP/RAL-2 16 Yes  Yes  (Kobayashi et al., 2007) 
Ani s 9 SXP/RAL-2 15 Yes  Yes  (Rodriguez-Perez et al., 
2008) 
Ani s 10 Not given 23 No  No  (Caballero et al., 2011) 
Ani s 11 Not given 30 No  No  (Kobayashi et al., 2011) 
Ani s 12 Not given 33 No  No  (Kobayashi et al., 2011) 
Ani s 13 Haemoglobin 37 Yes  Yes  (Gonzalez-Fernandez et 
al., 2015) 
Anis 14 New Major 
allergen 
23.5 No  No  (Kobayashi et al., 2015) 
Ani s 24kDa 24kDa protein 24 Yes  Yes  (Park et al., 2012) 
Ani s FBPP Fructose-1, 6-
bisphosphatase 
40 Yes  Yes  (Lopez and Pardo, 2011, 
Baur and Posch, 1998) 
Ani s CCOS3 Cytochrome c 
oxidase subunit 3 
29 No  No  (Kim et al., 2006) 
Ani s Cytochrome 
B 
cytochrome b 42 No  No  (Mari et al., 2009, Faeste 
et al., 2014) 
Ani s NADHDS4L NADH 
dehydrogenase 
subunit 4L 
9 No  No  (Mari et al., 2009, Faeste 
et al., 2014) 
Ani s Troponin Troponin-like 
protein 
19 Yes  No  (Mari et al., 2009, Faeste 
et al., 2014) 
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Table 3.4: Transcriptome-described Allergens of A. pegreffii Identified in The Proteome. 
 
Unigene ID IUIS 
Nomenclature 
Closest Match 
in Allergen 
Online 
database 
Closest Match 
in Nr 
Size 
(bp) 
CE ES References 
CL872.Contig1
_AP1A 
 
Unassigned Heat shock  
70 kDa protein 
Heat shock 
protein 70 (A. 
pegreffii) 
644 Yes Yes (Baird et 
al., 2016, 
Faeste et 
al., 2014) 
CL1265.Contig
1_AP1A 
Unassigned cyclophilin Peptidyl-prolyl 
cis-trans 
isomerase 3 (A. 
suum) 
171 Yes Yes (Baird et 
al., 2016) 
Unigene10435_
AP1A 
Unassigned cyclophilin Peptidyl-prolyl 
cis-trans 
isomerase 3 
[T. canis] 
172 Yes Yes (Baird et 
al., 2016) 
Unigene2939_
AP1A 
Sal s 2.0101 Enolase 3-2 Enolase 
[Anisakis 
simplex] 
431 Yes Yes (Baird et 
al., 2016, 
Faeste et 
al., 2014) 
Unigene6873_
AP1A 
Asc s 13.0101 Glutathione S-
transferase 
1 
Sigma class 
glutathione S-
transferase 
[Baylisascaris 
schroederi] 
203 Yes Yes (Baird et 
al., 2016, 
Faeste et 
al., 2014, 
Arcos et 
al., 2014) 
Unigene8467_
ASIA 
Thu a 3.0101 Fructose 
bisphosphate 
aldolase 1 
Ascaris suum 351 Yes Yes (Baird et 
al., 2016, 
Faeste et 
al., 2014) 
Unigene2527_
ASIA 
Thu a 3.0101 Fructose 
bisphosphate 
aldolase 2 
Ascaris suum 347 Yes Yes (Baird et 
al., 2016) 
CL1712.Contig
2_ASIA 
unassigned Polyprotein 
allergen/antige
n, partial-
ABA-1 
allergen, 
partial 
Ascaris suum 160 Yes Yes (Baird et 
al., 2016) 
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3.4 Discussion 
The result of this study is consistent with the previous proteomic work on crude extract of the sibling 
species A. simplex performed by Arcos and colleagues (Arcos et al., 2014) as well as by Faeste et al. 
(Faeste et al., 2014). Arcos et al. (Arcos et al., 2014) performed a proteomic analysis on the crude extract 
of both A. simplex and A. pegreffii. Over 95% of proteins identified in these 2 studies were also found by 
proteomic analysis of A. pegreffii CE and ES products in this study. Such proteins include fructose 
aldolase bisphosphate (FABP), enolase, actin, filamin, haemoglobin, triosephosphate isomerase, 
glyceraldehyde3-phosphate dehydrogenase and 14-3-3 proteins. These proteins have been previously 
identified in the CE of A. simplex and A. pegreffii  (Arcos et al., 2014, Faeste et al., 2014) as well as from 
the ES of other helminths (Sotillo et al., 2010, Liu et al., 2009, El Ridi and Tallima, 2009). This finding 
affirms the notion that parasites employ a conserved set of proteins for parasite–host interaction 
mechanisms and host immune response evasion (Liu et al., 2009).  
3.4.1 Proteins common to both crude and excretory/secretory products 
Some proteins were shared between ES and CE. Several identified in this work, particularly those shared 
between CE and ES products, had a higher abundance in ES than in CE. Some of these proteins are 
glycolytic enzymes such as glyceraldehyde-3-phosphate dehydrogenase (GADPH) and enolase. GADPH 
has been identified in ES product from adult Echinostoma friedi  (Bernal et al., 2006) and enolase from 
ES product of Fasciola hepatica (Bernal et al., 2004), both trematodes, while also being identified on the 
surface of filarial parasites such as Onchocerca volvulus (Jolodar et al., 2003). Enolase and GAPDH have 
been reported to facilitate invasion and migration in host tissue. Therefore, the presence of shared proteins 
between CE and ES may not be due to contamination (Jolodar et al., 2003). Since a number of ES 
proteins from A. pegreffii were found in both CE and ES, one can suggest based on this that this group 
most likely include proteins critical for survival, to manage stress of change of environment and to deflect 
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possible immune response. In addition, the presence of such proteins in both CE and ES products 
suggests that secretion of these proteins might follow non-conventional secretory pathway (Sotillo et al., 
2010). Many of the proteins gave significant matches to the same band indicating that each band 
comprises more than one protein. 
3.4.2 Excretory/Secretory proteins of A. pegreffii 
A number of proteins, identified as part of A. pegreffii excretory/secretory molecules in this study were 
not predicted to be secreted molecules. These proteins must have reached the exterior or be released by 
novel or alternative mechanisms indicating that the mechanism, by which these molecules are released, 
needs further investigation. According to Hewitson et al. (Hewitson et al., 2009), bioinformatic 
approaches to predict secreted proteins on the basis of signal peptide sequences may have some merit 
(Harcus et al., 2004, Nagaraj et al., 2008), however, it has been noted that in metazoans not all secretory 
proteins will be exported from the organism. It is also reported that a large proportion of proteomic data 
show a significant number of ES proteins are not encoded with a signal peptide (Cass et al., 2007, 
Hewitson et al., 2008, Moreno and Geary, 2008). This emphasizes the importance of empiric proteomic 
studies.  
The secretome of A. pegreffii was found to be high in abundance for particular sets of proteins, which 
include (i) Enzyme regulator proteins implicated in immunomodulatory roles (Hewitson et al., 2009). 
These include serpins, cystatins and Alpha-2-macroglobulins. The macroglobulins are known to inhibit 
proteases from all catalytic classes including serine-, cysteine-, aspartic- and metalloproteinases and in 
addition function as an inhibitor of thrombin, coagulation and fibrinolysis. (Sottrup-Jensen, 1989, de Boer 
et al., 1993). 
(ii) Peptidases, such as neprilysin known to regulate and inactivate signalling peptides involved in the 
immune system (Bland et al., 2008); aminopeptidases such as leucine aminopeptidases and puromycin-
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sensitive aminopeptidases belonging to the M17 and M1 classes of aminopeptidases and cysteine 
peptidases, all of which have been implicated in functions critical to the development, establishment and 
survival of parasites within the mammalian host (Robinson et al., 2008).  Damage associated molecular 
pattern (DAMP) homologous proteins such as annexins, and pathogen-associated molecular pattern 
(PAMP) molecules such as thioredoxin peroxidase, able to modulate immune cells were also identified. 
Normally, classical PAMPs such as bacterial lipopolysaccharide activate innate immune cells (including 
dendritic cells and macrophages) that promote pathogen clearance by pro-inflammatory Th1-mediated 
responses. In contrast, helminths PAMPs stimulate innate cells that drive a Th2-biased environment 
(Perrigoue et al., 2008). Other helminth proteins with immunomodulatory properties identified include 
nematode galectins and macrophage migration inhibitory factors (MIFs). Hewitson et al. suggested that in 
a Th2 environment, MIF may be functioning to prevent the classical, pro-inflammatory, activation of 
macrophages in mammalian hosts (Hewitson et al., 2009).   
The proteins found in the ES of AP indicate specific functional adaptation for immune modulation, tissue 
invasion, feeding and digestion with nematode development. The result of this study agrees with the 
statement by Dissous et al. (Dissous et al., 2006) which states that parasitic helminths remain major 
pathogens of both humans and animals throughout the world and the success of their infection is 
dependent on their capacity to counteract host immune responses and to exploit host-derived signal 
molecules for their development. 
3.4.3 Allergens identified in A. pegreffii 
The results of this work show that some of the previously described allergens of Anisakis simplex were 
not identified in this study. These include Ani s 6, Ani s 11, Ani s 11-like, Ani s 12 and Ani s 14. 
However, they have been identified in the transcriptome of A. pegreffii (Baird et al., 2016).  Their absence 
in the proteomic data generated from this study might be as a result of low expression of these proteins in 
the proteome at the time of collection of A. pegreffii extracts which is an indicator of the regulation of 
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particular processes, only some of which were defined at the time of extract collection (Bennuru et al., 
2011). In addition, this may also be due to instability of some proteins under the conditions used for 
extraction. Most of the allergenenic proteins were found in both crude and excretory/secretory products 
except for the structural molecule allergens (paramyosin and tropomyosin) which were present in only the 
crude extract. The result of this work has increased our knowledge of the repertoire of A. pegreffii ES 
antigenic/allergenic proteins and the identification of ES proteins may help in the discovery of new 
candidates for immunodiagnosis.  
3.4.4 Absence of potential allergy-reducing molecules in the A. pegreffii proteome 
The results from this study also showed that among the protein repertoire of A. pegreffii identified, certain 
molecules critical for allergy-reduction were absent. Homology Blast search of the transcriptome and 
genome of A. simplex using the sequences of these molecules found in other helminths, confirmed the 
absence of these proteins in Anisakis.  
The best-characterized helminth-derived product shown to reduce allergic responses is suggested to be 
ES-62, a secreted 62 kDa glycoprotein from a filarial nematode (Acanthocheilonema viteae) (Melendez et 
al., 2007, McInnes et al., 2003, Erb, 2009). This molecule is reported to contain phosphorylcholine 
moieties, which are largely responsible for immunomodulation. Other suggested known helminth-derived 
products that may have the potential to reduce allergic responses as reported by Daniłowicz-Luebert 
(Danilowicz-Luebert et al., 2011) include smCKBP (S. mansoni egg-secreted chemokine-binding 
protein), sm22.6 (soluble protein associated with the S. mansoni tegument) PIII (a multivalent antigen of 
S. mansoni adult worms) and sm29 (a membrane bound glycoprotein on the S. mansoni adult worm 
tegument), schistosomal lysophosphatidylserine (lyso-PS) and PAS-1 (protein of Ascaris suum 1) of 
Ascaris spp. Homologs of these molecules were not found among the proteins identified in the proteome 
of A. pegreffii in this study. A further confirmatory search of the whole transcriptome data of A. simplex 
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and A. pegreffii as well as in the genomic data of A. simplex by a homology Blast using the sequences of 
the above named proteins resulted in homologs of these proteins not being identified in Anisakis.  
Human anisakidosis has been known to be peculiar because the implicated parasite in this infection is not 
adapted to live in humans and infection is transitory. Hence, differences have been expected between A. 
simplex pathogenesis and those caused by other helminths in humans. Overt hypersensitivity reactions as 
is seen in Anisakis infection are rare in other helminths unless provoked by natural or drug-induced death 
of parasites residing in tissues (Audicana and Kennedy, 2008). The result of this work, which shows the 
absence of major allergy-reducing molecules in Anisakis, has shed more light on the biology of this 
parasite and its secretion of molecules that result in overt hypersensitivity. The absence of major 
molecules associated with allergy-reduction in Anisakis, may be one of the contributing factors as to why 
Anisakis nematodes are able to induce a Th2-biased immune response like all other helminths and yet be 
able to also elicit allergic responses. Further studies need to be done to affirm that the absence of these 
molecules contribute significantly to the allergy-inducing properties of Anisakis spp. 
In conclusion, one-dimensional liquid chromatography followed by mass spectrometry (1D/LC/MS/MS) 
analyses of AP crude and excretory/secretory products have identified proteins of key metabolic 
pathways, immunomodulation and allergenicity. This study provides the first in-depth characterization of 
the ES products from the third larval stage of Anisakis pegreffii, comparing the excretory/secretory 
molecule content with the crude extract. This is a crucial step in enhancing our knowledge and 
understanding of the biology of this parasite and its interactions with its mammalian host. The study 
provides a basis for further molecular investigations aimed at exploring the biological role of the proteins 
identified and their potential utilisation as diagnostic and/or therapeutic targets. 
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 PROTEOMIC ANALYSIS OF ANISAKIS CHAPTER 4:
PEGREFFII EXOSOMES 
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4.1 Introduction 
Different cellular pathways, which include conventional and unconventional secretory routes, are 
employed in exporting eukaryotic molecules (Nickel and Rabouille, 2009, Schekman, 2010). Proteins 
secreted conventionally go through the classical endoplasmic reticulum (ER) Golgi dependent secretory 
pathway (Schekman, 2010). This pathway is dependent on a N-terminal signal peptide and is responsible 
for polypeptide translocation into the lumen of the ER (Schekman, 2010). Alternatively, proteins lacking 
these signal peptides are transported independently of the classical ER Golgi route by the unconventional 
secretion pathway (Nickel and Rabouille, 2009). Microvessicles and exosomes are the major types of 
nano-sized lipid bilayer membrane-bound vesicles described, known to carry several atypical secreted 
proteins (Tkach and Théry, 2016). Their size and cargo content determine their names (Marcilla et al., 
2012). They are described to be secreted into the extracellular space after fusion of the multivesicular 
bodies with the cell plasma membrane, often in a regulated manner (Pasquale, 2016). The extracellular 
vesicles with a size range of 30 to 100nm in diameter are defined as exosomes (Urbanelli et al., 2013) 
while vesicles with sizes ranging from 100-1000nm in diameter are called microvesicles (Muralidharan-
Chari et al., 2010).  
4.1.1 Biogenesis of Exosomes 
According to van Niel and colleagues, inward budding of endosomal membranes is known to result in 
progressive accumulation of intraluminal vesicles (ILVs) within large multivesicular bodies (MVBs). The 
components of the cytosolic environment are engulfed within the ILVs while the transmembrane proteins 
are incorporated into the invaginating membrane (van Niel et al., 2006). Depending on their biochemical 
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properties, intracellular MVBs could either traffic to lysosomes, where they undergo proteosomal 
degradation (i.e., ‘degradative MVBs’) or, alternatively, to the plasma membrane (PM), where they fuse 
with the PM and release their contents (ILVs) into the extracellular space (exocytic MVBs); ILVs 
released into the extracellular space are referred to as ‘exosomes’ (Simpson et al., 2009). Three known 
mechanisms by which membrane vesicles are released into the extracellular microenvironment are 
described as (i) exocytic fusion of MVBs resulting in exosomes, (ii) budding of vesicles directly from the 
PM resulting in shedding microvessicles (SMVs)  and (iii) cell death leading to apoptotic blebs (Abs), 
(which are vesicles released by dying /apoptotic cells) (Mathivanan et al., 2010a). 
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Figure 4.1.  A schematic diagram of protein and RNA transfer by extracellular vesicles 
 
[Adapted from (Mullin, 2016)]. Rectangles=transmembrane proteins; Triangles=membrane associated 
proteins; Exosomes are released into the extracellular region after fusion of multivesicular endosomes 
(MVEs) with the plasma membrane. Exosomes are released into the extracllular milieu when MVEs 
fuse with the plasma membrane. (1) Microvesicles (MVs) and exosomes may anchor at the plasma 
membrane of a target cell. (2) Vesicles bound to the plasma membrane either fuse with the plasma 
membrane or are (3) engulfed. (4) Engulfed vesicles may then fuse with the delimiting membrane of 
an endocytic compartment. 
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4.1.2 History and Origin of Exosomes 
The first report of exosomes was in 1983 when they were first identified in reticulocytes and as a 
mechanism to release transferrin receptors during maturation (Pan and Johnstone, 1983, Harding et al., 
1983). They later became of interest to immunologists when it was discovered that they contain major 
histocompatibility complexs (MHCs) and that they can present antigens (Raposo et al., 1996).  With the 
report of transferable functional mRNAs and miRNAs between mast cells via exosomes (Valadi et al., 
2007), this had been an additional driving force in the study of EVs as a mechanism of cell–cell 
communication. 
4.1.3 Functions of Exosomes 
Exosomes have been shown to have various functions in immune cell activation and suppression 
(Montecalvo et al., 2012, Deng et al., 2013)  as well as play roles in tissue homeostasis (Aswad et al., 
2014). Other roles have also been demonstrated for EVs in diseases including cancer, since tumors also 
secrete these vesicles (Saleem and Abdel-Mageed, 2015). Exosomes are now being tried in clinical 
initiatives to determine their potential for drug delivery, their usefulness as diagnostic biomarkers, and 
their potential as therapeutics. Their roles in parasite infection are also being detailed in recent 
investigation outputs (Coakley et al., 2015). 
These vesicles transport a variety of bioactive molecules, which includes specific proteins, lipids and 
nucleic acids that subsequently become enriched in these vesicles while being assembled (Tkach and 
Théry, 2016). Exosomes in recent and current investigations are shown to effect distinctive and 
substantial intercellular forms of communication on recipient cells.  
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The transfer of their exosomal cargo drastically influences the properties of recipient cells (Tkach and 
Théry, 2016). In other words, exosomes have been described to mediate the spread of immune regulatory 
biomolecules as well as other pathogenic molecules. Hence, their association with dampening 
immunological responses, neural communication and tissue repair (Pasquale, 2016).  
4.1.4 Mechanisms of Exosomes Cell-to-Cell Communication 
Possible mechanisms by which exosomes communicate with their target cells include  (i) juxtacrine 
(close contact) fashion, which activates the target cell or (ii) by protease cleavage of exosomal membrane 
to release the content, which acts as ligands for cell surface receptor in target cells or  fusion of exosomes 
with the target cell resulting in the non selective transfer of  of exosomal contents to the target cell 
(Mathivanan et al., 2010a). 
4.1.5 Exosomes in Parasites 
EVs have been described in a number of parasites including Schistosoma japonicum (Wang et al., 2015); 
Schistosoma mansoni (Sotillo et al., 2016), Echinostoma caproni, Fasciola hepatica (Marcilla et al., 
2012), Dicrocoelium dendriticum (Marcilla et al., 2014) and Opisthorchis viverrine (Chaiyadet et al., 
2015).  
4.1.6 Cell-to-Cell Communication by means of Parasite Exosomes 
Most parasites at different stages in their life cycle rely on the ability to communicate with one another, 
between themselves as well as with their hosts, but the mechanisms underpinning this communication are 
under investigation. Research in this area has largely been directed to parasite secreted soluble proteins, 
most of which are known to down-modulate the host immune response (Coakley et al., 2015). 
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 In the past few years, EVs have been shown to be another component of parasite secretion products that 
may provide the answer to the unrecognized mechanism that packages and protects information in certain 
sets of proteins for cargo, uptake and integration into other cells (Coakley et al., 2015). 
4.1.7 Communication with Hosts 
Active release of these microvesicles by the parasites occurs in the host with the host cells taking up these 
vesicles. In a report by Marcilla et al. (Marcilla et al., 2012), it was shown that trematode extracellular 
vesicles contain most of the proteins previously identified as components of excretory/secretory product 
(ESP), as confirmed by proteomic, electron microscopy and immunogold labelling studies. 
Demonstration of uptake of these vesicles by host cells suggests important functions for these structures 
in host-parasite communication. In addition to these parasitic proteins, host proteins have been identified 
in these structures (Marcilla et al., 2012). The fusion of exosomes with host cells has also been shown for 
the protozoan parasite Trichomonas vaginalis (Hansen et al., 2015). The results from these previous 
studies suggest that parasite-secreted exosomes or microvesicles containing parasite proteins are able to 
unpack their content into host cells. This results in the molecules released playing roles in host gene 
regulation, leading to host immune response dampening and subsequent increased parasite survival 
(Hansen et al., 2015).  
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AIMS 
Based on the findings of Chapter three, which showed that certain proteins in the excretory/secretory 
system of A. pegreffii must have reached the exterior or be released by novel or alternative mechanisms, 
this chapter therefore aims to: 
1) Identify the exosomes of A. pegreffii  
2) Investigate by LC-MS/MS the cargo protein content of exosomes of A. pegreffii 
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4.2 Specific Methods 
The general methods of parasite materials collection; molecular identification of A. pegreffii, preparation 
of excretory/secretory products (ES) and parasite crude extracts (CE); 1D- LC-MS/MS analysis and 
protein identification are as described in the general methods in Chapter 2. The following are the specific 
methods for this chapter. 
4.2.1 Purification of extracellular vesicles 
Exosomes secreted by A. pegreffii L3 larvae were purified from the culture media obtained from 
preparation of excretory/secretory product. Exosome purification was by differential ultracentrifugation 
according to the protocol described by The´ry et al. (Thery et al., 2006). The culture media was divided 
equally into 2 centrifuge tubes (50 ml each), and centrifuged. The first 3 centrifugations were 10 min at 
3000 X g, 20 min at 2,000 X g, and 30 min at 10,000 X g to remove large dead cells and cell debris. After 
each centrifugation the supernatants were collected and used in the subsequent step. The final 
supernatants were ultracentrifuged at 100,000 X g for 70 min at 4ᴼC to pellet the exosomes using ultra-
speed centrifuge (L8-80M) (Beckman, USA). Finally, the pellets from the 2 tubes, which were not visible 
to the naked eye, were washed in PBS and another ultracentrifugation at 100,000 X g for 70 min was 
performed to eliminate contaminating proteins. The final pellet obtained was resuspended in PBS and 
stored at -80 ᴼ C until samples were analysed by transmission electron microscopy (TEM) and SDS-
PAGE with LC-MS/MS. Proteomic analysis method for the exosomes is as described under general 
methods. 
4.2.2 Transmission Electron Microscope 
Exosome samples were processed according to the protocol of Thery et al. (Thery et al., 2006). Briefly, 
purified concentrated exosomes frozen at –80◦C were thawed and mixed with an equal volume of 4% 
paraformaldehyde to fix the sample. Kumeda and colleagues (2017) have shown that the membrane structure of 
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exosomes retained integrity irrespective of the storage temperature. In addition, they also reported that freezing and 
thawing had little effect on particle size (Kumeda et al., 2017).   
On each Formvar-carbon coated electron microscope grid, 5 μl of the resuspended pellet was deposited 
and covered to let the membranes adsorb for 20 min in a dry environment. Phosphate buffered saline 
(PBS) (100-μl) drops were added to a sheet of Parafilm. Grids were transferred, membrane side down on 
to drops of PBS with clean forceps to wash the sample on the grid. Thereafter, grids were transfered to a 
50-μl drop of 1% glutaraldehyde for 5 min. The grid was then transferred to a 100-μl drop of distilled 
water and allowed to stand for 2 minutes. This was repeated seven times for a total of eight water washes. 
Samples were then contrasted first in a solution of uranyl oxalate, ( pH 7) for 5 minutes and then 
contrasted and embedded in a mixture of 4% uranyl acetate and 2% methyl cellulose in a ratio of 1:9, 
respectively. Subsequently, the grids were transfered to a 50-μl drop of methyl cellulose-UA for 10 min 
on ice. The grids were then removed with stainless steel loops and excess fluid blotted dry by gently 
pushing the loop sideways on filter paper leaving behind a thin film over the exosome side of the grid. 
The grid was air-dried for 5 minutes while still on the loop. Grids were then stored in an appropriate grid 
box until use. The samples were observed under the TEM microscope at 80 kV. 
4.2.3 1-D LC-MS/MS 
A portion of the pellet was precipitated with acetone. SDS-PAGE was performed for both the acetone 
precipitated and non-acetone precipitated exosome pellets. Exosomes protein on SDS-PAGE gel with 
protein bands and without protein bands were cut up into small pieces and digested with trypsin. In 
addition, the acetone–precipitated pellet was resuspended in 500µl of 0.5 M triethylammonium 
bicarbonate buffer (TEAB), reduced with 100 µl of 10 mM dithiothreitol and incubated at 600C for 1 h. 
This was taken through the in-solution tryptic digestion method as described in the general methods. 
Hence, LC-MS/MS was performed on 3 samples per replicate, namely the non-acetone precipitated 
sample on SDS-PAGE gel (in-gel digestion), acetone-precipitated sample on SDS-PAGE gel (in-gel 
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digestion) and an in-solution sample of acetone precipitated proteins dissolved in buffer and thereafter 
digested, on which LC-MS/MS was subsequently performed. This was to ensure recovery of almost all 
exosomes proteins that may be present. 
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4.3 Results 
4.3.1 SDS-PAGE Analysis 
The pellet obtained after ultracentrifugation was analysed by SDS-PAGE to profile the proteins of the 
exsomses. Initially, no protein bands were observed on the SDS-PAGE gel (Figure not shown). 
Subsequently, the protein content of the exosomes was precipitated with acetone. The pellet was 
resuspended in SDS-PAGE buffer. Most of the proteins bands were below the limit of detection of SDS-
PAGE stained with Coomassie. (Figure 4.2). Silver staining was not used in this study as it is known to 
interfere strongly with mass spectrometry analysis and would require specific modifications for 
compatibility with mass spectrometry (Rabilloud, 2012). Though, there are Silver staining protocols that do 
exist that are compatible with mass spectrometry, use of such protocol would be at the expense of sensitivity, 
making it less suitable for quantification. 
 
Figure 4.2.  SDS-PAGE analysis of Anisakis pegreffii exosomes stained with Coomassie 
Blue. 
 
M=10-250kDa Molecular marker, (Biorad). 
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4.3.2 Transmission Electron Microscopy (TEM) 
The pellets were further processed for visualization by TEM. Small vesicles that displayed the features 
and size of exosomes and microvessicles were observed. Ultrafiltration and size exclusion were employed 
to rule out the possibility of presence of artifacts as recommended by Wilms et al. (Willms et al., 2016). 
The sizes ranged between 48-100nm (Figure 4.3 2A-D). 
 
 
Figure 4.3.  (A-D)- Transmission Electron Microscopy (TEM) of A. pegreffii exosome 
proteins. 
 
Red arrows indicate exosome-like materials in different samples of TEM-processed ultracentrifuged 
pellets. 
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4.3.3 LC-MS/MS Analysis 
Anisakis pegreffii EVs in-gel and in-solution were digested with trypsin and LC-MS/MS was performed. 
Sixty different proteins were identified and all the 3 samples analysed for each replicate (2 replicates) by 
LC-MS/MS had almost the same content of proteins. Thirty-two of these sixty (53%) were homologous to 
mammalian EV proteins in Exocarta (http: //www .exocarta .org). Among the proteins identified were key 
exosome markers which include Heat Shock protein (HSP)-70, enolase and elongation factor 1-alpha.  
4.3.4 GO Annotation 
Uniprot Gene ontology, analysis of A. pegreffii exosome proteins yielded 23 biological process terms. 
Using the quantitative value of normalized spectra analysed in scaffold software, actin domain containing 
protein was the most abundant protein enriched in A. pegreffii exosomes, followed by vitellogenin-6 and 
polyprotein ABA-1. A well-represented functional group is the structural molecule proteins (9 matches), 
which included tropomyosin, myosin heavy chain, alpha sarcomeric, and tubulin proteins. Other proteins 
representation varied across a wide group of functionalities, such as metabolism, binding and 
oxidoreductases (Figures 4.4 – 4.6).  
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Figure 4.4.  Uniprot GO Annotation of the Molecular Functions of A. pegreffii exosomes 
proteins. 
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Figure 4.5.  Uniprot GO Annotation of the Biological Processes of A. pegreffii exosomes 
proteins. 
 
 
Figure 4.6. Uniprot GO Annotation of the Cellular Component origin of A. pegreffii 
exosomes proteins. 
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4.3.5 Relative abundance and expression of 4 antigenic proteins identified in the exosomes 
Other proteins enriched in the vesicles included some allergernic proteins such as tropomyosin, 
polyprotein ABA-1 and glyceraldehyde-3-dehydrogenase.Normalized spectral counts were assigned to 
each identified protein using the “Quantitative Value” assignment tool within the Scaffold software used 
for organizing protein identifications and comparing spectral counts across samples. Spectral counts 
across all samples were compared and the relative abundance and expression of 4 antigenic proteins 
identified in the exosomes, crude extract and excretory/secretory product of A. pegreffii are shown in 
Figures 4.7-4.11.  In biosamples 1 for both ES and CE, the quantity of these protein were too low to 
detect as shown in the Figures.The proteins identified in the A. pegreffi exosomes are shown in Table 4.1. 
 
 
Figure 4.7:  Relative abundance of Tropomyosin normalized spectra (Ani s 3) in A. 
pegreffii proteome. 
 
Spectral counts across all samples were compared and the relative abundance and expression 
of tropomyosin protein identified in the exosomes, crude extract and excretory/secretory 
product of A. pegreffii is shown. 
Biosample 1_CE-1=biological replicate 1 for crude extract 
Biosample 2_CE-2=Biological replicate 2 for crude extract 
Biosample 3_ES-1=Biological replicate 1 for excretory/secretory product 
Biosample 4_ ES-2=Biological replicate 2 for excretory/secretory product 
Biosample 5_ Exosome samples 
Note: Biosamples 1- No protein spectra identified in these replicates for CE and ES. 
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Figure 4.8:  Relative abundance of Polyprotein ABA-1 allergen normalized spectra in A. 
pegreffii proteome. 
 
Spectral counts across all samples were compared and the relative abundance and expression of 
polyprotein ABA-1 allergen protein identified in the exosomes, crude extract and excretory/secretory 
product of A. pegreffii is shown. 
Biosample 1_CE-1=biological replicate 1 for crude extract 
Biosample 2_CE-2=Biological replicate 2 for crude extract 
Biosample 3_ES-1=Biological replicate 1 for excretory/secretory product 
Biosample 4_ ES-2=Biological replicate 2 for excretory/secretory product 
Biosample 5_ Exosome samples 
Note: Biosamples 1- No protein spectra identified in these replicates for CE and ES. 
 
Figure 4.9: Relative abundance of Glyceraldehyde-3-dehydrogenase normalized spectra 
in A. pegreffii proteome. 
 
Spectral counts across all samples were compared and the relative abundance and expression of 
Glyceraldehyde-3-dehydrogenase protein identified in the exosomes, crude extract and 
excretory/secretory product of A. pegreffii is shown. 
Biosample 1_CE-1=biological replicate 1 for crude extract 
Biosample 2_CE-2=Biological replicate 2 for crude extract 
Biosample 3_ES-1=Biological replicate 1 for excretory/secretory product 
Biosample 4_ ES-2=Biological replicate 2 for excretory/secretory product 
Biosample 5_ Exosome samples 
 
Note: Biosamples 1- No protein spectra identified in these replicates for CE and ES. 
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Figure 4.10:  Relative Abundance of Vitellogenin-6 normalized spectra in A. pegreffii 
proteome. 
 
Spectral counts across all samples were compared and the relative abundance and expression 
of vitellogenin-6 protein identified in the exosomes, crude extract and excretory/secretory 
product of A. pegreffii is shown. 
Biosample 1_CE-1=biological replicate 1 for crude extract 
Biosample 2_CE-2=Biological replicate 2 for crude extract 
Biosample 3_ES-1=Biological replicate 1 for excretory/secretory product 
Biosample 4_ ES-2=Biological replicate 2 for excretory/secretory product 
Biosample 5_ Exosome-Exosome samples 
Note: Biosamples 1- No protein spectra identified in these replicates for CE and ES. 
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Figure 4.11:  Relative Abundance of Leucine Aminopeptidase (LAP) in A. pegreffii 
proteome. 
 
Spectral counts across all samples were compared and the relative abundance and expression 
of leucine aminopeptidase protein identified in the exosomes, crude extract and 
excretory/secretory product of A. pegreffii is shown. 
Biosample 1_CE-1=biological replicate 1 for crude extract 
Biosample 2_CE-2=Biological replicate 2 for crude extract 
Biosample 3_ES-1=Biological replicate 1 for excretory/secretory product 
Biosample 4_ ES-2=Biological replicate 2 for excretory/secretory product 
Biosample 5_ Exosome-Exosome samples 
Note: Biosamples 1- No protein spectra identified in these replicates for CE and ES. 
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Table 4.1: A. pegreffii Exosome Proteins and Homologs in Exocarta database. 
 
# Homologous 
protein 
Uniprot ID Signal 
peptide 
Trans- 
membrane 
Homolog 
found in 
Exocarta 
database 
1 Myosin-4 
(Unc-54) 
A0A0B2VVW7 N N Y 
2 Elongation factor 
1-alpha 
A0A0B2W5Q7 N N Y 
3 Neprilysin-1 A0A0B2VA80 N Y N 
4 V-type 
proton ATPase 
subunit c 
F1L3T5 N N Y 
5 40s ribosomal 
protein s13 
F1LFC7 N N Y 
6 60s ribosomal 
protein l27a 
U1MAQ4 N N Y 
7 Centromere-
associated protein 
E (CENPE) 
A0A0B2VLA2 N N Y 
8 Gut esterase 1 A0A0B2W709 N N N 
9 Leucine 
aminopeptidase 
U1NWM0 N N Y 
10 Vitellogenin-6 A0A0B2V8F3 Y N N 
11 Polyprotein ABA-
1* 
Q06811 N N N 
12 Aminoacylase-1 
(peptidase M20) 
F1L6C7  N Y 
13 Serotonin 
receptor protein 
Q86LL7 Y Y N 
14 Tropomyosin * C0L3K2 N N Y 
15 Hypothetical 
protein 
ASU_01958 
unknown N N Unknown 
16 TBA-1 precursor Q06811 N N N 
17 Glyceraldehyde-
3-phosphate 
dehydrogenase * 
A0A0M3K2Y3 N N Y 
18 PREDICTED: 
histone H3.3-like, 
partial 
G1MZV0 N N Y 
19 Myosin heavy 
chain 
F1KQF1 N N Y 
20 Spindle- and 
centromere-
associated protein 
F1KQ60 N N N 
21 Pyruvate kinase 
muscle isozyme 
F1LFH3 N N Y 
22 Protein RHY-1 Q9XVW1 N Y N 
23 Succinate 
dehydrogenase 
iron-sulfur 
Q09545 N N N 
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24 kynureninase 
Ascaris suum 
U1NUN5 N N Y 
25 dolichyl-
diphosphooligosa
ccharide--protein 
glycosyltransferas
e subunit 1 
U1M7N6 N Y Y 
26 cytoplasmic 
intermediate 
filament protein 
F1KZN6 N N N 
27 heat shock protein 
70 * 
A0A0R5QAG5 N N Y 
28 40S ribosomal 
protein S23 
A0A1S0U911 N N Y 
29 Putative leucine-
rich repeat-
containing protein 
A0A0B2V722 N N N 
30 malate 
dehydrogenase 
A0A0M3KBA5  Y N 
31 adenylate kinase F1LHW2 N N Y 
32 galactoside-
binding lectin 
(galectin) 
F1L9M1 Y N Y 
33 beta carbonic 
anhydrase 1 
U1NDQ3 N N N 
34 ribosomal protein 
S14 
F1LHE1 N N Y 
35 hypothetical 
protein 
ASU_07427 
A0A0B2W0L0 N N Unknown 
36 putative 
elongation factor 
1-gamma 
F1L9C6 N N Y 
37 LIM domain and 
actin-binding 
protein 1 
(LIMA1) 
A0A0B2VMH7 N N Y 
38 Endoplasmin 
(Hsp90b1) 
A0A0B2URQ0 Y N Y 
39 F-actin capping 
protein beta 
subunit 
F1LBI3 N N N 
40 Ascaris suum F1KPN0 N N Y 
41 cat eye syndrome 
critical region 
protein 5 
F1L8B6 N N Y 
42 beta-tubulin 
isotype 1 
A0A0M3IZK3 N N Y 
43 nad-dependent 
malic 
P27443 N N N 
44 spermidine 
synthase 
F1L7H4 N N Y 
45 Basement A0A0B2UP16 N N N 
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membrane 
proteoglycan 
(unc-52) 
46 propionyl- 
carboxylase alpha 
A0A0B2UYS3 N N N 
47 sucrase- intestinal U1NX15 N N N 
48 extracellular 
superoxide 
dismutase 
F1L7A0 N N N 
49 UV excision 
repair protein 
Rad23 
A0A1I7VLX6 N N Y 
50 cytoplasmic 
intermediate 
filament protein 
P23730 N N N 
51 alpha- sarcomeric U1MST7 N N Y 
52  A0A0B2VEN6 N N Y 
53 None None Y N  
54 tubulin alpha 
chain - mouse 
A0A183UCC8 N N Y 
55 Hypothetical 
protein 
NONE N N Unknown 
56 apolipophorin 
 
A0A0B2VHM0 N N N 
57 shTK 
domain protein 
A0A0B1TEE9 Y N N 
58 Actin 2 A0A0B4SVM4 N N N 
59 Histone H2B 1 A0A0B2V381 N N  
60 Putative 3-
hydroxyacyl-
CoA-
dehydrogenase 
A0A0B2W1B9 N N N 
Note: *=Allergenic proteins in exosome cargo; N=not present; Y=yes, present. 
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4.3.6 Secretory Pathways of Proteins Identified In Exosomes 
A number of peptidases, such as leucine aminopeptidases, neprilysin and peptidase M20 were found in A. 
pegreffii exosomes. Four hits corresponded to proteins with unknown functions. About 25% of the 
proteins identified in A. pegreffii exosomes either possess N-terminal signal peptides or were predicted to 
be secreted through unconventional pathways. A comparison of the proteome dataset of A. pegreffii with 
the exosome cargo content of A. pegreffii, showed that of the remaining proteins, 9 hits were proteins 
found only in crude extract, three were found also exclusively in exosomes and were not present in the ES 
while the remaining proteins, which constitute half of the proteins identified in the exosomes, were all ES 
proteins. These proteins were not predicted to have signal peptides or to be secreted through the 
unconventional route. The five matches corresponding to membrane proteins include protein RHY-1 
(regulation of hypoxia-inducible factor 1), dolichyl-diphosphooligosaccharide protein, a 
glycosyltransferase protein, a serotonin-receptor protein, and neprilysin-1 and malate dehydrogenase 
protein. The proteins exclusively found in exosomes, and not identified in the ES and crude extracts of A. 
pegreffi, include serotonin-receptor, adenylate kinase and an unknown/uncharacterized protein. 
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4.4 Discussion 
In this study, L3 larvae of Anisakis pegreffii were found to secrete exosomes-like bodies. Secretory 
activity is critical for Anisakis pathogenesis. Over 53% of the protein content identified in the exosomes 
of A. pegreffii in this study were homologues of proteins reported in the exosomes of other organisms 
which have been deposited in Exocarte database. The vast majority of allergens and immunomodulatory 
molecules characterized for A. pegreffii are extracellular. Most of the A. pegreffii molecules identified in 
the previous chapter from the CE and ES lacked the leader peptide necessary for conventional secretion, 
which strongly suggests an unconventional secretion pathway for the molecules characterised in this 
chapter.  
Abundant round-shaped material with the expected size of exosomes was obtained after 
ultracentrifugation in this study. Visualization with TEM confirmed their presence in the 
excreted/secreted material of A. pegreffii.  Exosome protein compositions are known to vary depending 
on the cell type of origin (Mathivanan et al., 2010b). The results of this study agrees with this statement 
as it is clearly evident that exosomes from different cell types of L3 larvae of A. pegreffii were isolated as 
reflected in the group of proteins identified. Cytoskeletal proteins identified in this study, including actin, 
myosin, tubulin, alpha sarcomeric and tropomyosin are among the subset of proteins reported to be 
common to all exosomes (Mathivanan et al., 2010a, Mathivanan et al., 2010b). Their presence indicates 
that the exosomes that cargo these proteins were derived from the cytoskeletal cells. According to Thery 
et al, exosomes from different cellular sources are known to contain proteins specific for their cell type of 
origin and when released into the extracellular milieu, can be taken up by recipient cells at sites distal to 
their release (Thery et al., 2002).  
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Exosomes are also known to be enriched with heat shock proteins, such as Hsp70 and Hsp90.  Hsp70 was 
one of the proteins identified in A. pegreffii exosomes in this study. It is reported that  Hsp70  is identified 
in 89% of the proteomic studies on exosomes (Mathivanan et al., 2010a). In addition, a high portion of 
proteins enriched in A. pegreffii exosomes were implicated in carbohydrate metabolism, indicative that 
the parasite's main energy source is derived from carbohydrate metabolism and exosomes might be 
involved in transporting proteins needed for this function within the parasites and to the host for parasite 
survival. 
Molecules carried by exosomes are described to have the ability to tap into the regulatory networks in 
host cells if the proteins are homologs of host cells. Exosomes have been extensively studied for their 
contributions to physiology, immunity, cancer, and intercellular communication, revealing an impressive 
diversity of functions depending on their cellular source (Del Cacho et al., 2016). The presence of 
proteins in A. pegreffii exosomes, such as the allergens tropomyosin, polyprotein ABA-1 and peptidases 
such as Leucine aminopeptidase as observed in this study, implies that exosome transport is probably the 
mechanism by which these molecules are released to be taken up by host cells.  Host cells that may take 
up these parasite molecules include antigen presenting cells. The effect of this may be to dampen the host 
cell immune response as in the case of parasite peptidase molecules uptake and/or to provoke an immune 
response when an allergenic molecule such as tropomyosin is taken up. The presence of allergens, such as 
tropomyosin and polyprotein ABA-1, as identified in this study, in A. pegreffii exosomes, provides 
evidence for the route of allergic sensitisation to live parasites. 
In conclusion, the present study constitutes the first report of the existence and composition of exosome-
like vesicles in the L3 larvae of the parasite, A. pegreffii and in Anisakids parasites as a whole. The 
identified structures appear to play critical role in transportation of immunomodulatory and allergenic 
proteins. These proteins are stabilized against degradation by encapsulation within vesicles. The existence 
of extracellular vesicles in A. pegreffii explains the secretion of atypical proteins. In addition, exosomes 
Chapter 5 
123 
 
have been reported to interact with and manipulate host gene expression. It has been demonstrated that 
exosomes contribute to functions such as tissue repair, neural communication, immunological response 
and the transfer of pathogenic proteins (Simons and Raposo, 2009, Couzin, 2005). For instance, in H. 
polygyrus, it was shown that exosomes could suppress immunological response in vivo (Buck et al., 
2014).  In summary, the demonstration of the existence of exosome-like vesicles in A. pegreffii EVs may 
offer a new point of view for the study of Anisakis infections. A. pegreffii could be implicated in 
important roles in the regulation of host immunological responses to tolerate the parasite living in the 
host.  Further studies will address whether these vesicles constitute good targets for new control strategies 
and diagnostic tools (Marcilla et al., 2012).  
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 IMMUNOPROTEOMIC IDENTIFICATION OF CHAPTER 5:
CROSS-REACTIVE ALLERGENIC PROTEINS IN ANISAKIS 
PEGREFFII 
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5.1 Introduction 
Food allergy is believed to be on the increase (Hadley, 2006, Benede et al., 2016). In this period of 
globalization, it is observed that it is not only population that migrates but also foods; as the populace of 
various nations import and embrace foreign diets and exotic products (Hadley, 2006). The situation is 
made more complicated because of the different perceptions of the term ‘food allergy’ by different groups 
of people in a population. Food allergy is different from food intolerance and hypersensitivity, which 
could be a metabolic condition, such as lactose tolerance and coeliac disease (Pereira et al., 2005). The 
former is involved with the immune system whilst the latter is not. This has resulted in either an over-
estimation or under-reporting of food allergy and thus makes diagnosis difficult (Pereira et al., 2005).   
Fish, a common food, with a consumption growth rate of 3.6% yearly since 1963 (Tomm et al., 2013) is 
the exposure link between the parasitic marine nematode, Anisakis and man. It is logical that seafood 
allergy prevalence is higher in areas of high seafood consumptions (Sicherer and Sampson, 2006). 
Occurrence of food allergies is high in both children and adults and represents one of the most common 
causes of anaphylactic reactions. (Lopata and Lehrer, 2009). 
5.1.1 Anisakis and Allergic reactions 
Allergic reactions to proteins from acquatic parasitic nematodes of the genus Anisakis, family Anisakidae, 
are major contributors to adverse effects from consumption of contaminated fish and shellfish (Amin and 
Davis, 2012, Baird et al., 2014). Humans become infected accidentally with third-stage larvae (L3) of 
Anisakis by consuming parasitized raw or undercooked fish (Berland, 1961). Anisakis simplex sensu 
stricto and Anisakis pegreffii are frequently associated with allergic reactions and anaphylaxis (Mattiucci 
et al., 2013). It has been suggested that anisakiasis in Japan is associated mainly with infections by 
A. simplex   (Suzuki et al., 2010).  
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However, multiple reports of complicated clinical cases of anisakiasis in humans, linked to A. pegreffii 
and associated with multiple cases of gastro-allergic anisakiasis, have been documented in Italy 
(Mattiucci et al., 2013, D'Amelio et al., 1999). Whilst anisakiasis is relatively common in these two 
countries, cases have been reported from other countries including Australia (Shamsi and Butcher, 2011), 
China (Qin et al., 2013) and the USA (Ramanan et al., 2013). In Spain, Anisakis allergy is responsible for 
up to 8% of acute urticarial reactions, 25% of which progress to anaphylactic shock (Gamboa et al., 
2012). Indeed, it has been suggested that Anisakis allergy may account for up to 10% of all cases of 
idiopathic anaphylaxis in adults, particularly in regions where seafood consumption is high (Fernandez de 
Corres et al., 1996, Baeza et al., 2005). Therefore, this parasite is now considered as one of the 
masqueraders in seafood allergic reactions (Banks and Gada, 2013). 
5.1.2 Seafoods and Allergy. 
The term ‘seafood’ refers to both fish and shellfish (crustaceans and molluscs), which are considered two 
of the “big eight” food sources implicated in about 90% of all food allergies (Lopata and Lehrer, 2009, 
Lopata et al., 2010, Lopata et al., 2016, Wild and Lehrer, 2005). Seafood is also one of the major food 
commodities worldwide (Wild and Lehrer, 2005), and a high portion (up to 34%) of seafood consumed in 
most countries is imported from Asia (Shafique et al., 2012, Tacon and Metian, 2008).  A report in 2008 
showed shellfish as one of the most important food sources responsible for about 30,000 food-induced 
anaphylactic events occurring annually in the USA, in persons aged 6 years or older (Ross et al., 2008). 
Of these, 200 or more were reported as fatal (Ross et al., 2008). 
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 In Singapore, crustaceans and fish were reported as the most significant sensitisers in 40% and 13% of 
children with food hypersensitivity, respectively (Thong et al., 2007). In the same study, up to 33% of 
adults were sensitised to crustaceans, followed by molluscs (19%) and fish (4%) (Thong et al., 2007). In a 
recent study  conducted in Australia, fatal food anaphylaxis increased by 9.7% / year (1997-2013), with 
seafood being the most frequent trigger (Mullins et al., 2016). 
In a randomized study from Japan, a higher prevalence of sensitisation to Anisakis was reported as 
compared to seafood (Kimura et al., 1999). Furthermore, a Spanish study reported Anisakis as a hidden 
food allergen which was the leading cause of food allergy in Spain (GarciaPalacios et al., 1996). Several 
other reports have demonstrated that a risk for Anisakis-related allergic reactions exists among 
occupationally exposed seafood-processing workers (Scala et al., 2001). These findings support other 
reports of Anisakis-related allergic symptoms when handling fish or fishmeal (Scala et al., 2001).  
5.1.3 Seafoods, Anisakis and Allergy Cross-Reactivity. 
While a steady increase of allergic reactions to seafood is being acknowledged worldwide, the whole 
complement of allergens responsible for these reactions is yet to be fully elucidated. Indeed, molecules 
implicated in seafood allergy in shellfish (Lopata et al., 2010) and fish (Stephen et al., 2017) are 
numerous and diverse. Importantly, few data are thus far available on the number and nature of cross-
reactive allergens between both seafood groups and contaminating parasites. In particular, to date, the 
majority of studies on allergens from parasites contaminating seafood have focused on the nematode A. 
simplex (Faeste et al., 2014, Audicana and Kennedy, 2008).  
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While possible clinical cross-reactivity between Anisakis and other nematodes, as well as some 
invertebrates, has been discussed (Lozano et al., 2004, Pascual et al., 1997, Johansson et al., 2001, 
Rodriguez-Perez et al., 2014),  only a handful of studies have provided data on possible implicated 
allergens (Lozano et al., 2004, Pascual et al., 1997, Johansson et al., 2001, Rodriguez-Perez et al., 2014). 
The proteins Ani s 2 (paramyosin) and Ani s 3 (tropomyosin) from A. simplex, whose homologues can be 
found in crustaceans, dust-mites and cockroaches, are considered as major cross-reactive allergens 
(Ayuso et al., 2002, Guarneri et al., 2007). However, the whole repertoire of allergenic proteins from A. 
pegreffii, potentially cross-reacting with allergens from shellfish, fish or other allergen sources is not 
known. Recently, we have undertaken comparative analyses of the transcriptomes of A. simplex and A. 
pegreffii, coupled with in silico allergen prediction, which has led to the identification of up to 31 putative 
allergens in the latter (Baird et al., 2016). These data now requires experimental validation, together with 
a comprehensive assessment of the presence of cross-reactive allergens in this parasite, which is pivotal 
for the enhancement of current diagnostic procedures for seafood allergy. 
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AIM 
Based on these findings the aim of the following experiments is to: 
1) Identify and characterize A. pegreffii novel and potential cross-reactive allergens in shellfish 
allergic patients. 
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5.2 Specific Methods. 
The general methods of parasite materials collection, molecular identification of A. pegreffii, preparation 
of excretory/secretory products (ES) and parasite crude extracts (CE), 1D- LC-MS/MS analysis and 
protein identification are as described in the general methods in Chapter 2. The following are the specific 
methods for this Chapter. 
5.2.1 Patient Sera. 
Serum samples were obtained from 19 patients (mean age 32 ± 10.5 years; 11 females and 8 males) with 
a clinical history of allergic reactions to shellfish and/or positive by skin prick test (SPT) and/or 
PhadiaImmunoCAP system-(Uppsala, Sweden; >0.35kU/L;) to prawn, crab or lobster, as well as a non-
atopic control. Informed, written consent was obtained from each study subject and experimental 
protocols were approved by The Alfred Hospital Research Ethics Committee (Project number 192/07) 
and the Monash University Human Ethics Committee (MUHREC CF08/0225). 
5.2.2 Immunoblotting. 
Protein extracts of A. pegreffii and controls were separated by SDS gel-electrophoresis using 6 μg per 
lane and transferred to a Polyvinylidene difluoride (PVDF) membrane using a semi-dry blotting system 
(BioRad). Subsequently, the membrane was blocked with 5% w/v skim milk powder in phosphate 
buffered saline containing 0.5% Tween-20 (PBS-T) for 1 h. Patient serum was added (1:20 in 2% w/v 
skim milk in PBS-T) using the slot blot apparatus (Idea Scientific, MN, USA) and incubated overnight.  
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To detect IgE binding, the immunoblot was sequentially incubated with rabbit anti-human IgE antibody 
(Dako; 1:10000) and goat anti-rabbit IgG-HRP conjugated antibody (Promega; 1:40,000); after washing 
with PBS-T, the immunoblot was visualized using the enhanced chemiluminescent method (Sigma-
Aldrich, St. Louis, MO) (Kamath et al., 2014b). 
To detect the presence of specific cross-reactive crustacean allergens, the protein extracts were probed 
with one rat monoclonal anti-tropomyosin (mAb) (Abcam, Cambridge, MA, USA) (Kamath et al., 
2014a), one in-house generated rabbit polyclonal anti-crustacean antibody and one in-house generated 
rabbit anti-crustacean myosin light chain antibody (Kamath et al., 2014b). 
In addition, the presence of possible fish allergens was evaluated using one frog monoclonal anti-
parvalbumin antibody (PARV-19; Sigma, USA) (Saptarshi et al., 2014), one in-house generated rabbit 
anti-parvalbumin antibody (pAb) and one rabbit anti-aldolase antibody (Rockland, Inc.) with their 
corresponding secondary HRP-conjugated antibodies (Dako, USA); binding was visualized as described 
above. 
5.2.3 Mass Spectrometry (LC-MS/MS) and Analysis of Proteins. 
Following gel-electrophoresis, bands were excised, in-gel digested using trypsin and analysed by LC-
MS/MS using a Q-Exactive mass spectrometer (Thermo Scientific) as described in Chapter 2.  
5.2.4 Bioinformatic Analysis. 
An alignment using Blast against the Structural Database of Allergenic Proteins (SDAP) with the 
sequences of proteins identified by LC-MS/MS from the reactive bands was performed. This was to 
identify proteins with ≥65% sequence identity with allergens in the database.  
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5.2.5 Molecular phylogenetic analysis. 
The allergen database (WHO/IUIS) was interrogated for cross-reacting crustacean, mollusc and fish 
allergens homologues identified in A. pegreffii. Amino acid sequence alignments were generated using 
MUSCLE (Edgar, 2004) and phylogenetic relationships were inferred using the Neighbour-Joining 
method (10,000 replicates) (Stephen et al., 2017, Jenkins et al., 2007). Evolutionary distances were 
computed using the Poisson correction method and analyses were conducted using the MEGA 6 software 
(Tamura et al., 2013). 
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5.3 Results 
5.3.1 Immunoblotting with allergen specific Antibodies. 
There was no reactive band observed in either CE or ES with (i) anti-frog mono and anti-rabbit poly-
parvalbumin antibody. (Figure shown for only mono-parvalbumin; Figure 5.1). (ii) Myosin light chain 
antibody (Figure 5.2) or anti-aldolase antibody (Figure 5.3). The lack of binding may be due to the 
absence of the target protein in A. pegreffii as in the case of polyclonal antibodies or absence of a specific 
antibody epitopes in the case of the monoclonal antibodies. In contrast, the presence of tropomyosin (TM) 
in the CE was confirmed using a TM-specific mAb as well as a pAb anti-crustacean antibody (Fig. 5.4).   
 
Figure 5.1: SDS-PAGE and immunoblotting profile using anti-parvalbumin monoclonal 
antibody. 
 
(A) 12% SDS-PAGE of crude extracts (CE), excretory/secretory (ES) products of A. pegreffii and 
different fish samples stained with Coomassie brilliant blue; (B) immunoblotting with Parv 19 
Monoclonal Antibody. 
Note: the positive controls  were Barramundi, Basa and Salmon. 
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Figure 5.2:  SDS-PAGE and immunoblotting profile using anti-myosin light chain 
monoclonal antibody. 
 
(A) 12% SDS-PAGE of crude extracts (CE), excretory/secretory (ES) products of Anisakis pegreffii 
and heated prawn extract stained with Coomassie brilliant blue; (B) Immunoblotting with in-house 
made myosin light chain antibody. Note: the positive control Heated Prawn. 
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Figure 5.3: SDS-PAGE and immunoblotting profile using anti-aldolase antibody. 
 
(A) 12% SDS-PAGE of crude extracts (CE), excretory/secretory (ES) products of A. pegreffii 
and different fish samples stained with Coomassie brilliant blue; (B) Immunoblotting with anti-human 
aldolase antibody against six fish species and  Anisakis pegreffii crude extract and excretory/secretory 
product. Note: the positive controls Barramundi to Tuna. 
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Figure 5.4:  SDS-PAGE and immunoblot analysis using monoclonal anti-tropomyosin 
and polyclonal anti-crustacean antibody. 
 
(A) 12% SDS-PAGE of crude extracts (CE), excretory/secretory (ES) products of A. pegreffii and 
heated prawn extract (HPE) stained with Coomassie brilliant blue; (B) immunoblotting of CE, ES and 
HPE with monoclonal anti-TM antibody and (C) immunoblotting of CE, ES and HPE with polyclonal 
anti-crustacean antibody. Note: the positive control Heated Prawn. 
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5.3.2 Patient IgE immunoblotting analysis. 
The 19 patients analysed in this study had a history of clinical allergy to one or several shellfish species, 
and/or elevated IgE to shrimp, lobster and crab by ImmunoCAP (Table 5.1).  
Table 5.1: Information and clinical features of enrolled subjects sensitised to shellfish. 
 
Identification Sex Total IgE 
(IU/mL) 
Shrimp 
specific 
IgE 
(kUA/L) 
Lobster 
specific 
IgE 
(kUA/L) 
Crab 
specific 
IgE 
kUA/L) 
HDM 
specific 
IgE 
(kUA/L) 
Symptoms 
A M 136 4.54 ND ND ND O 
*B F 150 0.16 ND 0.06 3.25 As, R, An,O 
*C M 221 0.10 0.00 0.03 3.14 As, R, An, U, O 
D F 1946 9.5 9.43 2.42 14.1 R, An, O 
E F 2195 19.1 ND 0.91 >100 As, R, An,O 
F F 461 0.36 0.32 0.3 54.8 R, An, O 
G M 183 6.84 4.10 ND 31.7 NA 
H M 976 9.03 ND ND 13.6 R, An, O 
I F 238 5.93 2.73 6.05 16.7 O, An 
J F 372 1.82 0.35 0.53 3.9 O 
K F 28 9.8 ND 8.42 2.66 A, U 
L M 127 1.65 0.18 0.15 0.09 An 
M M 194 1.41 0.24 ND 0.35 R, An, O 
*N F 201 0.03 <0.01 0.01 0.05 R, An, U, O 
O F 440 0.5 0.39 0.55 ND An, U, O 
*P F 12 0.04 0.01 0.01 0.02 An, O 
*Q M 164 0.04 ND ND ND R, An, O 
R F 242 1.32 1.65 1.17 ND As, R, U 
*S M 243 0.04 ND ND 26.8 R, An, O 
F: female, M: Male, As: Asthma, R: Rhinitis, An: Anaphylaxis, U: Urticaria, O: Oral/facial symptoms, ND: Not 
determined; *patient sera negative for shellfish-specific IgE (ssIgE) by ImmunoCAP but positive history and 
positive on IgE immunoblot. 
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In addition, IgE antibodies binding to the invertebrate allergen house dust-mite (HDM) were quantified 
by ImmunoCAP. Immunoblot results revealed proteins from both the CE and the ES products of A. 
pegreffii cross-reacting to IgE in sera of patients used for this study. However, the binding patterns 
corresponding to ES were characterised by fewer protein bands when compared to those corresponding to 
the CE (Figures 5.5 and 5.6), indicating possible differences between proteins’ relative abundance and 
presence in these proteomes. Major bands were observed for the CE at ~37-39 kDa and ~100 kDa and 
195 kDa (Figure 5.5). A non-atopic control serum did not show significant binding to any CE and ES 
proteins of A. pegreffii (Figures 5.5 and 5.6). 
 
Figure 5.5. IgE antibody reactivity to A. pegreffii crude extracts. 
 
IgE immunoblot with sera from 19 shellfish sensitised patients, as well as from one non-atopic control. 
Numbers denote specific IgE binding reactive bands and are interpreted in Tables 5.2 and 5.3. 
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Table 5.2: Allerlogram of IgE Binding Patterns To Proteins From Crude Extract Of A. 
Pegreffii. 
 
Patient 
ID 
1 2 3 4 5 6 7 8 9 
A          
B          
C          
D          
E          
F          
G          
H          
I          
J          
K          
L          
M          
N          
O          
P          
Q          
R          
S          
Note: IgE binding intensities are graded as low (light grey), medium and strong (black). Sera from 19 
shellfish allergic patients as well as from one atopic control were used. 
Key:   =Low;                =Medium;                   = Strong 
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Table 5.3: List of proteins in A. pegreffii crude extract reactive bands and sequence 
identity to allergens. 
 
Reactive bands 
# and % of 
reactive 
shellfish 
allergic patient 
sera 
Proteins in reactive 
band 
Identified by  
LC-MS/MS 
MW at 
which 
protein 
migrated 
(kDa) 
Uniprot 
MW 
(kDa) 
Sequence 
similarity 
to 
allergen 
by blast in 
SDAP 
(%) 
Name of 
allergen 
Accession 
number  
and Organism  
1 (5%)  Fatty acid-binding 
protein-like protein 3  
16 20 23 Lep d 13 Q9U5P1-
Lepidoglyphus 
destructor 
[storage mite] 
  Essential light chain  16 18 42 Art 
fr.5.0101 
A7L499-Artemia 
franciscana [brine 
shrimp] 
  Myosin regulatory 
light chain 1 
 
16 19 35 Lit v 
3.0101 
EU449515-  
Litopenaeus 
vannamei [white 
leg shrimp] 
  Protein MCE-1 
 
15 18 26 Ory s 
33kD 
BAB71741-Oryza 
sativa [Rice] 
 
None of the above proteins present in reactive band 1, satisfied the defined parameters for cross-reactive allergen as 
specified for this study which is ≥65% sequence similarity to an allergen and reactivity with 50% of shellfish allergic 
patients sera. 
 
2 (5%)  estradiol 17-beta-
dehydrogenase 8  
25 26 37 Alt a 
8.0101 
P0C0Y4- 
Alternaria 
alternate 
[moulds) 
  Triosephosphate 
isomerase 
 
25 27 62 Arc s 
8.0101 
Q8T5G9- 
Archaeopotamobi
us sibiriensis 
(crustaceans 
species) 
  24 kDa protein  
 
25 24 10 Art v 
3.0202 
ACE07187- 
Prunus persica 
[peach] 
 
None of the above proteins found in reactive band 2, satisfied the defined parameters for cross-reactive allergen for 
this study. 
 
3 (5%)  14-3-3 zeta  28 29 16 Pan s 1 O61379- 
 
Panulirus 
stimpsoni 
[spiny lobster] 
  Putative 
peroxiredoxin prdx-3  
28 29 29 Tri a 
32.0101 
 
AAQ74769-
Triticum 
aestivum[wheat] 
 
None of the above proteins found in reactive band 3, satisfied the defined parameters for cross-reactive allergen for 
this study. 
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4 (5%)  Malate 
dehydrogenase 
 
35 36 57 Mala f 4 AAD25927- 
Malassezia furfur 
[mould] 
  Transaldolase 
 
36 42 54 Cla c 
14.0101 
ADK47394- 
Cladosporium 
cladosporioides 
[mould] 
  Annexin-A6 34 34 19 Eur m 14 AAF14270- 
Euroglyphus 
maynei 
 [mite] 
 
None of the above proteins found in reactive band 4, satisfied the defined parameters for cross-reactive allergen for 
this study. 
 
5 (≥50%)  fructose-bisphosphate 
aldolase 1 * 
 
38 39 66 Sal s 
3.0101 
B5DGM7- 
Salmo 
salar[atlantic 
salmon] 
  Tropomyosin* 38 41 99 Asc l 
3.0101 
Q9NAS5- Ascaris 
lumbricoides  
  
 
  72 Pen a 1 11893851- 
Penaeus aztecus 
[shrimp] 
    72 Lit v 
1.0101 
EU410072- 
Litopenaeus 
vannamei 
[whiteleg shrimp] 
  fructose-bisphosphate 
aldolase 2 
38 39 64 Sal s 
3.0101 
B5DGM7- 
Salmo salar 
[atlantic salmon] 
 
Three proteins were found in reactive band 5; two of the proteins identified (*) in this same band, had ≥65% 
sequence similarity with an allergen; and ≥50% of shellfish allergic patient sera reacted to this band. 
 
6 
(indeterminate) 
 Enolase 
 
48 48 71  
Sal s 
2.0101 
 
B5DGQ7- 
Salmo 
salar[atlantic 
salmon] 
  putative 
phosphoglycerate 
kinase 
 
48 45 15 Der f 
16.0101 
AAM64112- 
Dermatophagoide
s farina [mites] 
  4-hydroxybutyrate 
coenzyme a 
transferase  
48 51 9 Sch c 
1.0101 
D8Q9M3- 
Schizophyllum 
commune [mould] 
 
The protein enolase was among the proteins identified in reactive band 6 with sequence similarity to an allergen 
≥65%, however reactive bands were too faint to ascertain if ≥50% of shellfish allergic patients’ sera reacted with 
this protein in crude extract of A. pegreffii. 
 
7 (26%)  heat shock protein 70 
 
70 71 76 Cla h 
5.0101 
P40916- 
Cladosporium 
herbarum [mould] 
  myosin tail family 
protein 
 
71 108 38 Blo t 11 AAM83103-
Blomia tropicalis 
[mites] 
  myosin heavy chain  66 138 40  
Der p 11 
 
AAO73464-
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 Dermatophagoide
s pteronyssinus 
[mites] 
 
  chaperone DnaK  
 
67 84 51 Cla h 
5.0101 
P40918- 
Cladosporium 
herbarum[mould] 
 
Among proteins found in reactive band 7 which had sequence similarity above the threshold specified, was HSP 70, 
however, the percentage of shellfish allergic patients sera which reacted to this band was less than 50% 
 
8 (50%)  Myosin tail family 
protein 
 
71 108 38 Blo t 11 AAM83103-
Blomia tropicalis 
[mites] 
  Myosin heavy chain  66 138 40  
Der p 11 
 
 
AAO73464-
Dermatophagoide
s pteronyssinus 
[mites] 
  Myosin-4 46 93 42 Ani s 2 AAF72796-
Anisakis simplex 
 
None of the above proteins found in reactive band 8 satisfied the defined parameters for cross-reactive allergen for 
this study. 
 
9 (11%)  Vitellogenin-6 187 201 21 
 
 
Gal d 
vitelloge
nin 
CAA49139-
Gallus domesticus 
The only protein found in reactive band 9, vitellogenin, did not satisfy the defined parameters for cross-reactive 
allergen for this study. 
   *=Novel putative cross-reactive allergens identified. 
  SDAP=Structural database of allergenic proteins; MW=Molecular weight. 
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Figure 5.6. IgE antibody reactivity to A. pegreffii excretory/secretory product. 
 
IgE immunoblot with sera from 19 shellfish sensitised patients, as well as from one non-atopic 
control. Numbers denote specific IgE binding reactive bands and are interpreted in Tables 5.4 and 
5.5. 
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Table 5.4: Allergogram of IgE binding patterns to excretory/secretory proteins of A. 
pegreffii. 
 
Patient ID 1 2 3 4 5 6 7 
A        
B        
C        
D        
E        
F        
G        
H        
I        
J        
K        
L        
M        
N        
O        
P        
Q        
R        
S        
Note: IgE binding intensities are graded as low (light Grey), medium and strong (Black). 
Key:   =Low;                =Medium;                   = Strong 
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Table 5.5: List of proteins in A. pegreffii excretory/secretory product reactive bands and 
sequence identity to allergens. 
 
Reactive bands 
number and % of 
reactive shellfish 
allergic patient sera 
Proteins in 
reactive band 
Identified by LC-
MS/MS 
MW at 
which 
protein 
migrated 
(kDa) 
Uniprot 
MW 
(kDa) 
Highest 
sequence 
similarity to 
an allergen 
by blast in 
SDAP (%) 
Name of 
allergen 
Accession number 
and Organism 
1 (5%)  Major allergen Ani 
s 1 
18 21 96 Ani s 1 AB100095- 
A. simplex 
  Peptidyl-prolyl cis-
trans isomerase 3 
 
18 19 79 Cat r 
1.0101 
CAA59468- 
Catharanthus roseus 
(Rosy periwinkle) 
  fatty acid-binding 
protein-like protein 
3 
 
18 19 23 Lep d 13 Q9U5P1-
Lepidoglyphus 
destructor [storage 
mite] 
 
The number of patient sera reactive to proteins in this band was only one; hence none of the proteins with ≥65% sequence 
similarity to an allergen could be identified as a putative cross-reactive allergen since reactivity with 50% of shellfish 
allergic patients’ sera was not satisfied as one of the parameters defined to identify putative cross-reactive allergen in this 
study.  
 
2 (5%)  Triosephosphate 
isomerase 
 
25 27 62 Arc s 
8.0101 
Q8T5G9- 
Archaeopotamobius 
sibiriensis 
(crustaceans species) 
  superoxide 
dismutase 
 
25 25 51 Hev b 
10.0101 
AAA16792- Hevea 
brasiliensis [latex) 
  Glutathione S-
transferase 1  
 
25 24 38 Bla g 5 O18598- Blatella 
germanica  
  24 kDa protein 
 
25 24 10 Art v 
3.0202 
ACE07187- Prunus 
persica [peach] 
 
None of the above proteins found in reactive band 2 for ES, satisfied the defined parameters for cross-reactive allergen for 
this study. 
 
3 (5%)  Malate 
dehydrogenase 
 
35 36 57 Mala f 4 AAD25927- 
Malassezia furfur 
[mould] 
  Transaldolase 
 
35 42 54 Cla c 
14.0101 
ADK47394- 
Cladosporium 
cladosporioides 
[mould] 
  YjeF-related 
protein, C-terminus 
containing protein 
 
35 33 20 Der f 3 P49275- 
Dermatophagoides 
farinae 
  Annexin-A6 35 34 19 Eur m 14 AAF14270- 
 
Euroglyphus maynei 
[mite] 
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None of the above proteins found in reactive band 3 for ES, satisfied the defined parameters for cross-reactive allergen for 
this study. 
 
 
4 (≥50%)  fructose-bisphosphate aldolase 1 * 
 
38 39 66 Sal s 3.0101 B5DGM7- 
Salmo salar[atlantic 
salmon] 
  fructose-bisphosphate aldolase 2 38 39 64 Sal s 3.0101 B5DGM7- 
Salmo salar[atlantic 
salmon] 
  hemoglobin 38 39 9 Chi t 8 P02227- Chironomus 
thummi thummi [midge] 
  Galactoside-binding lectin  38 37 10 Tab y 2.0101 ADM18346- 
 
Four proteins were found in reactive band 4; one of the proteins identified in this band, has ≥65% sequence similarity with an 
allergen; and ≥50% of shellfish allergic patient sera reacted with this band. 
 
5 (≥50%)  Enolase 
 
48 48 71  
Sal s 2.0101 
 
B5DGQ7- 
 
Salmo salar[atlantic 
salmon] 
 
  4-hydroxybutyrate coenzyme a 
transferase  
48 51 9 Sch c 1.0101 D8Q9M3- Castanea 
sativa [chestnut tree] 
 
 
 Imidazolonepropionase 
 
48 45 5 Cas s 1 CAD10374-
Dermatophagoides 
farina [mites] 
 
Three proteins were found in reactive band 5; one of the proteins identified in this band, enolase, has ≥65% sequence 
similarity with an allergen; and ≥50% of shellfish allergic patient sera reacted with this band. 
 
6 (5%)  cytosolic 10-formyltetrahydrofolate 
dehydrogenase  
53 100 41 Alt a 10 P42041- Alternaria 
alternata [mould] 
  6-phosphogluconate 
decarboxylating 
 
53 55 8 Alt a 3 P78983- Alternaria 
alternata [mould] 
None of the above proteins found in reactive band 6 satisfied the defined parameters for cross-reactive allergen for this study 
 
 
7 (5%)  Vitellogenin-6 187 201 21 
 
 
Gal d 
vitellogenin 
 
 
CAA49139-Gallus 
domesticus 
The only protein found in reactive band 9, vitellogenin, did not satisfy the defined parameters for cross-reactive allergen for 
this study. 
The shaded column = (%) sequence similarity to an allergen with the darker shade indicating the protein with ≥65% sequence 
similarity to an allergen; *-Novel putative cross-reactive allergens identified; SDAP=Structural database of allergenic proteins; 
MW=Molecular weight. 
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5.3.3 Identification of IgE-binding proteins by MS analysis  
 
The intensity of the reactive bands in the IgE immunoblots are graded in the allerlogram Tables 5.2 and 
5.4 for CE and ES of A. pegreffii, respectively. The grade ranged from strong to moderate and light 
intensity. Protein bands were excised from SDS-PAGE gels of CE and ES products based on IgE-binding 
patterns. Proteins with the molecular weight size corresponding to the reactive bands were further 
analysed by 1D-LC-MS/MS. 
5.3.4 Bioinformatic Analysis 
The sequences of proteins identified were used in a Blast search against the Structural Database of 
Allergenic Proteins (SDAP) database. However, the focus was on reactive bands in which ≥ 50% of 
patients reacted and in which the protein of interest has a sequence similarity of ≥65% with one or more 
allergens in SDAP. The list of proteins identified in both crude extract and excretory/secretory product of 
A. pegreffii reactive bands as well as similarity in their sequence identity to allergens, are listed in Tables 
5.3 and 5.5, respectively. 
Putative cross-reactive allergens were then identified from these groups of protein in selected reactive 
bands, based on high mascot score and ≥65% sequence identity with an allergen. Two reactive bands 
were further characterized in the CE-the band corresponding to 37-39kDa because of the signal strength 
and over 50% patient sera reactivity; while in the ES, 2 other protein bands were also characterized. 
Though the intensities of reactive bands in the ES were not as strong as those in the CE, they were 
however characterised as these bands were considered of moderate signal strength.  
Hence, fructose bisphosphate aldolase 1 and enolase were identified in the ES of A. pegreffii as putative 
cross-reactive allergens, while tropomyosin, in addition to fructose bisphosphate aldolase 1, was 
identified in the CE. Peptides of the putative cross-reactive allergens identified by LC-MS/MS in this 
study are listed in supplementary Tables S1 and S2. 
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5.3.5 Molecular phylogenetic analysis 
To investigate the nature of the potential immunological cross-reactivity between Anisakis allergens and 
related invertebrate allergens, the phylogenetic relationships between the three-major IgE binding 
proteins of A. pegreffii and their crustacean homologues were evaluated (Figures 5.7A and B, Figure 5.8). 
A. pegreffii enolase (Figure 5.7A) clustered together with the banana prawn homologue to the exclusion 
of fish enolases, while the A. pegreffii aldolase clustered separately from the fish homologues (Figure 
5.7B). Tropomyosin clustered together with homologues from prawn and crab, to the exclusion of those 
from oyster and abalone (Figure 5.8). 
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Figure 5.7. The phylogenetic tree of A. pegreffi putative novel cross-reactive allergens.  
 
Phylogenetic relationship of A. pegreffii’s novel putative cross-reactive allergens (A) Enolase (B) 
Fructose bisphosphate aldolase- with homologues from shellfish, based on Neighbour Joining 
analysis. Bootstrap values supporting each clade are indicated. 
 
 
 
 
(A). Enolase
(B). Fructose bisphosphate aldolase
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Figure 5.8. The phylogenetic tree of A. pegreffi tropomyosin, a cross-reactive allergen. 
 
Phylogenetic relationship of A. pegreffii’s tropomyosin with homologues from shellfish, based on 
Neighbour Joining analysis. Bootstrap values supporting each clade are indicated. 
 
 
 
 
 
 
  
Tropomyosin
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5.4 Discussion 
Hypersensitivity reactions to a variety of food sources containing homologous proteins is a significant 
clinical problem (Sicherer, 2001, Popescu, 2015) . Infected fish contaminated with parasitic nematodes of 
the genus Anisakis may induce possible clinical cross-reactive responses in subjects with allergies to 
crustaceans, as a consequence of a high amino acid sequence identity between crustaceans and parasite 
proteins, such as tropomyosin (Lopata et al., 2010). A. simplex is recognised by the WHO/IUIS 
nomenclature committee as the parasite with the largest number of known allergens (Caraballo and 
Acevedo, 2011, Fitzsimmons et al., 2014). In particular, while recent transcriptomic investigations of A. 
simplex and A. pegreffii led to the identification of up to 38 and 31 putative allergens, respectively (Baird 
et al., 2016), it is likely that the full repertoire of allergens for these parasite nematodes is yet to be 
discovered (Baird et al., 2016).  
Fructose bisphosphate aldolase was identified in the proteome of AP in this study. Reactivity was not 
observed with rabbit anti-goat aldolase antibody although reactivity occurred between the rabbit anti-goat 
aldolase and fish aldolase. However, 24 hour exposure (figure not shown) showed weak reactivity in 
crude extract and a weaker reactivity in ES. This result may be due to (i) variation of protein and allergen 
composition or (ii) the aldolase protein of Anisakis not having significant similarity to that of human, due 
to differences in the epitope binding site.  In addition, there was no reactivity with the antibody against 
parvalbumin. Parvalbumin was not identified in the proteome of A. pegreffii in this study. Hence absence 
of reactive band with parvalbumin in A. pegreffii extracts may indicate absence of the protein in A. 
pegreffii.  
Further analysis focused on A. pegreffii allergens potentially responsible for cross-reactivity in shellfish 
allergic patients. Over 50% (n=>10) of shellfish allergic patients reacted to tropomyosin from CE of A. 
pegreffii. Tropomyosin has been long known as an important pan-allergen. It  has been isolated from 
crustaceans (Kamath et al., 2013), as well as HDM and storage mites (Aki et al., 1995), insects including 
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cockroaches (Asturias et al., 1999) and from nematodes such as Anisakis and Ascaris species (Reese et 
al., 1997). Tropomyosin is a major cross-reactive allergen widely reported in shellfish and HDM-
sensitised subjects (Kamath et al., 2017). It is however, suggested that it might not be the only allergen 
responsible for cross-reactivity in such individuals (Boquete et al., 2011, Kamath et al., 2017). 
In this study, 2 novel cross-reactive allergens were identified in addition to tropomyosin in A. pegreffii 
proteome. Fructose bisphosphate aldolase migrated at the same molecular weight size as tropomyosin. It 
could be observed that 2 bands were merged together for some patients at 37-39kDa in the crude extract 
and the intensity was strong.  Fructose bisphosphate aldolase protein also gave a high reactivity in ES 
with sera of shellfish allergic patients. FBA has recently been described by our group (Baird et al., 2016) 
as well as by other researchers (Faeste et al., 2014) as a putative allergen of A. pegreffii and A. simplex. It 
was also just recently described as an allergen in prawns (Kamath et al., 2014a). Though FBA was 
previously identified as a major fish allergen with limited cross-reactivity (Kuehn et al., 2013), IgE-
binding frequency of Anisakis FBA was >50% against sera of shellfish allergic patients in this study. 
An additional protein was identified in the ES, namely enolase. This protein was also identified in the CE 
of A. pegreffii in this study. Due to the weakness of the intensity of the reactive bands, the number of sera 
reactive to this protein in the CE was indeterminate; however, its presence in the ES was significant. 
Enolase has been previously described as an allergen in Anisakis and fish but not yet in crustaceans 
(Faeste et al., 2014). Enolase has furthermore been described as a major cross-reactive allergen not only 
in fish and cockroaches, but also in plants and fungi (Chuang et al., 2010, Tomm et al., 2013). In this 
study, enolase in A. pegreffii extracts, displayed a high frequency of IgE-binding (≥50%) to sera from 
shellfish allergic patients. Reactivity to enolase in CE and ES, however, varied across subjects as 
observed in their binding intensity, which may indicate differences in the sources of enolase expression 
and/or relative abundance in A. pegreffii. According to information available for patients whose sera were 
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tested in this study, four subjects with IgE binding to enolase had a history of allergy to fish and 
crustaceans.  
Sera from patients sensitised to crustacean shellfish utilised in this study have reacted to additional 
allergen proteins, other than tropomyosin, which suggests a role for these proteins as cross-reactive 
allergens between crustaceans and Anisakis, and supports the hypothesis that multiple proteins are 
responsible for immunological and clinical cross-reactivity between crustaceans and the fish parasite 
Anisakis. Although six of the patients in our study had negative ImmunoCAP for shellfish-specific IgE 
(ssIgE) against shrimp, crab or lobster they were each atopic with a strong clinical history of seafood 
allergy and positive serum IgE immunoblotting. This reflects the current issue with limited reliable 
diagnostic agents. 
Other protein bands were observed at positions consistent with the known shellfish allergens, however, 
these proteins did not satisfy the criteria defined for cross-reactive allergens in this study as fewer than 
50% of patients sera reacted to these proteins. This might have been due to a low abundance of these 
proteins in A. pegreffii extracts in this study. Such proteins include myosin regulatory light chain (~15 
kDa) and paramyosin (~100 kDa), a cross-reactive protein described in diverse invertebrates (Popescu, 
2015). Other proteins detected include 70 kDa heat shock protein, which has been known to be implicated 
in insect-nematode cross-allergies (Johansson et al., 2001); transaldolase protein previously identified as a 
significant IgE cross-reactive allergen family of Cladosporium and Penicillium species (Chou et al., 
2011); fatty acid binding proteins (FABPs)  identified as minor allergens in mites (group 13) and 
cockroaches (Thomas et al., 2002), with the mite FABP shown by Munera et al. (Munera, 2015) to have a 
high degree of IgE cross-reactivity with shrimp FABP. A larger study needs to be carried out to confirm 
that these proteins are not implicated in cross-reactivity between shellfish and Anisakis. 
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In summary, in this study, three proteins (tropomyosin, enolase and fructose bisphosphate aldolase 1) 
have been identified as putative IgE binding cross-reactive allergens between A. pegreffii and shellfish. 
The data obtained from the result of this study provide a platform for further investigations into hidden 
allergens in shellfish and Anisakis, as well as other unrelated allergen sources, which may assist in the 
development of novel sensitive diagnostic tools for allergy detection.  
Improved component-resolved diagnosis is not only relevant for patients with possible allergy to A. 
pegreffii, but also for the estimated ~3% of the world’s population affected by shellfish and/or fish allergy 
(Liu et al., 2010). Knowledge of allergens that are cross-reactive between A. pegreffii and the many 
different species of fish and shellfish consumed worldwide is central to improved patient management 
and future development of immunotherapeutics.  
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 IDENTIFICATION AND MOLECULAR CHAPTER 6:
CHARACTERISATION OF LEUCINE AMINOPEPTIDASE 
OF A. SIMPLEX AND A. PEGREFFII. 
 
 
 
 
 
 
 
 
 
Chapter 6 
156 
 
6.1 Introduction. 
Proteolytic enzymes have been found to contribute significantly to the function of almost all organisms 
(Rawlings, 2013). They are required to remove the initiating methionine from newly synthesized, 
cytoplasmic proteins, to cleave the signal peptides from proteins that have gone through the secretory 
pathway, to remove propeptides from enzymes, as well as receptors and hormones synthesized as 
precursors in order to activate these proteins, to release individual proteins and peptides from 
polyproteins, to destroy potentially lethal proteins from parasites and pathogens, to release antigenic 
peptides from parasites and pathogens as well as to obtain amino acids from food proteins (Rawlings, 
2013). 
Key activities in the host-parasite interface have been connected to proteases. Proteases have been 
discovered to be associated with critical molecular tasks that lead to successful parasitism. These enzymes 
contribute to parasite nutrition, tissue invasion, and evasion of the host immune response. Increasingly 
recognised as potential targets for chemotherapeutic agents, parasite proteases play important roles in 
parasite biology (Rawlings et al., 2014). Proteases have been classified into serine, threonine, cysteine, 
aspartic and metalloproteases, based on their catalytic sites.  
6.1.1 Proteases of Anisakis Described 
A number of proteases secreted by Anisakinae have been investigated. These include the D-like aspartic 
protease cloned by Ni and colleagues (Ni et al., 2012). In another study,  activity of selected hydrolases in 
the ES of Contracaecum rudolphii showed activity of leucine arylamidase, valine arylamidase and 
chymotrypsin, while the remaining proteases revealed no detectable activity (Dziekonska-Rynko and 
Rokicki, 2005). A serine protease and serine protease inhibitor from infective larvae of the parasitic 
nematode Anisakis simplex ((Morris and Sakanari, 1994) was purified by Morris and Sakanari. The serine 
protease was found identical with that of porcine trypsin. Another serine protease identified, was found to 
Chapter 6 
157 
 
be similar to a secreted tissue-destructive serine protease from the pathogenic bacterium Dichelobacter 
nodosus (Morris and Sakanari, 1994). Furthermore, in the investigation by Sakanari and Mckerrow, 2 
classes of proteases were detected in A. simplex: a metallo aminopeptidase and a trypsin-like serine 
protease (Sakanari and McKerrow, 1990). Recently, a group of peptidases with roles in host tissue 
penetration and digestion encoded by transcripts in both A. simplex and A. pegreffii were shown to be 
differentially expressed as reported in a study by Cavallero et al. (Cavallero et al., 2018). Putative 
peptidases identified in that study included (i) aspartic peptidases M1 (n = 1), (ii) astacin peptidase M12A 
(n = 5),   (Grandea et al.) (iii) peptidase M13 (n = 2), (iv) serine carboxypeptidase S10 (n = 1), as well as 
hemopexin-like metallopeptidases, carboxylesterases and ShKT Stichodactyla helianthus toxin (n = 3). In 
same study it was noted that in particular, transcripts encoding for metalloproteinases (i.e. 
aminopeptidases, astacins and neprilysins) were particularly abundant in A. simplex.  
6.1.2 Leucine Aminopeptidases (LAPs) 
Metallo-aminopeptidases that catalyse the removal of N-terminal amino acid residues are the leucine 
aminopeptidases (LAPs). LAP is an exopeptidase metallo-exoprotease belonging to the M17 peptidase 
family. It preferentially cleaves a leucine residue at the N-terminus of proteins and peptides, although they 
display a broad amidolytic activity to other amino acid hydrolysis (Rawlings et al., 2014). Leucine 
aminopeptidases (LAPs) are found in animals, plants and microorganisms and they comprise a diverse set 
of enzymes with different biochemical and biophysical properties. Catabolism of endogenous and 
exogenous proteins, gene expression modulation, peptide and protein processing and turnover, antigen 
processing and defense are the physiological processes in which these proteins have been implicated 
(Matsui et al., 2006).  
The active site of LAPs of the M17 peptidase family is located in the C-terminal domain, considering 
most LAPs contain two unrelated domains. Two metal ions are required for activity by LAP and activity 
is usually best at neutral or basic pH. LAPs are sensitive to bestatin and amastatin (Rawlings et al., 2014). 
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Due to their important functions in the life cycle of pathogenic microorganisms such as Plasmodium, 
Fusobacterium nucleatum and Trypanosoma brucei, LAPs have emerged as novel and promising targets 
for drug design (Stack et al., 2007, Skinner-Adams et al., 2012, Rogers et al., 1998). In addition, a strong 
IgG response was shown in vaccination trials using Fasciola hepatica LAP (FhLAP) for rabbit 
immunization. A high level of protection was achieved after experimental infection with F. hepatica 
metacercariae. This affirmed FhLAP as a relevant candidate for vaccine development (Acosta et al., 
2008).  
6.1.3 LAP in other parasites and localization 
The function of LAP in different parasites is under investigation. LAP null mutants of Caenorhabditis 
elegans were shown to exhibit growth rate reduction, which subsequently delayed onset of egg laying 
(Joshua, 2001). In a study by Jia et al., the enzymatic activity of LAP was characterized in  T. gondii LAP 
(TgLAP) (Jia et al., 2010). Furthermore, in Streptomyces coelicolor, leucine aminopeptidase deletion was 
found to  increase actinorhodin production and sporulation (Song et al., 2013). In malaria parasites, 
leucine aminopeptidase-like enzymes have been ascribed with the function of haemoglobin digestion. 
They are believed to function in the terminal stages of haemoglobin digestion in order to generate free 
amino acids, used for parasite protein synthesis (Gavigan et al., 2001). In T. gondii, TgLAP has also been 
found to have the ability to release free amino acids as the final step in protein catabolism (Jia et al., 
2010). 
The LAP of liver fluke has been shown to be expressed in the excretory/secretory product and therefore in 
the gut of the fluke (Marcilla et al., 2008, Marcilla et al., 2012). In Clonorchis sinensis, the carcinogenic 
liver fluke, LAPs (CsLAP1 and CsLAP2) have been demonstrated to be expressed throughout the 
development of the parasite, co-localizing in the epithelial cells of the gut of the fluke. They are believed 
to probably participate in the terminal cleavage of peptides just before absorption from the gut lumen 
(Kang et al., 2012). Peptidases related to LAPs expressed in the gut and tegument of Schistosomes (S. 
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japonicum and S. mansonii), have also been described (McCarthy et al., 2004). LAPs in schistosomes 
have been found in eggs, miracidia, cercaria and egg hatching fluid.In addition, it was demonstrated in 
Schistosomes that egg hatching did not occur when the specific inhibitor for metalloproteinases, bestatin, 
was applied. Both LAPs of S. mansonii SmLAP1 and SmLAP2 were implicated in egg hatching (Xu and 
Dresden, 1986). 
The work described in this chapter extends the study of proteases in Anisakis species to investigating 
activity, function and localization of secreted leucine aminopeptidase (LAP) in both A. simplex and A. 
pegreffii.  
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AIMS 
Metallopeptidases were the most abundant among the classes of peptidases identified in the proteome of 
Anisakis pegreffii (as described in Chapter 3). In addition, one of these classes of aminopeptidases, 
leucine aminopeptidase (LAP), was identified in Chapter 4 among the cargo content of exosomes of A. 
pegreffii. Hence this chapter therefore aims to: 
1. Express and purify a functional recombinant leucine aminopeptidase (LAP) protein of 
Anisakis in Escherichia coli. 
2. Evaluate the biochemical properties and function of this protease. 
3. Demonstrate the localisation region of the enzyme in Anisakis pegreffii L3 Larvae. 
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6.2 Methods  
The general methods of parasite materials collection, molecular identification of A. pegreffii, preparation 
of excretory/secretory products (ES) and parasite crude extracts (CE), 1D- LC-MS/MS analysis and 
protein identification are as described in the general methods in Chapter 2. The following are the specific 
methods for this chapter. 
6.2.1 Specific Materials 
Leucine-7-amido-4-methylcoumarin hydrochloride and L-Leu-β-naphthylamide  substrates with bestatin, 
Fast Blue B Salt, potassium cyanide BioUltra, ≥98.0% (AT), Methyl Green Zinc chloride salt for 
microscopy, ES-62 and 1, 10-phenanthroline were purchased from Sigma Aldrich (Australia). Pre-cast 
gels (4-12%), buffers, molecular weight  markers and all standard molecular biology reagents used were 
from Sigma Aldrich (Australia) except otherwise stated. 
6.2.2 Specific Methods 
6.2.2.1 Leucine Aminopeptidase Gene Synthesis 
Due to time constraints and unsuccessful amplification of the LAP gene from A. pegreffii L3 larvae 
extract at the first few trials, a fragment of a secreted LAP gene from A. simplex, based on the published 
genomic data of A. simplex was synthesized by G-block script (Australia) (Uniprot accession number: 
A0A0M3KDK6). Restriction enzyme sites for both HindIII and Nde1 were introduced into the 
synthesized fragment at the 5’ and 3’ end, respectively.  In designing of the sequence, introns of the LAP 
gene from A. simplex were removed and the final gene size synthesized was a 950bp gene (See Appendix 
for details of gene synthesized). The synthesized gene fragment was provided in a lyophilized tube, which 
was then re-suspended in the laboratory as specified by the manufacturer for further downstream 
application.  
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6.2.2.2 PCR Primer Design 
PCR Primers based on the whole LAP gene: Forward primer (5’- 
GCATGAAAGCTTTTACAGGTAGTAATTTAAATA) which contained an HindIII site (underlined) 
and the Reverse primer (5’-GCATGACATATGATGATTGTTGTTTTCAGC), which introduces an Nde1 
site (underlined) were designed using Primer 3 software. Both enzyme sites are able to fuse N-terminal 
and C-terminal His6 tag.  Those restriction enzymes were chosen because they both do not have 
recognition sites within the gene but do have in the pET28a vector. Six nucleotides were added at the 5’ 
end of each primer to increase their stability. The primers were ordered from GeneWorks Custom Oligo 
Service, Australia.  
6.2.2.3 Appropriate Gene Size Confirmation 
The synthesized gene used as a template, was amplified according to instructions by manufacturers using 
the above-mentioned primers with a cycling condition of: 94 °C for 1 min; 94 °C for 30 s; 50 °C for 
1 min; 72 °C for 2 min; 15 cycles, followed by a 7 min extension at 72 °C. Amplified product was run for 
1 hour at 100 volts on a  1.5% agarose gel (0.5 agarose dissolved in 50 ml TAE buffer) premixed with 
Sybr safe  (5µl to 50mls of agarose gel=1:10,000 dilution) to confirm the right gene size has been 
amplified. This was visualised under the Biorad UV transilluminator. 
6.2.2.4 Digestion of Gene and Plasmid 
The amplified product was purified using the Isolate II PCR and Gel purification kit (Bioline) according 
to the manufacturer’s instruction. Subsequently, the purified gene product and the plasmid to which the 
gene would be inserted (pET28a) were separately double digested by HindIII and Nde1 (NEB) to create 
two sticky-ended DNA fragments using the NEB protocol for double digestion as shown below (Table 
6.1). Equal amounts of digested DNA were thereafter electrophoresed on 1.5% agarose gels as earlier 
described for 2 hours at 60V. 
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Table 6.1: Double Digestion Protocol. 
Components Reaction volume 
Restriction enzyme 1 10units (1µl) 
Restriction enzyme 2 10units (1µl) 
DNA 1µg 
10 X NEBuffer 48 µl 
Total reaction volume ~50 µl 
Incubation time 1 hour 
Incubation Temperature 37°C 
 
6.2.2.5  Ligation of Gene (LAP) into Plasmid (pET28a). 
The digested products were purified after electrophoresis and visualization of bands which indicated 
complete and correct digestion. The LAP gene was inserted and ligated into the pET28a plasmid vector 
using the T4 DNA Ligase NEB protocol as described below in table 6.2. Plasmid with insert was 
amplified and PCR products were purified with Isolate II PCR and Gel purification kit (Bioline). The 
reaction was set up as shown below on ice. 
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Table 6.2: Ligation Protocol. 
Components 20 µl Reaction 
T4 DNA Ligase Buffer (10X), thawed and 
resuspended at room temperature 
2 µl 
pET 28a Vector DNA (5369bp) 50 ng (0.020 pmol) 
Insert DNA (950bp) 37.5ng (0.060 pmol) 
Nuclease free water To 20 µl 
T4 DNA Ligase 
1 µl 
 
The table shows a ligation procedure using a molar ratio of 1:3 vector to insert. The reaction was gently 
mixed by pipetting up and down and given a brief microfuge. The mixture was then incubated at room 
temperature for 10 minutes and subsequently heat inactivated at 65°C for another 10 minutes.  
6.2.2.6 Sequencing. 
To the purified plasmid DNA with the insert (10μl), was added 1μl of the forward and reverse sequencing 
primers in separate tubes according to Australian Genome Research Facility (AGRF) specification and 
was sent for sequencing. The primer sequence used are forward primer- 5`-
TAATACGACTCACTATAGGG-3`  (20bp) and reverse primer- 5`-
TTATGCTAGTTATTGCTCAGCGGTGG-3` (26bp) obtained from  the Biotechnology Laboratory, 
Chapter 6 
165 
 
RMIT University, Bundoora, Victoria, Australia. This was to confirm the correct orientation and insertion 
of the gene in the pET 28a plasmid vector. 
6.2.2.7 Competent Cells Preparation. 
E. coli DH5α and E. coli BL21 DE3 were separately grown overnight in 5ml LB broth each. The 
overnight culture was then inoculated into 200ml LB broth and grown at 37°C on the shaker (220 rpm) 
until an OD 600 nm 0.35 to 0.4 (Early-Mid-Log-Phase) was reached. The E. coli cultures were chilled on 
ice for 30 minutes and divided 50ml each in Falcon tubes, which were thereafter centrifuged at 3500 x g 
for 15 minutes at 4°C. Supernatant was removed and pellets were resuspended in 50ml ice-cold sterile 
Milli-Q water until the pellets disappeared. The centrifugation process was performed again using the 
same conditions. Pellets were resuspended in 25ml ice-cold sterile Milli-Q water and centrifugation was 
repeated. After this centrifugation, the pellets were resuspended in 25ml of 10% ice cold glycerol, and the 
tubes for each E. coli strain were pooled to have 1 tube for each strain and the centrifuge protocol 
repeated as described. Finally, the cells were resuspended into a double pellet volume (around 300 μl) of 
10% ice-cold sterile glycerol, and cell aliquots of 50μl in each eppendorf tube were stored at - 80°C. 
6.2.2.8 Transformation. 
Chilled reaction mixture of ligated plasmid with insert was used to transform 50 μl competent cells of 
each of E. coli strain dH5α (for maintenance and propagation) and E. coli BL21 DE3 (for protein 
expression). Briefly, competent cells were thawed on ice and 50 µl of competent cells was added to 
chilled 5 ng (2 μl) of the ligation mixture DNA. The cells and DNA were mixed gently by pipetting up 
and down and subsequently placing on ice for 30 minutes. The mixture was then heat shocked at 42°C for 
30 seconds. At room temperature, 950 µl of SOC media was added to the tubes and placed at 37°C for 60 
minutes with vigorous shaking (250 rpm). Selection plates incorporated with kanamycin (50 µg/µl) was 
warmed to 37°C. The cells and ligation mixture (100 µl) were then spread onto the plates and incubated 
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overnight at 37°C. True transformants were selected and presence of the gene was verified by 
amplification of the gene using the designed primers. This protein was expressed and purified from the 
transformed E. coli BL21 DE3.  
6.2.2.9 Protein Expression. 
Expression of the protein was carried out using an in-house terrific broth protocol. Briefly, E. coli strain 
was transformed and grown overnight on LB agar with kanamycin antibiotics at 37 ᴼC. Pre-induction 
terrific broth (200 mL) (recipe stated under Appendix 1) was inoculated with 1 colony or 20 µl 
transformant from the selection plate or culture. Culture was incubated overnight at 28 ᴼC with fast 
shaking. The overnight culture was harvested by centrifugation at 4000 X g for 10 minutes. Pellets were 
washed and resuspended in 20mL PBS and then re-harvested by centrifugation. Resulting pellet was 
resuspended in 200 mL expression terrific broth (recipe in general methods). The new culture was 
equilibrated by incubating at induction temperature for 15 minutes. Isopropyl β-D-1thiogalactopyranoside 
(IPTG) was added to desired concentration (1 mM). Protein was then expressed for 2-6 hours at 28 ᴼC 
with fast shaking. 
6.2.2.10 Protein Purification. 
E. coli cell culture expression culture was pelleted by centrifuging at 5000 x g for 10 minutes at 4 ᴼC 
and frozen at -80 ᴼC until use. For purifying His6-LAP, cell pellets were resuspended in lysis buffer 
(20mM Phosphate buffer pH 7.4 and 1mg/ml lysozome). Volume is 1/10th volume of cell culture 
suspension that pellet was obtained from. Resuspended pellet was sonicated using a probe sonicator 
(Branson digital sonifier, 35% amplitude, Pulse On: 15 sec; Pulse Off: 30 sec; three cycles), and 
thereafter centrifuged for 5 min at 10,000 x g to remove debris. The supernatant was collected and filtered 
using a 0.45 μm membrane filter (Millipore, Billerica, MA, USA). 
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6.2.2.11 Preparation and Packing of Immobilized Metal Affinity Chromatography (IMAC). 
A 1ml polypropylene column (Qiagen) was prepared for IMAC purification of LAP protein by washing 
with 10ml Milli-Q water, with both sides of the column open, to obtain a steady speed of water flow and 
removal of air bubbles. Iminodiacetic (IDA) sepharose was added to the column and left to settle to the 
pre-marked 1ml column level with the end of the column stoppered with a cap. The resin was then 
washed with 10ml MilliQ water (10 column volumes (CV)) to remove the ethanol in which the resin was 
stored. Next, the column was charged with 0.5ml (0.5 CV) of 0.2M NiSO4 and washed with 10ml (10 
CV) of MilliQ water to remove unbound metal ions. The flow through was collected in a disposable tube 
and discarded. Finally, the column was equilibrated with 5 ml (5 CV) of the equilibration wash buffer 
containing 20mM Phosphate buffer, 400mM NaCl and 5mM Imidazole at pH of 7.4.  
6.2.2.12 Optimization of IMAC protein purification.  
A 5ml sample of cell lysate obtained as described above was added to the column and mixed with the 
resin by slowly flipping the column up and down. The column was incubated at 4ᴼC for 1 hour with 
gentle horizontal shaking to keep the sample mixed with the resin. Column was thereafter returned to the 
vertical position and left to settle for 30 minutes. Crude eluent was collected and the column was washed 
with 10 ml (10 CV) post sample wash buffer, and then the flow through eluent containing unbound 
protein was collected. Successively, 1ml of elution buffer containing increasing concentrations (20 mM - 
500mM) of imidazole was added to the column and fractions of 1 ml were collected in 1.5ml 
microcentrifuge tubes.  
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6.2.2.13 SDS-PAGE Electrophoresis and Western blotting  
Samples were heated with SDS-loading buffer at 37ᴼC for 10 minutes before being subjected to SDS-
PAGE.  Gels were stained with Coomassie blue for 1 hour and destained overnight. Presence of protein of 
interest was confirmed with Western Blot. A separate SDS-PAGE electrophoresis, which was unstained 
with a pre-stained marker (listed in general methods and reagents), were used. The proteins on the gel 
were transferred to a nitrocellulose membrane using the iBlot TM Dry Blotting System (Invitrogen). 
Briefly, the anode stack containing the membrane was placed on the iBlot, and the SDS-PAGE gel was 
carefully placed on the membrane anode stack.  A filter-paper pre-soaked in deionized water was placed 
on top of the gel and air bubbles rolled out using the blotting roller provided in the iBlot equipment. 
Subsequently, the cathode stack was placed on the filter paper with the electrode side facing up. A 
disposable sponge was positioned on the top of the cathode stack. Blotting was performed following a 
preset program and time (7 minutes). The nitrocellulose membrane was thereafter ready for further 
processing.  
The nitrocellulose membrane was blocked in 25ml of 5% (w/v) bovine serum albumin (BSA) in Tris-
buffered saline with 0.05% Tween 20 (TBST) for 1 hour on the shaker at room temperature. The 
membrane was then washed 3X for 5 minutes each time. The membrane was probed with primary 
antibody (anti-his antibody developed in mouse and diluted (1:3,000) in 1% BSA in TBST for 1 hour. 
Subsequent washing of the membrane with TBST 3X as before, was followed. The secondary antibody 
(rabbit anti-mouse antibody-25 ml diluted 1:3,000) in 1% BSA in TBST conjugated to alkaline 
phosphatase (AP) substrate was then applied to the membrane for 1 hour, as before on the shaker. 
Membrane was washed again 3X with TBST for 5 minutes each and then immersed in the AP detection 
buffer (Biorad), following the manufactuer’s instructions. Membrane was left to develop colour intensity 
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in the dark for 3-5 minutes before washing excess detection buffer off with distilled water. Coloured 
protein bands were visualized. 
6.2.2.14 Evolutionary relationships of Anisakis LAP with homologs. 
LAP sequence was used as a query for Blast searches of databases at the NCBI and EBI servers and also 
the transcriptome of A. pegreffii in-house generated database. Relevant matches were retrieved. Sequence 
alignments were generated with MEGA 6 (Tamura et al., 2013).  The evolutionary history was inferred 
using the Neighbour-Joining method (Saitou and Nei, 1987).   The tree is drawn to scale, with branch 
lengths (next to the branches) in the same units as those of the evolutionary distances used to infer the 
phylogenetic tree.   The evolutionary distances were computed using the Poisson correction method 
(Zuckerkandl and Pauling, 1965) and are in the units of the number of amino acid substitutions per site. 
The analysis involved 13 amino acid sequences. All positions containing gaps and missing data were 
eliminated. Evolutionary analyses were conducted in MEGA6 (Tamura et al., 2013). 
6.2.2.15 Enzymatic analysis of Anisakis LAP. 
The aminopeptidase activities of recombinant Anisakis LAP was measured by monitoring the release of 
cleaved moieties from the fluorogenic peptidyl substrates l-Leucine (Leu)-7-amido-4-methylcoumarin 
hydrochloride in a 96-well black plates using a final volume of 200 μl, enzyme (final concentration 
20 μM)) and substrate (final concentration 10 μM)  (Acosta et al., 2008, Song et al., 2008). All 
experiments were carried out in duplicate, and the mean and standard deviation (SD) were calculated. 
6.2.2.15.1 Optimum pH for LAP of Anisakis spp. 
The optimum pH for enzymatic activity was first determined by incubating the purified enzyme in 0.1 M 
sodium acetate (pH 3.5, 4.5, 5.0 and 6.0), 0.1 M Sodium phosphate (pH 7.0), 0.1M Tris-HCL (pH 7.4) 
and 0.1 Sodium phosphate (pH 8, pH 8.8), respectively. For each pH step, the appropriate blank was 
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separately measured as a control. The optimum buffer and pH was subsequently used in all other enzyme 
activity assays.  
6.2.2.15.2 Effect of Metal ions on enzymatic activity of Anisakis spp LAP. 
The effect of metal ions on the enzymatic activity was assayed by incubating LAP with the divalent 
cations generated from MgCl2, MnCl2, CaCl2, FeCl2 and ZnCl2 at a final concentration of 1mM for each 
metal ion (Chen et al., 2011). The enzyme activities of the aliquots of sample against the substrate were 
analyzed as described above. Results were expressed as percentage of enzymatic activity with respect to a 
control without metal ions.  
6.2.2.15.3 Inhibition studies for LAP of Anisakis spp. 
For inhibition studies, Anisakis LAP was incubated first for 15 minutes separately in the presence of N,N-
ethylenediaminetetraacetic acid (EDTA),  1,10-phenanthroline, trans-epoxy-succinyl-L-leucylamido (4-
guanidino) butane (E-64) or bestatin (a final concentration of 10µM for all the inhibitors) and thereafter 
the substrate was added and incubated for 1hr. Results were expressed as percentage of enzymatic activity 
with respect to a control without inhibitors. Activity was measured and expressed as the mean of two 
different experiments. The effects of different concentrations of bestatin inhibitor, the specific 
aminopeptidase inhibitor were assayed by pre-incubating the enzyme with different concentrations of the 
inhibitor (10µM, 20 µM, 30 µM, 40 µM and 50 µM) for 10 min at 37 °C. After the incubation period, 
remaining enzyme activity was assayed as above adding the substrate and incubating for 2 hr at 37 °C. 
Results are expressed as % of or relative activity with respect to control conditions.  
6.2.2.16 Processing of procathepsin L5 protease of Fasciola hepatica by Anisakis LAP. 
Recombinant Anisakis LAP was incubated with recombinant procathepsin FhCL5 (inactivated or 
unprocessed CL5) at pH 4.5 or pH 7.4. Purified recombinant pro FhCL5 (50 μg) was mixed with 1μg 
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recombinant Anisakis LAP according to Robinson et al. (Robinson et al., 2011). Briefly, the mixtures 
were incubated in either 0.1M sodium acetate (pH 4.5) or 0.1 M sodium phosphate (pH 7.4), each 
containing 1 mM DTT for 3 h at 370C. Reactions were stopped by the addition of E-64 (10 mM). Samples 
were taken at different time-points to observe the progress of digestion. The time points were 0, 
45minutes, 1 hour 30 minutes, 2 hour 15 minutes and 3 hours, respectively. Samples were analyzed on 4-
12% SDS-PAGE gels, stained with Coomassie stain and/or transferred to nitrocellulose membranes for 
immuno-detection as previously described. 
6.2.2.17 Histochemical Staining of Leucine Aminopeptidase of A. pegreffii in L3 Larvae. 
The parasite tissues/larvae were either fixed in formol-calcium or were put in small plastic cassette and 
embedded in optimal cutting temperature (Cygler et al., 1993) compound medium. After the samples in 
OCT became solid (indicated by white color), they were frozen for 3 minutes and then cut into many 
sections (10 um thick) by a microtome and thereafter spread over gelatin coated slides.  LAP 
histochemical staining was performed according to the method described by Pokharel and colleagues 
(Pokharel et al., 2006) referring to Nachlas et al’s protocol (Nachlas et al., 1957) with little modification. 
Briefly, the sections were incubated with the incubating solution [L-Leu-β-naphthylamide 0.5 mM, 
sodium chloride (0.34%) and Fast Blue B salt (0.05%)] and kept in a moist dark chamber for 2 h. 
Thereafter, the slides were rinsed consecutively in 0.85% saline, 0.1 M copper sulphate and again with 
saline for 2 min each. The sections were counterstained with 2% methyl green for 3 min and rinsed in 
distilled water. Finally, the counterstained sections previously fixed in formol-calcium were mounted in 
DPX for permanent slide preparation. Sections for negative controls were incubated in the incubating 
medium without the substrate. The slides were observed under a stereomicroscope fitted with Infinity 
Capture software for image capture. 
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6.3 Results 
6.3.1 Database searched.  
When the project described in this chapter was designed, the peptide data generated from the first 
proteomic analysis, which identified aminopeptidases in A. pegreffii, was searched against the then just 
released draft genome of A. simplex, which was made into a database for this analysis. This was before 
the transcriptome data of A. pegreffii was published. Proteases identified were confirmed encoded in the 
transcriptome of A. pegreffii, published thereafter.  
6.3.2 Anisakis simplex and A. pegreffii LAP proteins. 
A fragment of a secreted LAP gene based on the published genomic data of A. simplex was synthesized 
by G-block script (Australia) (Uniprot accession number: A0A0M3KDK6) and cloned in the laboratory 
into a pET28a vector transformed into E. coli BL21 DE3. 
A subsequent search with A. pegreffii proteome data against the newly constructed database of A. 
pegreffii trasncriptome identified two leucine aminopeptidases in the A. pegreffii proteome. These are 
leucine aminopeptidase LAP-1; (Unigene648_APIA; 477aa) and a hypothetical protein 
(CL3092.Contig1_AP1A; 246aa) identified as leucyl aminopetidase (LAP-2) by Blast search. Protein 
based Blast program comparing the A. simplex LAP sequence with each of these LAPs in A. pegreffii, 
showed 87% identity and 56% query coverage with the leucyl aminopetidase of 246aa (LAP-2). The 
protein sequences blast and sequence alignment is shown in Figures 6.1 and 6.2. However, there was no 
significant similarity with LAP 1 of A. pegreffii.  
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Figure 6.1. Protein Sequence Blast of A. simplex LAP and A. pegreffii LAP-2. 
 
A. Pegreffii LAP-2 is also known as leucyl aminopeptidase (CL3092.Contig1_AP1A; 246aa). 
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Figure 6.2. Sequence alignment of A. simplex LAP gene (A0A0M3KDK6) and A. 
pegreffii LAP-2 (CL3092). 
 
Note: The LAP-2 protein obtained from the transcriptome data of A. pegreffii has a shorter sequence, 
which may be due to incomplete transcripts of such proteins obtained from the transcriptome data. 
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Due to the high sequence similarity between the LAP proteins from A. simplex and A. pegreffii, from this 
point forward, I would also refer to the LAP protein in this chapter as A. pegreffii LAP. 
6.3.3 Restriction Digestion. 
The vector used in this study for cloning was pET28a with a size of 5369 base pairs (bp) (Figure 6.3). The 
double digestion using HindIII and Nde1 restriction enzymes produced fragments that are approximately 
4419 and 950 bp as expected (Figure 6.4). 
 
 
Figure 6.3. Vector Map of Pet 28a (5369 bp): KanR, lacl, f1 origin of replication. 
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Figure 6.4. Agarose gel electrophoresis of restriction digests. 
6.3.4 Expression and Purification of Anisakis LAP. 
The active recombinant form of Anisakis LAP was produced in E. coli BL21 DE3, expressed as a soluble 
protein and purified by IMAC using 20mM phosphate buffer with 400mM NaCl and 150mM Imidazole 
at pH 7.4. It is a protein migrating at 33kDa, as confirmed by SDS-PAGE and Western blotting (Figure 
6.5 A, B).  
 
5369
4419
950
200
1  =Molecular Marker (HyperLadderTM 1kb-Bioline)
2  =Uncut Plasmid
3   =Digested Plasmid with no insert ligated
4-6=E. coli DH5α with Plasmid and LAP gene insert
7-9=E. coli BL21 DE3 with Plasmid and LAP gene insert
10 = LAP PCR product (950bp). A control for insert size
LAP=Leucine aminopeptidase
bp
1     2   3  4   5  6   7  8  9  10
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Figure 6.5. Leucine Aminopeptidase of Anisakis Expression and Purification by IMAC. 
 
(A)= 4-12% SDS-PAGE  (B) Western blot of expression and purification of Anisakis LAP. 
 
6.3.5 Sequence Alignment and Phylogenetic Analysis. 
A comparison of the amino acid sequence of Anisakis LAP with sequences in the GenBank database 
indicated that Anisakis LAP has characteristic features of members of the family peptidase M17. This 
protein is identified in Toxocara canis, Brugia malayi and other species as LAP-2, while in some other 
species it is referred to as cytosol aminopeptidase.  Multiple sequence alignment of the amino acid 
sequence of Anisakis LAP with other organisms including helminth, shellfish, other parasites and humans 
was performed. This phylogenetic comparison with homologous enzymes from different species 
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demonstrates that the all metazoan LAPs constitute a well-defined group diverse from similar enzymes 
from Cestodes, Apicomplexa and vertebrates. FhLAP and other flatworm orthologs constitute a well-
defined cluster distant to the LAP enzymes of vertebrate. In addition, Anisakis LAP was evolutionary 
closer to shellfish LAP than to other helminths. Interestingly, LAP-1 of Anisakis was shown to be 
evolutionary closer to human LAP than to LAP-2 of Anisakis, or other helminths and shellfish LAP 
proteins (Figure 6.6). 
 
Figure 6.6. Phylogenetic Analysis of Leucine Aminopeptidase of Anisakis  spp. 
6.3.6 Activation of ProCathepsin L5 of Fasciola hepatica by Anisakis LAP. 
SDS-Page analysis of processing of inactivated FhCatL5 by Anisakis LAP is shown in Figure 6.7 (A-C). 
The 37 kDa unprocessed FhCatL5 was processed by LAP at pH 4.5. After 1hr 30min, the band of 
FhCatL5 at ~37kDa decreased in intensity and by 3hrs, the band was no longer visible while a second 
band at ~25kDa was still visible. 
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Figure 6.7. 4-12% SDS-PAGE Activity of Anisakis LAP. 
 
(A-C): 4-12% SDS-PAGE Gel of the Activity of (A). Leucine Aminopeptidase (LAP) of Anisakis on 
inactivated Cathepsin L5 (CL5) at pH (B). 4.5 and (C). 7.4. 
Lane L5=catL5 as control, M=Molecular marker (Sigma , Colour burst). 
Lanes 1-5  (pH 4.5)  are time points 0, 45 mins, 1.30 min, 2.45 min and 3hours, respectively. 
Lanes 7-11(pH 7.4) are time points 0, 45 mins, 1.30 min, 2.45 and 3hours, respectively. 
 
At pH 7.4, there was no observed activity of LAP on FhCatL5, as the band at ~37kDa retained its 
intensity for the time period of the experiment. This is shown in both the SDS-PAGE (Figure 6.7C) and 
Western blot (Figure 6.8).  Within the time period of 3 hours Anisakis LAP had processed the pro 
FhCatL5 at pH 4.5 while no activity occurred at pH7.4.  
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Figure 6.8. Western blot showing activity of Anisakis LAP on cathepsin L5. 
 
Western blot showing the activity of Leucine Aminopeptidase (LAP) of A. pegreffii on inactivated 
Cathepsin L5 (CL5) at pH 4.5 and 7.4. 
6.3.7 Enzymatic properties of recombinant Anisakis LAP. 
6.3.7.1 Optimal pH. 
To investigate the enzymatic characteristics of Anisakis LAP, recombinant Anisakis LAP was prepared 
and aminopeptidase activity was determined using the fluorogenic peptide Leucine-7-amido-4-
methylcoumarin hydrochloride substrate. Best activity was observed at pH 7.4, exhibiting a slight decline 
under mildly acidic (pH ≤ 7) and basic (pH 8.5) conditions. The optimal pH was pH7.4 for Anisakis LAP 
(Figure 6.9).  
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Figure 6.9. The Optimal pH of recombinant Anisakis LAP. 
 
Optimum pH of recombinant Anisakis LAP was carried out at 37˚C for 1 h. Each point represents the 
mean ± SD of duplicate samples that were incubated. 
 
6.3.7.2 Metal ion activity on Anisakis LAP. 
Since LAP of the M17 class is a metalloenzyme, the effect of divalent metal cations on recombinant 
Anisakis LAP was examined, as shown in Figure 6.10. The effect of divalent metal ions investigated 
showed that for Anisakis LAP, manganese was the optimal metal ion resulting in activity increment in the 
presence of Mn2+, closely followed by Mg2+ and Zn2+ with Ca2+ (Table 6.3).  
 
 
0
20
40
60
80
100
120
3.5 4.5 5.5 6.5 7.5 8.5
%
 R
el
at
iv
e A
ct
iv
ity
pH
pH 5.0
pH 6.0
pH 7.4
Chapter 6 
182 
 
Table 6.3: The effect of various divalent cations on the enzymatic activity of Anisakis 
LAP. 
Metal ions Concentrations (mM) Activity (%) 
Control (no metal ion) 0 100 ±2.8 
MgCl2 1 127 ±8.5 
MnCl
2
 1 138 ±5 
ZnCl
2
 1 127 ±0.5 
FeCl
2
 1 105 ±2.83 
CaCl
2
 1 124 ±5.7 
The data was repeated in duplicate and reflected the mean relative activity ± SD (n = 2). 
6.3.7.3 Effect of Inhibitors on Anisakis LAP. 
The effects of different protease inhibitors or metal chelators on the activity of each Anisakis LAP were 
assayed by preincubating each enzyme with each inhibitor or metal chelator as described previously. This 
was followed by measurement of residual enzyme activity on the substrate. Results were expressed as % 
of relative activity with respect to control, which did not contain any inhibitor or metal chelator, taken as 
100%. The inhibitor profile of Anisakis LAP is shown in Figure 6.10. The chelating agent 1-10-o-
phenantroline inhibited Anisakis LAP activity the most, followed by EDTA and then bestatin. E62, a 
cysteinase inhibitor, had no inhibitory effect on Anisakis LAP. In addition, hydrolytic activity of Anisakis 
LAP was significantly inhibited by bestatin with increased concentration (Figure 6.11). 
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Figure 6.10. The effect of inhibitors on the enzymatic activity of Anisakis LAP at a concentration 
of 1mM.  
 
The assays were performed in duplicate s and the mean and standard deviation (SD) was calculated. 
 
 
 
Figure 6.11. Effect of Different Concentration of Bestatin on the Enzymatic Activity of 
Anisakis LAP. 
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6.3.8 Localization of Leucine Aminopeptidase of A. pegreffii by Histochemistry. 
Using a chromogenic substrate, leucine amidolytic activity was predominantly detected by histochemistry 
at the cells of the lumen of Anisakis with reactivity distributed throughout the cells lining the gut 
epithelium. The pink to magenta (purple) colour obtained due to reaction of β-naphtylamine and Fast 
Blue B salt in the presence of Cu 2+ ions was considered as the positive (Figure 6.12).  
 
Figure 6.12. : LAP Localisationin Anisakis pegreffii L3 larvae tissues. 
 
Stereomicroscope images of histochemically stained Anisakis  L3 larvae tissues (10uM) for LAP 
Localisation. (Magnification ×40). 
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6.4 Discussion 
A number of reports have documented that the M17 family of metalloproteinase contains two metal 
binding sites having different affinity for metal ions (Kim and Lipscomb, 1993). Each binding site 
contains a Zn2+ ion for enzyme activity. Substitution of Mg2+ or Mn2+ at the first binding site occurs 
readily and activates LAP, whereas the second binding site binds Zn2+ much more strongly and 
substitution occurs slower than at the first binding site. In Anisakis LAP, we observed that the enzyme 
activity of LAP was increased by Mn2+, Mg2+ and Zn2+ in this order, supporting previous reports that 
divalent cations are essential for metallopeptidase activity and that the activity of M17 LAPs is enhanced 
by their addition (Acosta et al., 2008). 
Bestatin is an inhibitor that slowly attains equilibrium with the enzyme to form a tightly bound complex 
(Segel, 1975). The reaction progress curves observed for the hydrolysis of the substrate in this study in 
the presence of bestatin inhibitor shows a slow binding inhibition mechanism. The high inhibition profile 
shown by other compounds, apart from E64, can be explained by the faster chelating effect of these 
compounds.  
Acosta and colleagues (Acosta et al., 2008) reported that  LAP activity was consistently very low in 
cathepsin L-rich ES products and this could be as a result of degradation of LAP by cathepsin Ls. 
Interestingly, the result of this study showed interaction between Anisakis LAP and proFhCatL5, in which 
proCathepsin L5 (37kDa) was processed by Anisakis LAP. A most probable thought with regards to 
Acosta et al’s observation is that LAP is being used up as it processes inactivated CatLs, particularly 
CatL5. Further  investigation on the interaction of LAP and CatL5 to confirm this, needs to be carried out. 
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Anisakis LAP was observed to be situated close to the lumen where proteolytic events degrading host 
proteins takes place. It is predominantly distributed in cells lining the gut epithelium, in which the 
digestion of host protein occurs; this localization is similar to that of Schistosoma mansonii LAP 
(SmLAP) (McCarthy et al., 2004) and Paragonimus westermanii LAP (PwLAP) (Song et al., 2008), 
suggesting that Anisakis LAP is involved in process of protein digestion in the L3 larvae.  
The activity of Anisakis LAP in this study implies this enzyme may have multiple functions in Anisakis. 
The enzyme’s interaction with  proFhCatL5 at pH of 4.5, as well as its location in Anisakis gut lumen, 
suggests this. Furthermore, its enhanced activity at optimal pH of 7.4 suggests intracellular functions for 
Anisakis LAP. To further buttress this, LAP was among the proteases found in A. pegreffii exosomes in 
this study. The exosomes of a number of parasites have been reported to have among their protein 
contents a high number of proteases (Marcilla et al., 2012, Silverman et al., 2010). A. pegreffii LAP 
enzyme was identified in both the crude and excretory/secretory product. This overlap in LAP being 
found in the secretome and also in the exosome vesicle is an indication that the vesicles might be a 
mechanism by which LAP is released to sites of activity in the host by the parasite and may imply 
intracellular involvement in Anisakis spp.  
In addition, through the phylogenetic analysis, it was observed that LAP-1 of both A. simplex and A. 
pegreffii were evolutionary closer to human LAP than to LAP-2 of Anisakis, or other helminths and 
shellfish LAP proteins. This suggests that LAP-1 of Anisakis may be involved in immunomodulation as it 
is a homolog of human LAP. It may be able to mimick human LAP and dampen immune responses. 
Anisakis LAP’s association with exosomes enhances Anisakis’s LAP to modulate immune response. This 
is because such molecules carried by exosomes can be taken up by recipient cells at sites distal to their 
release and they can tap into the regulatory networks in host cells if the proteins are homologs of host 
cells (Thery et al., 2002). 
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In conclusion, studies on LAP in other parasites has highlighted it as a vaccine antigen candidate. The 
result of this study highlights  Anisakis LAP as a protein of interest in immunomodulatory activities. 
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General Discussion 
Existing as a complex of cryptic species with similar morphology but different genetic traits, are the 
morphospecies A. simplex sensu lato (s.l.), which consists of three sibling species, namely A. simplex 
sensu stricto (s.s), A. pegreffii and A. simplex C. They differ in their ecological traits, such as host 
preference and geographical distribution as well as in their genetic structure (Mattiucci et al., 1997). 
Among these species of Anisakis, A. simplex (s.s.) and A. pegreffii are known as the zoonotic species 
responsible for human anisakiasis and allergic sensitisation (Mattiucci et al., 2011, Mattiucci et al., 2013, 
Umehara et al., 2007, Fumarola et al., 2009, D'Amelio et al., 1999, De Luca et al., 2013).   
Various studies on the distribution of Anisakis spp. in fishes and cephalopods of the Mediterranean Sea 
have shown A. pegreffii as the Anisakidae parasite more widely distributed in the Mediterranean while A. 
simplex s.s. have a wider distribution in the Atlantic Ocean (Cavallero et al., 2012, Cipriani et al., 2015, 
Mattiucci and Nascetti, 2008). However, migratory events of different host organisms and other 
accidental events also enable the presence of A. simplex s.s. in the Mediterranean and vice versa for A. 
pegreffii. 
Over the last 20 -years, there has been an increase in reported cases of human anisakiasis throughout the 
world and in particular, reports of A. pegreffii implicated in human anisakiasis. This is probably 
attributable to: (i) the application of better diagnostic techniques (Mattiucci et al., 2011, Mattiucci et al., 
2013, Umehara et al., 2007, Fumarola et al., 2009, D'Amelio et al., 1999)  (ii) the increasing global 
demand for seafood; and (Grandea et al.) a growing preference for raw or lightly cooked food with the 
corresponding  increased risk of exposure to live parasites (European Food Safety Authority, 2010).   
Indeed, A. pegreffii thus far has been reported as the aetiological agent of invasive anisakiasis in Europe 
(Croatia, Italy (Umehara et al., 2007, Fumarola et al., 2009, D'Amelio et al., 1999, Mattiucci et al., 2011, 
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Mattiucci et al., 2013), Japan (Umehara et al., 2007, Arai et al., 2014) and South Korea (Lim et al., 2015). 
It has been demonstrated with molecular markers that A. pegreffii is able to cause gastric, gastro allergic 
and intestinal anisakiasis (Umehara et al., 2007, Mattiucci et al., 2013, Lim et al., 2015, Fumarola et al., 
2009, D'Amelio et al., 1999, Arai et al., 2014, Mladineo et al., 2016, Mattiucci et al., 2011). Furthermore, 
the Anisakis species mostly identified in Australia is Anisakis pegreffii (Shamsi et al., 2011, Jabbar et al., 
2012, Asnoussi et al., 2017). However, no detailed information is available regarding the secretome of A. 
pegreffii. Contents of secretomes are usually implicated in parasite survival, infection, invasion and 
immune evasion in the host as reported for other helminth parasites (Maizels and Yazdanbakhsh, 2003, 
Cass et al., 2007, Zhu et al., 2016, Ferguson et al., 2015). 
A central objective of the experimental work performed in this thesis was to look, in depth, at the protein 
repertoire of A. pegreffii through proteomic analysis of both the crude extract as well as the secretome. 
Comparative analysis of the content of these two extracts from A. pegreffii as well as with the protein 
content of A. simplex identified from previous proteomic analysis of A. simplex proteins (Arcos et al., 
2014, Faeste et al., 2014) was the focus of Chapter 3 of this thesis. The results in Chapter 3 of this study 
highlight the proteins identified in the proteome of A. pegreffii and their sources (either crude extract or 
excretory/secretory product). It also demonstrated the bias of most of the protein in ES for 
immunomodulatory activities. Over 95% of proteins identified in previously reported proteomic studies 
of A. simplex were also found present in the proteomic analysis of A. pegreffii CE and ES in this study. 
This affirms the cryptic relationship between these 2 sibling species. The result of this chapter provided 
the first in-depth characterization of the ES products from the third larval stage of Anisakis pegreffii, 
comparing the excretory/secretory molecule content with the crude extract. This is a crucial step in 
enhancing our knowledge and understanding of the biology of this parasite and its interactions with its 
vertebrate hosts.  
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Recently reported microscopy studies have shown evidence of extracellular vesicles in helminths such as 
Fasciola hepatica and Echinostoma caproni (Marcilla et al., 2012), Schistosoma japonicum (Zhu et al., 
2016) and Schistosoma mansoni (Sotillo et al., 2016). These vesicles were found to be actively released 
by the parasites and were found to be captured by the host cells playing a critical role in dissemination of 
parasite proteins in hosts, informing host-parasite interactions (Zhu et al., 2016). Chapter 4 of this thesis 
demonstrates that A. pegreffii secretes specific sets of proteins that are preserved against degradation by 
being enclosed within vesicles. This result constitutes the first report of the existence and composition of 
exosome-like vesicles in the L3 larvae of the marine parasite, A. pegreffii. The identified structures appear 
to play critical roles in transportation of metabolic, immunomodulatory and allergenic proteins.  These 
proteins are stabilized against degradation by encapsulation within vesicles. The result of this work has 
contributed to the increase in the knowledge of mechanisms employed by this parasite to release 
leaderless secreted molecules to sites of activity via non-classical pathways.  
Anisakis simplex third stage larvae (L3) have been described as a source of hidden allergens in fish 
(Fernandez-Caldas et al., 1998). Hypersensitivity to allergens of this nematode is found to be common in 
subjects who have anaphylaxis, urticaria/angioedema, or both after consumption of fish and who show 
negative skin test responses to fish proteins (Audicana et al., 1995, Kasuya et al., 1990). Antigenic cross-
reactivity has been described between A. simplex and Ascaris lumbricoides, Ascaris suum, Toxocara 
canis, Blattella germanica, Chironomus spp, Dermatophagoides pteronyssinus, Acarus siro and wasp 
venom (Kennedy et al., 1988, Pascual et al., 1997, Johansson et al., 2001, Bernardini et al., 2005, 
Rodriguez-Perez et al., 2014).  The results of Chapter 5 of this thesis extend the cross-reactivity study in 
Anisakis to A. pegreffii. A comprehensive IgE-cross reactive allergen binding analysis was performed 
with A. pegreffii whole parasite extract, as well as the excretory/secretory products, against the sera of 
confirmed shellfish allergic patients using an immunoproteomic approach. Tropomyosin was identified in 
the whole parasite extract in addition to two other cross-reactive allergens (enolase and fructose 
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bisphosphate aldolase) found in both whole parasite extract and the ES. More than 50% of shellfish 
allergic patients demonstrated reactivity to these 3 allergens in A. pegreffii. The recombinant protein of 
tropomyosin of A. pegreffii was recently confirmed as having cross-reactivity with shellfish allergic 
confirmed patients’ sera by our group (Asnoussi et al., 2017). Hence, in this study, we have identified 2 
new different reactive bands in addition to tropomysin, which are putative novel cross-reactive allergens 
described in A. pegreffii. These two novel putative cross-reactive allergens are proteins with close 
homologues in fish. The implications of these findings could be far reaching, as unexpected exposure to 
these cross-reactive allergenic proteins could trigger allergic reactions when shellfish-sensitised 
individuals ingest fish contaminated with Anisakis allergens. This result furnishes an important 
contribution towards the development of improved and sensitive allergy diagnostic platforms. 
Helminth parasites secrete proteases to gain entry into their hosts, and to feed on and migrate through 
tissues (Donnelly et al., 2006). A group of peptidases with roles in host tissue penetration and digestion 
encoded by transcripts were differentially expressed in both A. simplex and A. pegreffii as shown in a 
recent study (Cavallero et al., 2018). In that study it was noted that transcripts encoding 
metalloproteinases (i.e. aminopeptidases, astacins and neprilysins) were particularly abundant in A. 
simplex. A number of proteases secreted by Anisakinae have been previously investigated (Ni et al., 
2012). Little data exists on the peptidases found in the proteome of A. pegreffii. In Chapter 6 of this 
thesis, limited information on extracellular proteases from the Anisakis proteome was expanded by the 
proteomic analysis of A. pegreffii whole worm extract and excretory/secretory products. A family of M17 
aminopeptidase designated as leucine aminopeptidase (LAP) identified in the proteome of A. pegreffii 
when searched against the genome of A. simplex was identified. This was before the transcriptome data of 
A. pegreffii was released to the public. The 33kDa recombinant protein had a 87% identity to A. pegreffii  
LAP-2 which was identified later in this study by a search of the A. pegreffii proteome against the A. 
pegreffii transcriptome database.  This LAP recombinant protein of Anisakis simplex showed many 
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properties in common with other parasite LAPs, which have been extensively studied (Xu and Dresden, 
1986, Pokharel et al., 2006, McCarthy et al., 2004, Deng et al., 2012, Acosta et al., 2008). These include 
substrate specificity, pH optimum and activation by Mn2+ and Mg2+. As a result of this similarity, we 
were interested in determining whether the recombinant protein would exhibit any activity on pro-
cathepsin L5 protein of Fasciola hepatica as it has been previously reported by Acosta and colleagues 
that LAP activity was consistently very low in cathepsin L-rich ES products (Acosta et al., 2008).   
The result of this experiment was interesting as Anisakis LAP was found to process inactivated CL5. In 
addition, we further confirmed the abundant presence of LAP-2 in the gut lumen of L3 larvae of A. 
pegreffii by histochemistry. The results of this Chapter imply roles for LAP in Anisakis. These roles may 
be important for the parasite to activate its many proteases for invasion and digestion or may be used to 
release a modulated active form of mammalian cathepsin proteases to suppress the potency of the hosts’ 
immune response. Data emanating from this chapter has allowed the identification of one of the specific 
modulatory pathways targeted by this parasite. It also provides an interesting insight into studies 
involving homologs of this protein in other organisms and activity on cathepsin proteases, particularly 
those implicated in human inflammatory diseases. The results from such a study may initiate 
development of new therapeutic options in this direction. 
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Future Direction 
The results of this study has lead to much possible future work, however, the points below are considered important 
initial work that should be addressed: 
• Future work involving cloning and production of recombinant proteins of described putative 
cross-reactive allergens of A. pegreffii to confirm if they retained their cross-reactivity and for 
potential diagnosis of allergic sensitisation in patients. 
• In addition, investigating the effect of heat on the whole parasite extracts as well as the ES to 
ascertain their IgE-binding reactivity. 
• Future studies investigating comparative cross-reactive proteins of Anisakis to confirmed allergic 
sensitisation in children. This may provide insights into cross-reactive allergens in children as well 
as provide information on the development of a children-specific allergen panel. 
•  Future studies would also focus on the characterization of A. pegreffii-derived miRNAs and their 
functional analysis in host-parasite communication and gene regulation.  
• Future studies investigating further the interaction between Anisakis LAP or LAP homologs in 
other species and cathepsin proteases implicated in human inflammatory diseases in order to 
develop new therapeutic options. 
• Future studies on production of recombinant protein of Anisakis LAP-1 and investigation of 
immunomodulatory functions in this protein. 
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APPENDIX 1 
General Materials 
All reagents and chemicals used were analytical laboratory reagent grade. Solutions were prepared in 
deionised water obtained by filtration through a Millipore Milli-Q-water system (Liquipure, Melbourne, 
Australia) except where stated otherwise. Glasswares used, were initially washed with Pyroneg detergent 
(Diverey Pty Ltd, Melbourne, Australia), rinsed in tap water and subsequently in deionised water. All 
reagents, media, pipette tips, microcentrifuge tubes, dissecting instruments and glassware were sterilised 
by autoclaving at (121°C for 15 min) standard conditions, except stated otherwise. Unautoclaveable 
solutions that required sterilization were filter sterilized using 0.45μm or 0.22µM filter as specified for 
the reagent. Solutions were dispensed using Finnpipette (Pathtech, Australia). The pipettes were 
calibrated regularly following manufacturer’s recommendation. 
 
 
 
 
 
 
 
 
Appendix 1-General Materials 
223 
 
Reagents and Equipment used are herein detailed 
Reagents Suppliers 
λ-DNA stored at −20ºC. Promega, Australia. 
Acetic acid, glacial. Sigma-Aldrich Pty, Australia. 
Acetone.  Sigma-Aldrich Pty, Australia. 
Acrylamide/bisacrylamide 40% solution. Australia Scientific, Australia. 
Agarose (w/v) DNA grade. Bioline, Australia. 
Alkaline phosphatase (calf intestinal) . Sigma-Aldrich Pty, Australia. 
Alkaline phosphatase conjugates substrate kit. Biorad, Australia. 
Ammonium acetate. Ajax Chemicals Ltd, Australia. 
Ammonium chloride. BDH, Chemicals, Australia. 
Ammonium hydroxide (NH4OH). Sigma-Aldrich Pty, Australia. 
Ammonium persulphate (APS). Bio-Rad Laboratories, USA. 
Ammonium sulphate.  Sigma-Aldrich Pty, Ltd. MO, USA. 
Bacteriological agar.   Neogen, USA. 
Β-mercaptoethanol. Bio-Rad, Australia.  
Bovine serum albumin, fraction V (BSA). Sigma-Aldrich Pty, Australia. 
Bradford reagent. Sigma-Aldrich Pty, Australia. 
Bromophenol blue. Sigma-Aldrich Pty, Ltd, MO, USA. 
Brilliant Blue G. Sigma-Aldrich Pty, Ltd, MO, USA. 
Chelating Sepharose. GE Healthcare. 
Chemiluminescent Peroxidase Substrate-3. Sigma-Aldrich Pty, Ltd, MO, USA. 
Chloroform. Ajax Chemicals Ltd, Australia.  
Coomassie brilliant blue R-250 (w/v) . Bio-Rad Laboratories, USA. 
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Copper sulphate. Merck, Australia. 
Cover-slips. Mediglass, Australia. 
Cryovials (1.8ml). Naglene Company, USA. 
Dimethylsulphoxide (DMSO) . Merck, Australia. 
DNA Ligase (T4). New England Biolab, Australia. 
DNase I (bovine pancreas, grade 1). Boehringer Mannheim, Germany. 
EDTA. Merck, Australia. 
Ethanol (analytic). Merck, Australia. 
Ethidium bromide.                                                                               Sigma-Aldrich Pty, Ltd, MO, USA. 
Glacial acetic acid (v/v). BDH Chemicals, Australia. 
Glucose. Merck, Australia. 
Glycerol. Merck, Australia. 
Glycine. BDH Chemicals, Australia. 
Hydrochloric acid 32%. Ajax Chemicals Ltd., Australia. 
Imidazole. Sigma Aldrich. 
Immobilised Metal Affinity Chromatography 
Column (IMAC). 
Qiagen. 
Isopropyl- β-D-thiogalactopyranosider (IPTG). Bioline, Australia. 
Isoamyl alcohol.  BDH Chemicals, Australia. 
ISOLATE II Plasmid Mini Kit. Bioline, Australia. 
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Reagents Suppliers 
ISOLATE II PCR and Gel Kit. Bioline, Australia. 
ISOLATE II RNA Mini Kit . Bioline, Australia. 
Isopropanol.   Merck, Australia. 
Kanamycin. CSL, Australia. 
Lambda DNA. New England Biolab, Australia. 
Lysozyme. Boehringer Mannheim, Germany. 
Magnesium chloride (Hexahydrate).  BDH Chemicals, Australia. 
Methanol. BDH Chemicals, Australia. 
Microscope slides. LOMB Scientific Co., Australia. 
Microtitre plate (96, 48, 24, 12-wells). Nunc denmark 
Needle sterile (18G, 19G, 21G, 26G). Terumo Pty, Ltd, Australia. 
Newborn calf Serum (NCS). Thermofischer, Australia. 
Nickel Sulphate. BDH Chemicals, Australia. 
Nitrocellulose membrane (Hybond-C). Amersham, USA. 
Paraffin. BDH Chemicals, Australia. 
Petri dish. Nunc, Denmark. 
Phenol. BDH Chemicals, Australia. 
Phenylmethylsulfonyl fluoride (PMSF). Sigma chemicals, Co., Australia. 
Phosphate buffer saline (PBS) tablets. Oxoid limited, England. 
Potassium chloride. BDH Chemicals, Australia. 
Pre-stained Protein Molecular Weight Marker. Bio-Rad Laboratories, USA. 
Protein standards (SDS gel marker). Bio-Rad Laboratories, USA. 
Proteinase K. Promega, Australia. 
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Restriction enzymes. Promega, Australia. 
RNase. Boehringer Mannheim, Germany. 
Roswell Park Memorial Institute (RPMI) 1640 
Medium with 10 mM L-glutamine. 
Thermofischer, Australia (Gibco). 
Skim milk. Bonlac Foods Limited, Australia. 
Sodium acetate (NaOAc). BDH Chemicals, Australia.  
Sodium chloride NaCl (w/v). BDH Chemicals, Australia.  
Sodium citrate (dihydrate). BDH Chemicals, Australia.  
Sodium dihydrogen phosphate (NaH2PO4). BDH Chemicals, Australia.  
Sodium dodecyl sulphate (SDS). BDH Chemicals, Australia.  
Sodium hydroxide (NaOH). BDH Chemicals, Australia. 
TEMED  
(N,N, N’,N’-tetramethylethylenediamine).  
Bio-Rad Laboratories, USA. 
Tetro cDNA Synthesis Kit. Bioline, Australia. 
Tricine. BDH Chemicals, Australia 
Tris hydroxymethyl amino methane (Tris-) base. Boehringer Mannheim, Germany. 
Tris-HCL. Boehringer Mannheim, Germany. 
Triton-X-100. Sigma-Aldrich Pty, Ltd, MO, USA. 
Tryptone. Oxoid, UK. 
Tween-20. BDH Chemicals, Australia. 
Unstained Protein Molecular Weight Marker. Bio-Rad Laboratories, USA. 
Whatman blotting paper. Whatman, England 
Wizard® Genomic DNA Purification Kit. Promega, WI, USA. 
Yeast extracts. Oxoid, UK. 
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Equipment/Materials Supplier 
Camera (135 mm Polaroid MP4 Land Camera). Polaroid, USA. 
Cellulose Acetate Filter (0.65 μm). Sartorius GMBH, Germany. 
DNA Thermocycler (for PCR). G-Storm, England. 
GELDOC system. Bio-Rad Laboratories, USA. 
pH meter. Metrohm, Swiss. 
Sonicator. Branson Sonic Power Co., USA. 
Syringe (1 ml, 5 ml, 10 ml, 20 ml, 50 ml).  Terumo Pty, Ltd., Australia. 
Trans-blot electrophoretic transfer cell. Bio-Rad Laboratories, USA. 
Transilluminator (Novaline UV). Novex Australia Pty Ltd. 
Vortex mixer (V ml). Ratek Instruments, Australia. 
Balances: 
Analytical balance. Sartorius GMBH, Germany. 
Balance (0.1-500 g). U-Lab, Australia. 
Centrifuges:  
Microcentrifuge (EBA12). Zentrifugen, Germany. 
Bench top centrifuge (Centaur 2).  Graykon Scientific. 
High-speed centrifuge (L2-21 M/E). Beckman, USA. 
Ultra-speed centrifuge (L8-80M). Beckman, USA. 
Centrifuge tubes:  
1.5 ml Eppendorf centrifuge tubes. Sarstedt, Germany. 
10 ml centrifuge tubes. Labortechnik, Germany. 
15 ml centrifuge tubes. Labortechnik, Germany. 
50 ml centrifuge tubes. Labortechnik, Germany. 
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Electrophoresis Power Supply:  
PowerPac Basic. Bio-Rad Laboratories, USA. 
EPS 3000xi. Bio-Rad Laboratories, USA. 
Electrophoresis Units:  
DNA-Mini gel cast plate. Bio-rad Laboratories, USA. 
Protein -Mini Protean II gel system. Bio-rad Laboratories, USA. 
Filters: 
Syringe Filters (0.22μm, 0.45μm). Gelman Sciences, USA. 
Ultrafiltration-unit filters (XM, YM). Amicon, USA. 
Incubators: 
Bellsouth 100 still air incubator. Bellsouth, USA. 
Tissue culture (5 % CO2). Forma Scientific, USA. 
Microscopes:  
 Light microscope. Olympus Optical Co., Japan. 
Phase contrast microscope.  Nikon Kogaku KK, Japan. 
Stereomicrosocope. Olympus Optical Co., Japan. 
FEI Quanta 200 ESEM (ESEMTM) or the XL 30 
scanning Electron Microscope. 
Philips. 
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General Chemicals and Stock Solutions. 
  Agarose Gel Electrophoresis. 
(i). 0.5 M EDTA pH 8.0 (1L). 
 
186.1g of disodium EDTA (NA2 EDTA). 
800 ml Milli-Q water. 
Adjust pH of to 8 with NaOH. (~50ml of NaOH). 
Bring volume to 1 L with Milli-Q water.  
Stir vigorously on a magnetic stirrer and autoclave.  
Store at room temperature. 
 
(ii). 50X TAE Running Buffer 
242 g Tris base.  
100 ml 0.5M EDTA pH 8.  
57.1 ml Glacial acetic acid.  
900 ml Milli-Q water.  
Adjust pH to 8.5 with glacial acetic acid.  
Bring to final volume to 1 L with Milli-Q water.  
To prepare 1L of 1X TAE, measure 100 ml of 10X TAE and make it up to 1L with 900 ml Milli-Q water.  
(Grandea et al.). 1% agarose gel electrophoresis.  
 
 
 
1 g Agarose.  
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100 ml 1X TAE buffer.  
Melt in microwave for 2 min.  
Cast gel in gel trays and wait to set. 
 
(iv). 5X loading dye for agarose gels. 
50 ml 50% glycerol.  
10 ml 0.5 M EDTA pH 8.  
5 ml 1M Tris pH 7.5. 
Add 35 ml Milli-Q water to total 100 ml.  
 
 
Protein Methods. 
SDS-PAGE Stock Solutions. 
(i). 2M Tris-HCI (pH=8.8), 100ml.  
24.2gm Tris (hydroxymethy1) aminomethane. 
50ml Milli-Q water.  
Adjust pH of to 8.8 with HCL, and bring up the volume to 100 ml with Milli-Q water. 
 
(ii) 1M Tris-HCI (pH=6.8), 100ml. 
12.1gm Tris (hydroxymethy1) aminomethane.  
50ml Milli-Q water.  
Adjust pH of to 6.8 with HCL, and bring up the volume to 100 ml with Milli-Q water.  
 
(Grandea et al.). 10% SDS (W/V), 100 ml.  
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1g Sodium Dodeyl Sulfate (SDS).  
Milli-Q water to total volume of 100 ml. 
 
(iv). 50% Glycerol (v/v), 100 ml. 
50ml 100% Glycerol.  
50ml Milli-Q water.  
 
(v). 10X Gel Electrophoresis Running Buffer (2 Litter). 
60 g Tris base.  
288 g Glycine.  
20 g SDS.  
1.6 L Milli-Q water.  
Adjust pH of to 8.3 with HCL, and bring up the volume to 2 L with Milli-Q water. 
 
(vi). 1% Bromophenol Blue (w/v), 10ml. 
100 mg Bromophenol Blue.  
Milli-Q water to total volume of 10 ml.  
 
SDS-PAGE Working Solutions  
(i). 10 % Ammonium Presulphate, (10% APS).  
50μg Ammonium Presulphate.  
500μl Milli-Q water. 
 
(ii). 1X Gel Electrophoresis Running Buffer. 
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100 ml 10X Gel Electrophoresis Running Buffer.  
900 ml Milli-Q water. 
 
(Grandea et al.). 5X Sample Buffer. 
0.6 ml 1M Tris (pH 6.8).  
5 ml 50% Glycerol.  
2 ml 10% SDS.  
0.5 ml 2-mercaptoethanol.  
0.5 ml 1% Bromophenol Blue.  
0.9 ml Milli-Q water.  
 
SDS-PAGE Gel (1 gel). 
(i). 12% Resolving gel. 
3.13ml of 30% Acrylamide stock.  
1.88ml of 1.5M Tris-HCL pH 8.8.  
0.08ml of 10%SDS.  
2.38ml of MG water.  
37.5μl of 10% w/v APS.  
2.5μl of TEMED.  
 
(ii) 5% Stacking gel. 
0.33 ml of 30% Acrylamide stock.  
0.63 ml of 0.5 M Tris-HCL pH 6.8.  
0.03 ml of 10%SDS.  
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1.50 ml of MG water.  
12.5μl of 10% w/v APS.  
1.25μl of TEMED.  
 
Processing Gel after an SDS-PAGE run  
(i). Coomassie Staining Solution (1 gel). 
50 mg Coomassie Staining blue R220. 
10 ml 100% Methanol.  
5 ml 100% Acetic acid.  
35 ml Milli-Q water. 
 
(ii). Destaining Solution (1 L). 
500 ml Methanol.  
300 ml Milli-Q water.  
100 ml of Acetic acid.  
Adjust the total volume to 1000 ml with Milli-Q water.  
 
(Grandea et al.). Gel Storage Solution (5% Acetic acid).  
5 ml of Acetic acid.  
95 ml Milli-Q water.  
 
(iv). 10X PBS (Phosphate-Buffered Saline) Buffer (pH=7.4). 
80 g Sodium chloride.  
14.4g Sodium Phosphate dibasic (Na2HPO4). 
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2.4g Potassium dihydrogen phosphate (KH2PO4). 
2g Potassium chloride (KCL). 
Dissolve all together in 800 mL Milli-Q water, pH 7.4 adjusted with HCL. 
Bring volume to 1L with Milli-Q water; stored at RT.  
To prepare 1L of 1X PBS.  
Measure 100ml of 10X PBS and make it up to 1L with Milli-Q water (900ml).  
 
(v). 10X TBS (Tris-Buffered Saline) Buffer (pH=7.4).  
30g Tris base. 
 2g Potassium chloride (KCL). 
 80 g Sodium chloride.   
Dissolve all together in 800 mL Milli-Q water. 
Bring volume to 1L with Milli-Q water; store at RT.  
 To prepare 1L of 1X TBS.  
Measure 100ml of 10X TBS and make it up to 1L with Milli-Q water (900ml).  
 
(vi). PBS 0.5 Tween  
A 500μl Tween-20 was dissolved in 1LX PBS; stored at RT.  
 
(Nampijja et al.). TBS 0.5 Tween  
A 500μl Tween-20 was dissolved in 1LX TBS; stored at RT.  
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Processing Gel for Immunoblotting 
 
(i). Membrane blocking Buffer (5% skim milk or 5% BSA), 100 ml.  
5g skim milk or Bovine serum albumin. 
100 ml TBS 0.5 Tween.  
 
 (ii) Antibodies dilution buffer, 100 ml.  
1% skim milk/BSA TBS 0.5 Tween (1g skim milk/BSA + 100ml TBS 0.5 Tween) or  
1% skim milk/BSA PBS 0.5 Tween (1g skim milk/BSA + 100ml TBS 0.5 Tween).  
 
Cloning 
10 X Potassium phosphate Stock (Should be filter sterilized). 
170 mM KH2PO4 – 2.31g/100mL. 
720 mM K2HPO4 – 12.5 g/100mL. 
 
20% Glucose stock (Should be filter sterilized through 0.22 µm filter). 
10 g in 50mL of MilliQ Water. 
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Terrific broth buffer recipe table 
Lysis Buffer. 
0.1M Tris 0.5M Glycine Buffer (pH=8.7), 100ml. 
1.2114gm Tris (hydrooxymethy1) aminomethane.   
3.75gm Glycine.  
Dissolve all together in 80 mL Milli-Q water, adust pH to 7.4 with HCL. 
Bring volume to 100ml with Milli-Q water; store at RT. 
Ingredients Final 
concentration 
required 
Pre-induction 
TB media 
(200 mL) 
Recombinant 
expression TB 
media 
(200 mL) 
 
Tryptone 1.2% w/v 2.4 g 2.4 g  
Yeast extract 2.4% w/v 4.8 g 4.8 g  
Glycerol 0.4% v/v 800 µL 800 µL  
10X [KH2PO4 
(170mM) K2HPO4 
(720 mM)] 
17 mM 
72 mM 
20 mL 10 mL  
20% Glucose 2% w/v 20mL DON’T ADD  
MilliQ water Upto required 
volume 
Upto 200 mL Upto 200 mL  
IPTG 1M (238mg/mL) 1 mM DON’T ADD 200 uL  
pH adjusted to 7.2- 7.4     
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25mM Tris-HCL (pH8.0) 
 300mM NaCL 
 1mg/ml or 2mg/ml lysozyme (freshly prepared) 
 1mM or 2mM imidazole 
 Store at 4°C.  
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APPENDIX 2 
Molecular Markers 
  
 
 
Sigma  Aldrich–Colour burst Electrophoresis Marker
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Blue protein standard broad range marker (NEB)
Precision Plus Protein™ Kaleidoscope™ 
Prestained Protein Standards (Biorad)
Unstained Protein Standards (Biorad)
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Sequences of Lap-2 of A. simplex and A. pegreffii 
 
 
>tr|A0A0M3KDK6|A0A0M3KDK6_ANISI Putative aminopeptidase (inferred by orthology to 
a C. elegans protein) OS=Anisakis simplex OX=6269 PE=4 SV=1 
MIVVFSLLSAPLDLAKSLSEPTSDGVIVVSYCAKQLAECAPLKSLAPVVSEYLQLNAGAN 
NTASLIVVDKSVVPSGRLVYSGTGPVTRDQDDVRRFSTAARNAMKLALSAGMKSPILVTV 
PHQKYPQAELVAALGALHELHIPLNVREESEQKTKLSALALLPVSYEASKFLRLVQTIEA 
AFTVCRDIGDADPQRMSPPKVAEYVEEIFRGGCVKVRVTSDAKEIEREYPLMIAVNRASM 
GIEAHRPRLIALEYIPEGPIEETIMLVGKGNGRRPYCSSQLPNSSAGLHGQMAQLKNHYS 
RMKYLNYYL 
 
>A. pegreffii LAP-2 (CL3092.Contig1_AP1A) 
EESEQKTKLSALALLPVSYEASKFLRLVQTIEAAFTVCRDIGDADPQRMSPPKVAEYVEEIFR
GGCVKVHVTSDAKEIEREYPLMIAVNRASMGIEAHRPRLIALEYIPEGPIEETIMLVGKGVTL
DMGGADLKLHGAMYGMSSDKYGSAIVAGFFKALEVLRPKGIKVLGYMSMVRNALGADA
YTTDEVIKSRSGKRIQICNTDAEGRLIMLDPLTKMRELAVNEKNPHLFTLATLTGHVILSNG 
 
> Sequenced Leucine Aminopeptidase A. pegreffii Nucleotide sequence 3’ 5’  frame 3 A. 
pegreffii 
TGCGCGATAGTGACTCTTCAACTGAGCCATTTGGCCATGTAATCCAGCTGAACTGT
TTGGTAACTGAGAGGAACAATATGGCCTTCTACCATTACCTTTGCCTACTAGCATA
ATCGTTTCTTCGATTGGTCCTTCTGGAATGTATTCAAGAGCTATCAAACGAGGACG
ATGTGCTTCGATACCCATTGATGCACGATTCACTGCTATCATCAGCGGATACTCAC
GCTCTATTTCTTTTGCATCAGACGTGACACGAACTTTCACACAACCGCCTCGGAAT
ATCTCCTCAACGTATTCGGCCACTTTCGGCGGAGACATCCGTTGCGGATCCGCAT
CACCGATATCTCGACATACTGTGAAAGCAGCTTCGATCGTCTGAACGAGTCGCAG
AAATTTACTCGCTTCATACGAAACAGGTAGCAATGCAAGTGCTGAAAGTTTTGTTT
TCTGTTCACTTTCTTCGCGAACATTCAACGGTATATGTAGTTCGTGAAGTGCACCA
AGCGCAGCCACCAGCTCGGCTTGTGGGTATTTCTGGTGTGGTACTGTGACCAATA
TTGGTGACTTCATGCCCGCACTCAACGCCAATTTCATCGCGTTACGGGCTGCAGTC
GAGAATCTTCGCACGTCATCTTGATCGCGAGTCACGGGTCCAGTTCCCGAGTAAA
CCAAACGACCTGACGGTACCACTGACTTGTCAACTACGATCAACGATGCGGTATT
GTTCGCTCCAGCATTCAACTGAAGATATTCAGAGACAACGGGAGCGAGTGATTTC
AGTGGAGCACATTCTGCGAGTTGCTTGGCACAGTACGAAACAACAATGACTCCGT
CTGATGTAGGCTCTGATAACGATTTGGCCAAATCCAAAGGTGCTGAGAGAAGGCT
GAAAACAACATCTNAAATTGTTTCAGGACAAA 
>Leucine Aminopeptidase A. pegreffii Protein sequence 
 M K L A L S A G M K S P I L V T V P H Q K Y P Q A E L V A A LG A L H E L H I P L N 
V R E E S E Q K T K L S A L A L L P V S Y E A S K F L R L V Q T I E A A F T V C R D I 
G D A D P Q R M S P P KV A E Y V E E I F R G G C V K V R V T S D A K E I E R E Y P 
L M I A V N R A S M G I E A H R P R L I A L E Y I P E G P I E E T I M L V G K G N G R 
R P Y C S S Q L P N S S A G L H G Q Met A Q L K S H Y R A 
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Anisakis spp Leucine Aminopeptidase Sequence Electrophoregram 
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Supplementary Tables 
Table S1. Peptide sequences and Mascot score of IgE antibody reactive proteins identified in 
Excretory/Secretory product of A. pegreffii. 
# Predicted 
protein 
Mass 
(kDa) 
Protein 
accession 
Protein name Mascot 
score 
Peptide sequences 
1 38307 
 
Unigene8452_
AP1A 
 
Fructose-
bisphosphate 
aldolase 1 
450 ALQASALAAWGGKK 
AQANSLAAQGK 
ATVTCLQR 
AAFMKR 
GIIPGIK 
KGIIPGIK 
VSHEDIAR 
IAHAIVAPGK 
QILFTSSDEASK 
RAQANSLAAQGK 
ITEAVLAYTYK 
KIAHAIVAPGK 
GILAADESTGSMDKK 
KLKPIGLENVEENRR 
LKPIGLENVEENRR 
TDDGTPFVQVLQKK 
 
2 47148 Unigene2939_
AP1A 
 
Enolase 1127 GMPLYK 
IAPAIVAK 
YDLDFK 
YNQLLR 
IQMAIDK 
AVANINDK 
NFTEAMR 
KYDLDFK 
IQMAIDKK 
YIAELAGVK 
ACDCLLLK 
ERIQMAIDK 
LAKYNQLLR 
KACDCLLLK 
ANGWGVMVSHR 
MGSEIYHHLK 
ERIQMAIDKK 
AGAVHKGMPLYK 
ADEKKYDLDFK 
GNPTVEVDLTTEK 
YDLDFKNPNSDK 
VNQIGSVTESIEAAK 
VSIAMDTAASEFYK 
IEEELGSAAVYAGEK 
LAMQEFMIMPIGAK 
KYDLDFKNPNSDK 
LAMQEFMIMPIGAK 
AVANINDKIAPAIVAK 
EIDQFMLDMDGTANK 
VSIAMDTAASEFYKADEK 
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QVVMPVPSFNVINGGSHAGK 
 
 
Table S2. Peptide sequences and Mascot score of IgE antibody reactive proteins identified in Crude Extract of 
A. pegreffii. 
# Predicte
d protein 
Mass 
(kDa) 
Protein 
accession 
Protein name Mascot 
score 
Peptide sequences 
1 32137 
 
Unigene11859_
AP1A 
Tropomyosin 800 ALQREDSYEEQIR 
ANTVESQLK 
AQEDLSTANSNLEEKEK 
DLADGKAK 
DNALDRADAAEEKVR 
EAQMLAEEADRK 
EAQMLAEEADRKYDEVAR 
EDSYEEQIR 
EVDRLEESKDLADGK 
IEEELRDTQKK 
IEKDNALDRADAAEEK 
IVELEEELR 
KLAMVEADLERAEER 
KVQEAEAEVAALNRR 
KYDEVAR 
LAMVEADLERAEER 
LATDKLEEATHTADESERVR 
LEEATHTADESER 
LERIEEELR 
MMQTENDLDK 
MTLLEEELER 
QMTDKLER 
SFQDEERANTVESQLK 
SLEVSEEK 
SVQKLQK 
VQEAEAEVAALNRR 
VRQMTDKLER 
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2 47148 Unigene2939_A
P1A 
 
Enolase 1011 GMPLYK 
IAPAIVAK 
YDLDFK 
YNQLLR 
IQMAIDK 
AVANINDK 
NFTEAMR 
KYDLDFK 
IQMAIDKK 
YIAELAGVK 
ACDCLLLK 
LAKYNQLLR 
KACDCLLLK 
MGSEIYHHLK 
ADEKKYDLDFK 
GNPTVEVDLTTEK 
YDLDFKNPNSDK 
DGDKAVNHGKSVLK 
VNQIGSVTESIEAAK 
IEEELGSAAVYAGEK 
KYDLDFKNPNSDK 
AVANINDKIAPAIVAK 
LAMQEFMIMPIGAK 
VSIAMDTAASEFYK 
ERIQMAIDKK 
ANGWGVMVSHR 
AGAVHKGMPLYK 
EIDQFMLDMDGTANK 
EGLDLLNTAIALAGYTGK 
 
